setName	@SYSTEMATIC_NAME	@HISTORICAL_NAMES	@PMID	@AUTHORS	@GEOID	@EXACT_SOURCE	@GENESET_LISTING_URL	@EXTERNAL_DETAILS_URL	@CHIP	@CONTRIBUTOR	@CONTRIBUTOR_ORG	@DESCRIPTION_BRIEF	@DESCRIPTION_FULL	@TAGS	@FOUNDER_NAMES	@REFINEMENT_DATASETS	@VALIDATION_DATASETS	genes
EGFR_UP.V1_DN	M2633		16585219	Ma Y,Croxton R,Moorer RL Jr,Cress WD	GSE3542	EGFR vs contol; bottom 200 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in MCF-7 cells (breast cancer) positive for ESR1 [Gene ID=2099] and engineered to express ligand-activatable EGFR [Gene ID=1956].	Profiling of MCF-7 cell lines stably overexpressing ligand-activatable EGFR as models of overexpressed growth factor signaling, as well as control vector transfected cells (coMCF-7) and control vector transfected cells long-term adapted for estrogen-independent growth (coMCF-7/lt-E2).					4886	5174	2674	9687	4477	10395	4602	11254	10561	10964	2852	3667	1535	51454	1960	9130	4192	596	8357	3429	8334	2581	8839	2537	80303	8345	51309	5567	8344	3398	22996	10950	116039	120	6947	3800	8339	10388	51427	57535	8343	79068	794	1948	7594	6711	11201	7504	8365	1952	54894	6443	429	51449	8204	22876	22836	60481	11000	55827	4277	57396	3006	23089	51514	323	9665	6744	4147	56947	8346	25913	58155	55008	89927	1968	55635	288	7456	55601	9747	8969	6505	51071	1475	79170	6445	22824	27250	3480	55120	58495	4092	83990	2969	622	1299	2001	6658	857	54145	4698	2146	178	64699	1512	10280	684	3375	80210	79733	8805	1123	9315	624	55714	54898	51375	5241	3017	10874	84869	65982	23705	54892	57007	3832	3983	3993	5723	23312	839	3012	54664	23165	2887	22875	55034	9935	55602	84909	29919	55706	863	79868	1831	8777	799	399664	1363	8416	403	10098	56521	55094	55251	79682	80758	10125	56603	889	10793	27295	24148	23683	29994	10276	7290	55159	56904	4052	5954	6883	26046	2059	23678	23314	79718	57613	80230	8269	64116	3397	79184	51230	10124	90806	54913	4832	50865	6491	2037	55729	11001	56339	23015
EGFR_UP.V1_UP	M2634		16585219	Ma Y,Croxton R,Moorer RL Jr,Cress WD	GSE3542	EGFR vs contol; top 200 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in MCF-7 cells (breast cancer) positive for ESR1 [Gene ID=2099] and engineered to express ligand-activatable EGFR [Gene ID=1956].	Profiling of MCF-7 cell lines stably overexpressing ligand-activatable EGFR as models of overexpressed growth factor signaling, as well as control vector transfected cells (coMCF-7) and control vector transfected cells long-term adapted for estrogen-independent growth (coMCF-7/lt-E2).					2266	2633	4982	2244	2697	1848	6280	133	3694	1846	2650	2	444	1545	8418	25816	55790	57214	10161	2745	2034	4312	10761	27289	4680	3624	10644	65983	5791	27242	2150	3659	1052	10205	2114	22936	112399	6279	1956	1827	3976	4017	6310	2131	55332	1525	9076	5325	51083	65124	11320	5101	824	3491	6386	3620	7851	84981	2119	10451	6347	4217	2004	81537	1594	5142	840	30001	23528	23657	64759	6578	10979	1847	3887	23406	7035	1839	64089	3669	6674	4128	23034	29109	23231	6890	25897	3566	5698	55062	7474	8714	9590	2730	8835	80323	10150	3895	3995	6367	5238	9497	3855	3437	7280	64778	3554	11138	3790	3099	2634	602	83716	1906	58472	23433	7042	151011	10484	25825	6303	9568	9582	84223	56892	3601	6648	9060	27161	51129	655	5699	5031	4213	55604	467	2710	72	7804	211	10479	116984	2713	5873	2261	55076	56935	9015	3306	4319	7138	6004	22822	3383	316	51097	9456	22978	5366	868	9314	9766	6416	84159	5167	3673	6558	26286	4791	3726	93664	80757	55861	9517	6197	6286	6617	23474	3612	4026	5277	10184	23175	11343	3675	9915	8727	1490	3097	9260	1290	4783	259230
ERB2_UP.V1_DN	M2635		16585219	Ma Y,Croxton R,Moorer RL Jr,Cress WD	GSE3542	c-erbB-2 vs control; bottom 200 genes			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in MCF-7 cells (breast cancer) positive for ESR1 [Gene ID=2099] and engineered to express ligand-activatable ERBB2 [Gene ID=2064].	Profiling of MCF-7 cell lines stably overexpressing constitutively active c-erbB-2 as well as control vector transfected cells (coMCF-7) and control vector transfected cells long-term adapted for estrogen-independent growth (coMCF-7/lt-E2).					4886	5174	306	9687	26353	10395	8204	2274	1960	10561	11254	11031	10964	3429	3434	23586	4477	9411	9022	4609	1836	5366	64135	51454	7980	2674	22836	2852	8754	4603	596	55601	8839	4071	51133	55008	3480	51427	4256	6744	22876	857	3667	1105	3717	6947	79441	178	7594	466	1968	22824	445	23255	4147	11201	23189	64431	79657	4602	58155	79982	794	9694	4897	347902	10308	24138	26046	8491	51001	55183	6741	7290	55197	23160	55327	7272	51309	51444	1070	4092	29919	11103	51514	3983	89927	7504	9926	10196	55081	54877	10950	55035	5577	120	29889	1062	7074	80155	79868	65986	7637	54014	26271	9263	5723	10150	6760	64151	4085	839	5932	1894	6782	2348	7071	84869	64318	6542	429	23253	8777	4939	79101	11073	25788	8634	5205	2803	56603	80324	54955	3912	50999	23089	4938	3398	10600	54981	84909	9801	1299	80010	253959	4528	23015	112479	55236	9126	26018	79675	51012	6873	27107	29902	9520	26953	3800	54700	55635	9653	6491	684	2218	10125	10153	8467	23301	64860	10733	80264	7456	51018	4436	9440	8065	5965	22996	9847	81579	545	60496	29080	2537	23379	1371	55003	10635	55006	2317	79624	64844	10926	3665	3375	51030
ERB2_UP.V1_UP	M2636		16585219	Ma Y,Croxton R,Moorer RL Jr,Cress WD	GSE3542	c-erbB-2 vs control; top 200 genes			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in MCF-7 cells (breast cancer) positive for ESR1 [Gene ID=2099] and engineered to express ligand-activatable ERBB2 [Gene ID=2064].	Profiling of MCF-7 cell lines stably overexpressing constitutively active c-erbB-2 as well as control vector transfected cells (coMCF-7) and control vector transfected cells long-term adapted for estrogen-independent growth (coMCF-7/lt-E2).					1543	1048	116496	4982	1846	1545	7379	1601	4680	57214	55790	6277	51170	2034	112399	3554	81031	3887	81537	79679	2258	50617	1848	8659	3855	7852	602	9568	94009	3783	79695	253190	57016	2982	5791	2026	93664	6767	5142	9244	3576	5763	58473	5100	80761	27010	10610	444	3694	4128	25825	10577	27242	2119	230	51097	6676	4059	3338	5097	7903	6662	8564	79789	6712	55619	11045	3913	6558	8705	23180	6286	9415	168544	25849	55690	375056	7138	2330	4582	2983	9915	11320	10957	2052	22998	51129	9060	3691	7433	23530	23596	3306	113178	309	64856	8974	5265	5878	7423	4488	10076	151011	726	1906	8612	53635	54855	8714	43	767	9619	55861	2264	10205	23508	11138	58528	55062	1525	7851	65983	55885	10479	55332	5507	79762	56904	22891	8611	80307	9518	4041	51337	5144	831	4642	57876	333	2593	4016	6919	1646	7390	56475	400451	55450	8760	4833	10103	6533	439921	50515	9582	83464	8729	6386	9351	29763	5631	10397	23462	658	1475	79153	64764	57037	6303	4597	5734	2771	4854	665	79006	6310	4351	360	64097	3778	54858	824	80328	3217	9337	27344	604	22924	9764	542767	7408	25979
RAPA_EARLY_UP.V1_DN	M2643		12101249	Peng T,Golub TR,Sabatini DM		Rapa60 and Rapa120 vs ET60 and ET120; top 200 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in BJAB (lymphoma) cells by rapamycin (sirolimus) [PubChem = 6610346].						2875	3872	5688	1844	9389	2588	8729	8613	7226	6794	653361	3594	391518	4584	2050	23546	1297	148066	9919	78992	9855	25855	8898	8535	23225	10367	10466	4281	859	558	27113	5937	4340	2299	23130	4258	1397	1400	23201	4926	1801	2779	2896	80301	1549	6869	8175	3972	1408	23030	4093	10120	6621	5348	26098	2022	2159	80271	7025	10346	2835	4130	63923	27124	1300	6874	6307	9368	64405	4920	3959	3486	7054	3429	6699	1572	2323	57060	1120	10211	2675	11097	2752	219	5719	2560	2911	5539	8228	23498	5017	393	2797	23109	84179	10773	7466	7728	9796	4779	6640	5869	6404	5549	7551	2015	587	26001	2011	65125	4000	1010	11007	4224	3141	10024	9546	9997	728882	8370	81553	95	2101	6641	5076	1978	10226	2912	253943	26135	4807	8639	5742	785	8484	60682	130	10295	4613	4050	9885	26018	3784	23038	10518	23401	23761	5581	5126	50488	3303	23451	51172	10876	7106	23129	6663	22837	26707	2981	23397	9984	3590	2902	65018	9682	1298	43	8897	10158	5555	25841	7020	11072	4233	8623	81544	3814	51652	79068	5727	1828	90576	10013	3133	7515	6654	3851	11113	5662	22866
RAPA_EARLY_UP.V1_UP	M2644		12101249	Peng T,Golub TR,Sabatini DM		Rapa60 and Rapa120 vs ET60 and ET120; bottom 200 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in BJAB (lymphoma) cells by rapamycin (sirolimus) [PubChem = 6610346].						554	84720	375057	23386	2905	1946	2103	440193	148022	2263	5739	246	4353	5027	9677	7047	10435	7077	6011	1002	284439	2302	3749	2356	1509	54434	26959	745	388685	6953	8573	4146	8558	2561	8916	22926	2622	81875	192134	5255	3861	5729	6988	6327	6750	8844	1050	154796	2063	55547	3236	7448	25849	51066	290	3860	3880	444	3145	3665	26093	6585	5753	5626	6624	775	9674	7090	2762	11326	8648	165	5322	976	29114	23245	374378	53358	283212	55567	10905	23641	3630	9914	9355	5153	100287723	7940	5653	286	50937	3096	11346	2925	5003	6421	1814	55823	26038	2765	747	2173	576	6623	6833	8646	55970	4852	23468	23562	1290	5138	257407	2853	169611	147	25859	4297	3128	26330	9130	10409	22874	9087	758	9687	26257	3682	1291	26958	26151	126393	5582	11318	2779	9776	29851	8651	1066	439921	1579	438	1749	8395	5789	7127	3706	8314	8654	5553	8509	5746	10475	23155	4814	55752	3678	4924	23401	2280	2116	5188	4901	8722	8326	5141	1488	1195	124222	3897	8310	51046	7425	5530	22899	5883	3248	8287	3062	222161	1584	55811	901
HINATA_NFKB_IMMU_INF	M2645		12673201	Hinata K,Gervin AM,Jennifer Zhang Y,Khavari PA		Table 1: Immune/Inflammation			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Immune or inflammatory genes induced by NF-kappaB in primary keratinocytes and fibroblasts.	NF-kappa B regulates normal and pathological processes, including neoplasia, in a tissue-context-dependent manner. In skin, NF-kappa B is implicated in epidermal homeostasis as well as in the pathogenesis of squamous cell carcinoma; however, its function in the underlying mesenchymal dermis has been unclear. To gain insight into NF-kappa B roles in these two adjacent cutaneous tissue compartments, NF-kappa B effects on expression of 12 435 genes were determined in epidermal keratinocytes and dermal fibroblasts. Although NF-kappa B induced proinflammatory and antiapoptotic genes in both settings, it exhibited divergent effects on growth regulatory genes. In keratinocytes, but not in fibroblasts, NF-kappa B induced p21(CIP1), which was sufficient to inhibit growth of both cell types. Levels of growth inhibitory factor (GIF), in contrast, were increased by NF-kappa B in both settings but inhibited growth only in keratinocytes. These findings indicate that transcription factors such as NF-kappa B can program tissue-selective effects via both differential target gene induction as well as by inducing common targets that exert differing effects depending on cellular lineage.					3383	7127	6347	5806	6364	5970	3576	3659	4973	6372	3569	2920	9308	2921	3553	4790	4792
HINATA_NFKB_MATRIX	M2646		12673201	Hinata K,Gervin AM,Jennifer Zhang Y,Khavari PA		Table 1: Adhesion/Matrix/Cytoskeleton			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Matrix, adhesion or cytoskeleton genes induced by NF-kappaB in primary keratinocytes and fibroblasts.	NF-kappa B regulates normal and pathological processes, including neoplasia, in a tissue-context-dependent manner. In skin, NF-kappa B is implicated in epidermal homeostasis as well as in the pathogenesis of squamous cell carcinoma; however, its function in the underlying mesenchymal dermis has been unclear. To gain insight into NF-kappa B roles in these two adjacent cutaneous tissue compartments, NF-kappa B effects on expression of 12 435 genes were determined in epidermal keratinocytes and dermal fibroblasts. Although NF-kappa B induced proinflammatory and antiapoptotic genes in both settings, it exhibited divergent effects on growth regulatory genes. In keratinocytes, but not in fibroblasts, NF-kappa B induced p21(CIP1), which was sufficient to inhibit growth of both cell types. Levels of growth inhibitory factor (GIF), in contrast, were increased by NF-kappa B in both settings but inhibited growth only in keratinocytes. These findings indicate that transcription factors such as NF-kappa B can program tissue-selective effects via both differential target gene induction as well as by inducing common targets that exert differing effects depending on cellular lineage.					396	928	5055	390	3855	4323	5879	4312	2335	5054
CYCLIN_D1_KE_.V1_DN	M2647		12914697	Lamb J,Ramaswamy S,Ford HL,Contreras B,Martinez RV,Kittrell FS,Zahnow CA,Patterson N,Golub TR,Ewen ME		cyclin D1 (K112E) vs control; bottom 200 genes (diff-means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in MCF-7 cells (breast cancer) over-expressing a mutant K112E form of CCND1 [Gene ID=595] gene.						4842	547	7016	4145	5816	573	200081	9513	56252	6039	7024	4824	5588	5295	7337	100132596	11016	3437	1572	5173	5745	2781	216	1080	8402	687	6387	4636	6258	6906	1437	7140	7053	9812	6017	5671	3605	8193	10766	10059	269	814	22796	5089	4351	822	7584	3872	1815	931	2993	9589	104	6901	7351	405	9360	3852	23198	3625	2064	6844	4734	3987	3609	70	3860	5149	5596	4909	9674	4184	5336	857	5407	171558	2890	5179	1369	11006	4861	8396	3454	2138	88	6014	4542	57680	3071	6098	7374	7412	5184	4923	5134	63940	125	1400	1828	644099	4601	23076	2287	4745	2649	1591	3273	11080	5453	10974	5121	2697	3575	2921	2242	2623	7277	856	8789	1141	9517	2904	9771	6297	249	4099	2152	120	492	3249	251	6658	713	2995	10312	10141	1386	7691	2321	3446	10282	57007	3263	1281	1359	2618	6919	5624	4620	4599	3764	663	2009	2208	3554	6689	1258	23530	5452	1734	55567	2549	5050	238	2592	11013	5020	1618	284	951	9472	5105	10124	5239	7846	5305	963	939	9593	2041	629	6895	5593	4157	4033	2	1610	28	354	525	5869	7180	929	1559
CYCLIN_D1_KE_.V1_UP	M2648		12914697	Lamb J,Ramaswamy S,Ford HL,Contreras B,Martinez RV,Kittrell FS,Zahnow CA,Patterson N,Golub TR,Ewen ME		cyclin D1 (K112E) vs control; top 200 genes (diff-means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in MCF-7 cells (breast cancer) over-expressing a mutant K112E form of CCND1 [Gene ID=595] gene.						5653	10063	1762	4055	5310	6631	8312	7791	5351	1777	6368	4014	5479	3028	3339	1984	4586	1969	189	3362	10524	7851	2274	5211	3397	9784	6237	9314	5424	1052	3299	9647	8045	8242	3835	5805	151	5972	3934	6829	7855	5481	8519	6525	607	10538	2735	1396	3607	1960	4140	2644	6531	1021	8514	2128	51032	23169	6273	30850	440	2875	3833	7916	7048	1847	886	3304	4143	3040	6588	1263	10669	1043	55756	3084	7185	5794	23510	2720	80781	9413	7249	4778	2264	2805	10200	224	1119	22937	833	91289	3983	4752	346	336	5536	7905	1611	6484	4122	51230	8798	11031	1487	6310	1029	1874	3831	5585	372	6629	2492	762	2687	7703	2813	10238	3083	150	387590	341	1290	4324	80347	7866	3703	7064	8379	7139	9862	2114	2355	23517	1026	5279	7056	10808	1059	1143	8027	3632	836	7070	1346	9663	5648	6938	10991	3222	1837	5330	5261	6364	5774	1138	10024	5998	1846	5532	329	6010	7545	3101	861	650946	7020	8527	126208	1040	9984	5143	4249	2972	196	4882	1816	5432	403	4917	2771	1571	5630	1039	23203	10447	23170	7706	1773	7204
CYCLIN_D1_UP.V1_DN	M2652		12914697	Lamb J,Ramaswamy S,Ford HL,Contreras B,Martinez RV,Kittrell FS,Zahnow CA,Patterson N,Golub TR,Ewen ME		cyclin D1 vs control; bottom 200 genes (diff-means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in MCF-7 cells (breast cancer) over-expressing CCND1 [Gene ID=595] gene.						10766	3066	1981	251	857	10960	6689	694	7024	4909	7408	5816	5295	5134	200081	3872	6609	2319	9733	22796	6258	5184	901	288	2781	7372	2009	6856	5173	9513	9812	3805	9589	2072	5320	5089	930	3122	8546	547	2041	3350	2623	1128	687	51741	3071	3694	2997	8239	822	6098	675	4620	30	9820	405	573	7692	5588	3609	3479	10449	6617	2538	814	269	5453	2584	7072	11120	7140	23209	6895	6857	5664	1386	6259	23542	11016	7200	5465	1437	9517	8925	56252	9367	4494	1146	10978	4145	7852	4842	4636	6751	11006	6004	433	3257	3624	795	51083	441263	3273	6039	5050	7277	259	2825	23530	1618	7170	835	673	2078	9169	4641	4351	240	869	6017	5105	4913	7169	3675	6690	5775	3575	6844	523	9694	9360	6532	9472	2645	545	3605	1359	7163	3269	9674	93594	8505	4361	6792	4542	2549	3460	4734	3208	6275	2649	6702	11080	116828	23212	1591	3912	10638	90	6356	27113	3552	2799	6038	10781	177	57007	2146	1482	7374	10398	4238	9366	2984	7584	10803	3760	6820	842	4745	5939	57326	439	3852	7351	629	5049	2977	23369	2626
CYCLIN_D1_UP.V1_UP	M2654		12914697	Lamb J,Ramaswamy S,Ford HL,Contreras B,Martinez RV,Kittrell FS,Zahnow CA,Patterson N,Golub TR,Ewen ME		cyclin D1 vs control; top 200 genes (diff-means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in MCF-7 cells (breast cancer) over-expressing CCND1 [Gene ID=595] gene.						6631	10063	5310	8379	1263	5479	2833	5763	7791	7471	346	1969	1059	1043	8312	6573	4586	6237	1762	6588	3397	5653	6368	3339	5774	5536	8519	607	2232	2245	6195	3835	2875	290	4324	886	9159	6853	22937	5957	20	7222	3983	10669	4158	6256	1855	7916	2813	1984	9806	6010	6829	7070	4140	6531	6572	1489	836	768	4303	6404	7185	8798	5153	10151	1052	7703	5805	762	641	23065	23170	7084	1777	7855	2968	9314	4055	6890	6484	224	4297	3110	6285	7040	2128	495	5351	8844	3028	6776	653	4637	24142	335	7706	8045	5648	881	5076	2644	2981	9968	23385	4478	6525	5539	2492	8358	151	1816	4818	3222	2274	54498	7851	3362	4778	55756	11031	6876	26025	51352	2805	9413	2794	3101	3804	6442	5138	2118	909	7480	150	4985	25758	10538	8514	274	2114	5995	27065	6560	10481	53358	4249	10238	4143	4288	1958	8857	7980	1672	6536	3304	1549	1284	4661	3040	2720	3029	2687	4752	10244	1113	1376	7249	5923	7056	649	11099	1071	6257	1647	372	9270	1138	5273	51035	4713	8242	786	2588	7905	10232	10949	3270
CSR_EARLY_UP.V1_DN	M2655		14737219	Chang HY,Sneddon JB,Alizadeh AA,Sood R,West RB,Montgomery K,Chi JT,van de Rijn M,Botstein D,Brown PO	GSE3945	CSR_early (1 to 6 h) vs Control (0 h); bottom 200 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in early serum response of CRL 2091 cells (foreskin fibroblasts).	Foreskin fibroblasts CRL 2091 (ATCC) were serum starved for 48 hours, and harvested at the indicated time points after switching to media with 10% FBS essentially as described (Iyer et al., 1999). RNA from all of the sampled time points were pooled as reference RNA to compare with RNA from individual time points as described (Iyer et al., 1999)					8654	678655	160428	4081	121227	8200	55900	84173	23213	54507	10521	9860	9249	216	8861	1027	1153	100132292	84680	6502	89890	379	23250	23032	5190	23500	6295	91137	2535	2521	133	27031	57523	84679	80208	51147	7769	100527964	26959	79625	1277	1797	9924	651746	10628	8675	23593	275	114625	255520	120227	92285	55139	285343	120892	91947	51447	221400	1152	3206	10062	84750	728448	256302	399972	23543	112476	56672	89932	653602	57561	26152	100129482	6773	168544	2674	6495	89845	9751	254048	10307	56967	140691	81545	8436	27113	84809	10902	53349	26046	55734	2200	27343	2734	84224	8614	54862	51734	100132062	55876	8741	10411	8492	97	3339	81844	286343	23637	5379	79932	26048	220213	54855	55689	11154	55325	55793	5333	196513	3433	9847	29083	57189	9397	6091	9194	79777	388403	56254	7465	7020	64167	57709	8637	443	55023	284040	222	219736	26260	8148	388324	260294	84245	55729	65258	402483	7581	158747	54739	3543	55471	29841	147912
CSR_EARLY_UP.V1_UP	M2656		14737219	Chang HY,Sneddon JB,Alizadeh AA,Sood R,West RB,Montgomery K,Chi JT,van de Rijn M,Botstein D,Brown PO	GSE3945	CSR_early (1 to 6 h) vs Control (0 h); top 200 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in early serum response of CRL 2091 cells (foreskin fibroblasts).	Foreskin fibroblasts CRL 2091 (ATCC) were serum starved for 48 hours, and harvested at the indicated time points after switching to media with 10% FBS essentially as described (Iyer et al., 1999). RNA from all of the sampled time points were pooled as reference RNA to compare with RNA from individual time points as described (Iyer et al., 1999)					4092	1839	2297	2624	8412	81848	3399	5606	8204	7358	51491	7150	6525	6781	122786	162073	8325	30844	51060	9188	56262	57621	221527	23035	9775	3301	10921	84365	8178	114801	865	5978	7779	24147	23187	83641	5782	22919	29889	10105	23560	83716	3840	5329	6615	9185	388610	3142	9564	389558	55432	59274	22894	6428	29126	7334	6921	29080	6482	6597	2113	5770	7071	3589	9159	54149	51388	1736	91283	1746	126626	30836	29928	221710	10802	7862	945	167153	54931	7458	51621	1147	25799	11044	192134	623	6909	24145	9883	8767	4691	51068	23007	11055	10342	10276	219333	57050	11047	6566	92597	9933	2004	84933	1832	51105	285761	60673	10253	5829	5743	9154	3608	27065	83607	4907	6731	51569	3241	115265	4331	6662	7803	3159	1503	6996	51534	2152	168850	53371	54107	56919	23670	285704	143279	51330	6675	81566	7532	1973	29970	285672	9659	4650	55312	3624	90874	100287932	51083	6924	9136	3654	262	29982	83460	2542	84444	6461	5612	10096	4860	60488	57602	9686
CSR_LATE_UP.V1_DN	M2659		14737219	Chang HY,Sneddon JB,Alizadeh AA,Sood R,West RB,Montgomery K,Chi JT,van de Rijn M,Botstein D,Brown PO	GSE3945	CSR_late (12 to 36 h) vs Control (0 h); bottom 200 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in late serum response of CRL 2091 cells (foreskin fibroblasts).	Foreskin fibroblasts CRL 2091 (ATCC) were serum starved for 48 hours, and harvested at the indicated time points after switching to media with 10% FBS essentially as described (Iyer et al., 1999). RNA from all of the sampled time points were pooled as reference RNA to compare with RNA from individual time points as described (Iyer et al., 1999)					6307	3638	27147	6319	3087	4597	7148	23175	79987	57722	8492	134429	3992	10752	338773	256691	6309	3157	1717	3156	348487	4047	445	4311	3815	2995	10046	5920	10231	9415	23452	100507632	23475	7108	248	55332	57698	2934	5002	7123	55277	8660	3075	576	94	84795	59277	100289610	64115	94241	54536	57523	3897	9246	10346	2674	84680	79071	64221	3422	571	10682	84251	6356	2224	25891	11161	6322	1643	29798	1803	220323	10791	149478	79956	7832	8915	3949	2051	91351	5025	6648	10435	800	5333	651746	6347	3553	5592	6576	57189	196463	2222	9149	387758	23102	26018	136	51554	10608	5584	27123	4121	79762	1891	100287704	10867	8760	116535	23460	112476	114915	6439	25987	112574	56849	746	84293	653602	25894	148423	91694	389432	2619	125111	6868	8722	2621	285362	6641	94240	9770	83468	147463	5447	148932	1296	23566	2157	51626	55809	80833	2232	4856	3476	4794	1846	5228	1831	23500	4302	23313	678655	26960	100128178	8436	54704	221491	169611	9760	114818	2495	54739	3696	134147	2737	8654	55328	9435	4199
CSR_LATE_UP.V1_UP	M2660		14737219	Chang HY,Sneddon JB,Alizadeh AA,Sood R,West RB,Montgomery K,Chi JT,van de Rijn M,Botstein D,Brown PO	GSE3945	CSR_late (12 to 36 h) vs Control (0 h); top 200 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in late serum response of CRL 2091 cells (foreskin fibroblasts).	Foreskin fibroblasts CRL 2091 (ATCC) were serum starved for 48 hours, and harvested at the indicated time points after switching to media with 10% FBS essentially as described (Iyer et al., 1999). RNA from all of the sampled time points were pooled as reference RNA to compare with RNA from individual time points as described (Iyer et al., 1999)					6941	6387	2237	64785	55055	4496	4502	29128	51053	9319	4172	51659	8710	8520	440145	4490	388610	1901	7424	83716	5708	4501	201254	5036	4495	2175	10606	332	7076	148398	51728	3655	3486	2171	7078	10056	79801	3575	5393	10953	4500	7278	10611	222865	7222	4927	2009	5557	7283	4314	147183	79077	9138	51155	1503	22808	55143	140459	835	3875	10589	11200	4605	7277	79031	81610	84250	55706	6611	55859	10598	643180	3092	4150	3749	10113	27065	990	2305	8533	26155	6372	55276	7223	9521	29114	64388	3146	9304	7372	1020	6723	56942	84266	5424	8905	9123	83540	4053	2280	7169	84798	6921	22919	10726	8402	6241	56852	55646	896	7080	54107	9121	81624	25844	4153	3608	10419	4494	93081	4828	11130	84823	63967	91057	1984	2997	55142	92856	4619	8662	4522	84154	1580	86	865	51726	3835	2193	26128	54443	11065	8089	57097	5536	26091	2146	51096	84955	6627	84056	195828	8317	1841	6484	81831	983	27075	55884	1000	25764	29902	55872	285761	112495	5702	3814	57019	26586	4233	6751	10213
PIGF_UP.V1_DN	M2673		15516835	Schoenfeld J,Lessan K,Johnson NA,Charnock-Jones DS,Evans A,Vourvouhaki E,Scott L,Stephens R,Freeman TC,Saidi SA,Tom B,Weston GC,Rogers P,Smith SK,Print CG	GSE837	PIGF vs control; bottom 200 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in HUVEC cells (endothelium) by treatment with PIGF [Gene ID=5281].	HUVECs (human umbilical cord vein endothelial cells) are treated with the angiogenic factor PlGF (placental growth factor) in low or high serum media.					3494	7070	6192	10398	50840	5153	8653	921	2243	26140	25833	3489	5313	2995	730101	8514	1406	12	23293	26145	22983	956	8940	11318	387590	5794	1444	1050	8170	1907	23616	1209	735	4656	6360	1084	4753	1553	39	259197	5145	9726	205	26093	90586	6275	125	5168	1995	9704	863	10076	4130	5655	8497	3783	2077	775	3786	2688	1718	3691	9783	64067	9901	5829	441178	23263	6693	5310	1489	8394	6710	4542	4440	6462	23500	341	3881	2840	265	2890	2912	80781	10847	92154	4058	9229	25907	10024	58487	1506	23114	10630	4061	1521	4791	11129	4016	755	9722	5737	4967	5309	9283	23237	2220	57171	79987	4680	5296	491	954	7425	85446	6795	7328	29105	27341	27035	202559	11187	9940	9344	5076	3857	10233	55117	400961	1543	10249	2290	650	8287	2649	8324	84033	4882	652068	92017	64006	3050	3177	124152	8912	3748	8085	6385	7739	991	1302	9455	2626	27346	100271849	8742	6469	7128	5680	553	1031	5986	9402	5878	51412	9087	653399	9080	6602	478	25775	3485	7204	4924	4059	5971	23357	1946	241	816	2675	6752	2774	10252	2125	8433	3488	27339	8193	4684	23217	55532	4843	2784
PIGF_UP.V1_UP	M2674		15516835	Schoenfeld J,Lessan K,Johnson NA,Charnock-Jones DS,Evans A,Vourvouhaki E,Scott L,Stephens R,Freeman TC,Saidi SA,Tom B,Weston GC,Rogers P,Smith SK,Print CG	GSE837	PIGF vs control; top 200 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in HUVEC cells (endothelium) by treatment with PIGF [Gene ID=5281].	HUVECs (human umbilical cord vein endothelial cells) are treated with the angiogenic factor PlGF (placental growth factor) in low or high serum media.					2167	10234	4319	5743	273	114882	641339	10973	7980	4925	9236	1429	9169	4919	3673	285	545	6303	91304	10142	4750	23213	10219	6103	10443	2861	26278	9823	862	26036	11037	22915	5965	134728	51351	55312	2677	7503	25780	8781	221981	2743	9497	23469	178	5756	93436	669	79882	221830	6059	4189	5997	9652	8767	10210	5471	1359	23376	54505	50999	131544	794	27067	3572	4976	57213	5251	5567	9653	3799	2160	55183	10124	23761	55687	140890	23272	2701	7975	10351	2888	22823	6670	3658	9255	9631	9976	5980	1968	1462	57187	221154	5915	51490	11235	9197	9674	6814	4052	25977	23224	4675	5481	50618	3075	29994	2011	9857	4289	9655	113251	23382	10254	23139	9173	167227	9988	80055	254531	81550	9774	9321	34	5189	6996	140609	7360	1102	6049	4897	1777	4116	8342	1362	3091	2764	1385	8743	6940	26009	51567	1380	5723	3964	23517	10286	10914	3295	10795	6416	9	23012	6782	5597	25847	23325	996	23212	23607	8803	51360	1295	4534	7049	5321	64844	26019	56137	11342	175	571	5611	9360	7103	145389	8754	220988	6880	6367	259230	51109	22873	5906	489	4285	10051	79572	10153	9126	7276
VEGF_A_UP.V1_DN	M2675		15516835	Schoenfeld J,Lessan K,Johnson NA,Charnock-Jones DS,Evans A,Vourvouhaki E,Scott L,Stephens R,Freeman TC,Saidi SA,Tom B,Weston GC,Rogers P,Smith SK,Print CG	GSE837	VEGFA vs control; bottom 200 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in HUVEC cells (endothelium) by treatment with VEGFA [Gene ID=7422].	HUVECs (human umbilical cord vein endothelial cells) are treated with the angiogenic factor VEGF-A in low or high serum media.					2167	5999	273	9173	5055	8318	1719	7424	4232	9568	3673	1636	140609	3835	5997	7103	3625	56902	23223	6241	26040	26155	26872	22943	6675	8915	5255	9517	55183	4501	1434	6103	91304	9188	10733	51351	9360	3843	8829	5791	80055	9493	5756	6303	55687	10051	262	27284	8754	5099	7525	3161	285	343	4323	7112	6102	6094	9859	9169	11051	701	10914	4289	5965	54505	9497	7360	26278	10301	781	578	1359	8975	7443	9787	471	51109	26578	6368	9631	22915	8727	23317	5597	10403	2828	9334	9208	57187	9801	9933	3832	3569	2861	8341	23212	10200	7141	90355	7025	84830	7045	7347	4085	51367	79080	4683	56242	1033	687	9156	5906	996	7975	4999	10234	1968	9774	8202	898	1062	5984	79572	9652	7678	55660	5865	926	891	7706	1121	23376	4238	9133	444	1429	23362	10926	10153	867	22878	6767	4001	4173	5334	5567	55854	7019	5922	10196	6400	11177	1058	4644	10157	699	6885	7290	902	6542	6049	3690	9411	10940	10435	10762	2289	11068	10463	1164	7272	4131	7518	2321	7804	1271	332	10615	8490	2627	7090	23195	390	8930	22994	148229	34	5789	93436	5411	9852	9255
VEGF_A_UP.V1_UP	M2676		15516835	Schoenfeld J,Lessan K,Johnson NA,Charnock-Jones DS,Evans A,Vourvouhaki E,Scott L,Stephens R,Freeman TC,Saidi SA,Tom B,Weston GC,Rogers P,Smith SK,Print CG	GSE837	VEGFA vs control; top 200 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in HUVEC cells (endothelium) by treatment with VEGFA [Gene ID=7422].	HUVECs (human umbilical cord vein endothelial cells) are treated with the angiogenic factor VEGF-A in low or high serum media.					10398	4330	6347	2243	3383	6876	51754	1649	5310	23293	7125	1134	6691	26648	10391	4640	5971	1850	9235	3356	11117	8605	3691	6385	2109	57608	10379	3108	8497	6558	7755	7070	5696	5988	284001	4050	57016	3000	4791	25807	3663	60489	8292	9701	1621	9246	5168	8742	4249	3931	3064	7093	25999	23313	7318	9478	9537	7185	25859	10628	23247	9037	8864	6582	4688	8190	25759	1302	5697	1357	7629	8115	1421	5025	4061	5795	5017	1420	9413	6919	10133	9027	10123	930	7108	5986	387590	8277	57658	8085	1641	148066	2027	8660	5998	3700	10461	2898	28952	10903	8789	7461	54738	3779	54541	755	2329	9788	3669	353500	7188	282808	6452	3748	1893	256949	650845	1829	4542	2356	9355	820	56941	9973	229	5493	1185	219654	10220	23264	921	5303	3215	2213	4794	4147	50859	730101	4985	64777	4818	9495	4814	12	23152	2128	24	171586	2052	5737	7923	2116	4313	3398	25802	8468	6830	5075	10566	7275	23237	6354	23220	10873	4739	1444	23456	201229	124152	83752	5360	2558	9742	973	22898	9149	10014	782	22822	2735	51634	467	9452	2026	104	27124	23371	135	1740	154796	9957	6373	6469	5788	3291	2330
BCAT_GDS748_DN	M2677		15592430	Chamorro MN,Schwartz DR,Vonica A,Brivanlou AH,Cho KR,Varmus HE	GSE1473	beta-catenin S37A vs GFP; bottom 50 genes (mutual information)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in HEK293 cells (kidney fibroblasts) expressing constitutively active form of CTNNB1 [Gene ID=1499] gene.	293 cells, infected with RCAS-beta-cateninS37A or RCAS-GFP					79727	84263	64081	23204	2619	22980	1280	51056	7390	4603	24149	65250	22913	28965	27251	9252	80279	5160	5042	3507	157680	10793	80070	657	5959	55508	83449	10362	654056	55603	55770	10409	7580	29082	6591	9620	58486	51477	54541	4292	6502	55958	7276	27034	10695	653784	3142
BCAT_GDS748_UP	M2678		15592430	Chamorro MN,Schwartz DR,Vonica A,Brivanlou AH,Cho KR,Varmus HE	GSE1473	beta-catenin S37A vs GFP; top 50 genes (mutual information)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in HEK293 cells (kidney fibroblasts) expressing constitutively active form of CTNNB1 [Gene ID=1499] gene.	293 cells, infected with RCAS-beta-cateninS37A or RCAS-GFP					4602	26281	2650	4739	51176	4005	1780	6520	861	25797	5318	4488	2324	5243	202	23516	1670	25805	55041	4884	80150	10394	3680	9531	760	10447	23576	7262	2184	1051	79669	2571	7334	23406	3087	8406	2643	8324	360	84909	115207	7481	842	5144	3823	10912	58530	9540
BCAT.100_UP.V1_DN	M2679		15592430	Chamorro MN,Schwartz DR,Vonica A,Brivanlou AH,Cho KR,Varmus HE	GSE1473	beta-cateninS37A vs GFP; bottom 50 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in HEK293 cells (kidney fibroblasts) expressing constitutively active form of CTNNB1 [Gene ID=1499] gene.	293 cells, infected with RCAS-beta-cateninS37A or RCAS-GFP					654056	11336	51019	26297	7276	3882	1830	55096	24142	6591	26102	79640	7113	3488	55103	1618	5367	80776	643326	56062	11067	8322	100132476	352961	2742	1135	388567	79932	83660	10650	160313	1795	3507	5304	27251	6910	65250	1010	8838	7071	8337	268	5071	55603	7552
BCAT.100_UP.V1_UP	M2680		15592430	Chamorro MN,Schwartz DR,Vonica A,Brivanlou AH,Cho KR,Varmus HE	GSE1473	beta-cateninS37A vs GFP; top 50 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in HEK293 cells (kidney fibroblasts) expressing constitutively active form of CTNNB1 [Gene ID=1499] gene.	293 cells, infected with RCAS-beta-cateninS37A or RCAS-GFP					22943	26281	58530	638	7481	2119	4005	5168	1670	25797	2026	339457	5502	2650	79156	140578	861	2523	284119	8507	10912	5947	2571	3680	23428	7984	1848	6926	3667	1045	3929	1917	5274	3549	5243	100288413	8372	652	8470	3198	1428	2202	3040	928	1846	79007	5611	55640	54440
ATF2_S_UP.V1_DN	M2681		15691874	Bailey J,Tyson-Capper AJ,Gilmore K,Robson SC,Europe-Finner GN	GSE1059	ATF2-small vs Control; bottom 200 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in myometrial cells over-expressing a shortened splice form of ATF2 [Gene ID=1386] gene.	Human myometrial cells taken from biopsies of pre-menopausal non-cancerous non-pregnant uteri were cultured in complete MEM D-valine medium plus 10% FCS, and stably-transfected with the pcDNA3.1/V5-His TOPO vector (Invitrogen) harbouring ATF2-small gene or a control empty-vector.					3485	1116	1674	56901	6445	11075	5740	5743	1475	5493	2199	9244	2	1404	1545	6424	79695	6586	115207	2643	4879	5320	6943	12	283131	27295	4982	6347	9317	645619	4642	1803	56521	79987	10351	1307	2353	9627	84561	26499	11199	8490	722	7139	5732	1301	23235	10659	9284	7490	6507	9936	3708	9358	7412	3751	3399	125	26249	6356	205	1311	9672	84612	11145	26011	5350	10687	10691	5997	7410	8514	64116	2252	10653	2254	4919	54210	5918	80760	104	55890	13	4330	326	90865	80352	7448	3400	3292	4781	4619	150244	9013	11240	885	9159	9737	7090	51129	2619	881	23492	2026	3062	57828	22837	1047	23562	3856	2202	57214	79575	79150	53616	3728	64172	57829	5364	1294	1306	55022	78987	4803	55790	6006	2742	3556	8527	79789	79917	84223	284217	22846	55315	57604	10610	9180	4608	29965	140	6813	10580	2121	4778	654	2875	2331	1612	3908	8710	57088	3566	54813	1397	22904	55667	4091	3554	7163	5426	1791	710	9056	55365	23761	9659	2563	22809	7130	8471	5972	55916	658	30001	4054	51279	10402	8714	8620	9920	80772	6361	79228	6522	31	55280
ATF2_S_UP.V1_UP	M2682		15691874	Bailey J,Tyson-Capper AJ,Gilmore K,Robson SC,Europe-Finner GN	GSE1059	ATF2-small vs Control; top 200 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in myometrial cells over-expressing a shortened splice form of ATF2 [Gene ID=1386] gene.	Human myometrial cells taken from biopsies of pre-menopausal non-cancerous non-pregnant uteri were cultured in complete MEM D-valine medium plus 10% FCS, and stably-transfected with the pcDNA3.1/V5-His TOPO vector (Invitrogen) harbouring ATF2-small gene or a control empty-vector.					6450	9076	79642	26468	2852	26063	59339	56892	3576	10974	81029	5580	4747	2188	4142	925	7223	100133941	79187	95681	4826	9235	5307	79025	2305	9355	4312	57185	2021	60494	3283	5075	79762	2953	85477	3236	29802	8995	55799	81492	3887	8516	1469	10125	9506	8544	3452	10112	8707	22808	29123	64849	256227	7276	2146	79623	2769	27344	306	23217	79682	80830	5332	8608	7378	5116	7083	6275	4317	5698	3699	491	2290	22879	3310	29104	22885	257	4131	58504	9603	139081	388569	23314	7226	116832	54507	3231	9982	4647	11226	8082	5017	3357	29954	3045	388714	7153	81887	79007	10279	8287	5406	9051	92014	225	5623	7374	83445	55702	9077	9630	79977	2919	2158	8288	317	647070	81491	51117	78998	8029	9037	79870	442194	8786	4359	1181	6280	406	1473	1122	9143	5328	5649	56033	154	5730	55540	202	56998	79143	9940	9493	4835	7292	9369	1656	6549	8811	51666	6490	3293	57460	79863	719	3745	80008	1506	23495	3655	11170	79633	1033	9752	10599	79145	11172	26045	22871	8928	8291	55296	1948	26212	10941	10331	91543	53832	25803	9274	26266	2114	4741	27329	54959	91752	57626	2302	5371	9118	55515	10234
ATF2_UP.V1_DN	M2684		15691874	Bailey J,Tyson-Capper AJ,Gilmore K,Robson SC,Europe-Finner GN	GSE1059	ATF2 vs Control; bottom 200 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in myometrial cells over-expressing ATF2 [Gene ID=1386] gene.	Human myometrial cells taken from biopsies of pre-menopausal non-cancerous non-pregnant uteri were cultured in complete MEM D-valine medium plus 10% FCS, and stably-transfected with the pcDNA3.1/V5-His TOPO vector (Invitrogen) harbouring ATF2 gene or a control empty-vector.					1116	5743	9672	4879	27295	2643	2353	6347	64167	5740	10687	136	55790	11145	6943	9284	2619	3212	51816	2952	9903	6586	4982	1404	79987	11199	10659	645619	5918	9244	56901	5091	1545	5493	2199	7412	31	84561	3485	79695	56521	6424	65080	7163	2254	5350	8527	30001	3751	115207	9317	22998	10653	4919	8863	2252	57214	5806	23015	10630	150094	5320	9358	4345	64288	13	80149	4642	3759	6356	10085	1012	12	5357	9818	4781	50650	79895	11037	55755	51279	6387	23556	6648	22834	3792	9936	2742	1491	2121	80760	11067	57419	5321	9627	2936	81894	9915	3075	8940	79901	80223	8714	3400	5304	54210	137886	968	11341	51313	79961	6274	1311	205	4621	9159	399491	885	81932	8553	10363	6198	23126	3728	3554	55022	84223	5980	57212	9653	6038	6445	10351	4239	2979	5272	5318	9738	7448	22914	910	57088	9013	51704	5934	283131	55890	57161	6813	5292	6701	2202	10166	4091	151987	629	6667	23761	635	90865	6474	4330	3556	28231	9333	8840	9451	9668	26499	80201	9659	5737	6319	92	2861	326	64116	8660	768	4299	10129	10614	10610	1909	2331	55667	8751
ATF2_UP.V1_UP	M2686		15691874	Bailey J,Tyson-Capper AJ,Gilmore K,Robson SC,Europe-Finner GN	GSE1059	ATF2 vs Control; top 200 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in myometrial cells over-expressing ATF2 [Gene ID=1386] gene.	Human myometrial cells taken from biopsies of pre-menopausal non-cancerous non-pregnant uteri were cultured in complete MEM D-valine medium plus 10% FCS, and stably-transfected with the pcDNA3.1/V5-His TOPO vector (Invitrogen) harbouring ATF2 gene or a control empty-vector.					4312	2290	3814	2953	4747	81029	79642	9235	6450	930	6776	9076	5075	9630	1473	4142	81887	22885	11122	9854	2167	3887	80303	7378	27284	8525	7226	27344	56892	58504	27147	4826	8516	8995	51193	79682	10077	8938	81491	2021	5365	50486	11226	5307	7434	647835	29925	10763	50485	3991	5424	2305	54894	10391	4133	27043	3283	3855	347	81628	3777	388569	2769	84034	3671	1233	4331	79187	23457	5888	51659	9830	3310	29122	79870	10733	719	6275	8852	57408	4741	3248	79924	317	95681	29103	26094	79172	80054	925	81492	9196	1146	3384	8823	81490	79887	116372	4795	2268	3237	10312	9752	51514	3211	9982	6295	257	5731	4762	5050	5332	9833	222663	5580	3481	442194	5420	4832	29123	3166	5947	26281	256227	266	915	3978	54829	8821	51308	10863	23217	646372	6702	542767	55702	26083	24146	2488	2188	5328	6524	239	55690	320	114088	55821	7083	4756	64785	5097	64151	64220	9328	5300	3003	5331	139081	2662	3806	8811	6045	668	399665	64170	53942	353514	23468	1280	5055	390616	5406	4739	58511	4793	2978	8315	56341	10750	4050	23617	23495	3737	23632	2880	5121	23181	79981	23400	3231	9379	55237
ATM_DN.V1_DN	M2691		15892871	Elkon R,Rashi-Elkeles S,Lerenthal Y,Linhart C,Tenne T,Amariglio N,Rechavi G,Shamir R,Shiloh Y	GSE1676	ATM_siRNA_0 vs controls; bottom 150 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in HEK293 cells (kidney fibroblasts) upon knockdown of ATM [Gene ID=472] gene by RNAi.	Expression profiling of cells knocked-down for ATM and control un-infected cells and cells infected with siRNA against LacZ.					5075	56981	10077	51190	2668	416	54413	10891	1830	6295	2041	2054	7757	9262	3706	23591	11148	25769	56729	51284	2845	23658	2241	10371	3749	51291	7224	22808	6356	11330	29774	8111	4099	1770	7113	23498	331	969	56155	50487	8976	2159	1411	2561	51378	8477	7472	56132	55811	51716	94	6716	653423	7093	6876	4188	9953	4760	2220	6482	4253	5364	5781	6783	23759	3691	155	27159	1908	10942	4978	29892	7696	3755	2957	11069	929	4103	4915	1544	50939	8358	57824	11154	3429	10214	64066	11027	11141	4680	3753	26261	51224	3812	57047	64343	1536	22797	7010	4826	2906	677	59067	8557	29122	58530	257	5639	4246	6490	9982	9517	2921	27023	215	6036	51050	54093	6555	6568	1420	7123	23676	9182	30819	1573	2918	26253	29899	3061	10587	553	3973	189	6005	5962	1439	5333	23566	659	57089	2330	2219	3075	26576	1183	2206	3452	9132
ATM_DN.V1_UP	M2692		15892871	Elkon R,Rashi-Elkeles S,Lerenthal Y,Linhart C,Tenne T,Amariglio N,Rechavi G,Shamir R,Shiloh Y	GSE1676	ATM_siRNA_0 vs controls; top 150 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in HEK293 cells (kidney fibroblasts) upon knockdown of ATM [Gene ID=472] gene by RNAi.	Expression profiling of cells knocked-down for ATM and control un-infected cells and cells infected with siRNA against LacZ.					81890	54739	55367	3761	29104	4633	5979	2209	3982	2742	6898	7087	26230	1299	10018	64240	8291	2897	4261	3487	7125	2185	28234	7439	27019	4051	8736	6494	9356	1942	10734	10272	11074	1271	925	27285	2250	5260	3699	29881	5864	1114	6676	11166	6375	948	9495	65009	6529	7410	5360	10873	8650	2826	3558	8968	1185	623	1757	2321	55515	6853	4804	27239	7294	1842	6121	8140	1559	53405	11009	9563	56287	321	3293	8843	104	23742	3891	1591	64077	10351	58503	5673	5028	4782	765	5148	930	7422	1053	6620	29924	2027	859	3284	590	7276	31	8749	1359	654231	1750	5493	54210	7140	1441	81492	2162	7761	80328	2692	3250	6819	4225	58510	6274	4795	1394	9401	2705	3991	6524	7185	2658	3938	5966	8521	627	64579	6273	6002	23562	1193	26330	3972	9846	10039	8739	2212	1472	25799	7762	1395	6715	55742
P53_DN.V2_DN	M2693		15892871	Elkon R,Rashi-Elkeles S,Lerenthal Y,Linhart C,Tenne T,Amariglio N,Rechavi G,Shamir R,Shiloh Y	GSE1676	p53_siRNA vs controls; bottom 150 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in HEK293 cells (kidney fibroblasts) upon knockdown of TP53 [Gene ID=7157] gene by RNAi.	Expression profiling of cells knocked-down for p53 and control un-infected cells and cells infected with siRNA against LacZ.					53916	3996	26499	50809	1993	11162	659	1733	56894	9557	23682	1675	29899	5089	26297	2166	56163	7080	3207	5228	10818	51291	23676	1270	7125	6578	9369	2984	5540	6296	3045	84694	8863	11257	80896	5730	2289	51760	3004	9187	3487	7161	728	81563	64374	2045	240	2138	57101	3239	2121	29944	10842	586	3346	10672	56341	10255	899	64129	3248	3008	51302	5368	4908	55503	2572	4007	5893	6531	10936	6883	5454	3764	8329	6335	3676	8437	3489	56165	3991	1870	6752	8218	11027	4793	2028	7439	22936	2167	6615	741	64284	28965	64240	81602	5781	6751	10332	7288	658	3765	1058	30820	51762	5149	10949	5176	3605	2358	651	6641	11077	4325	81890	7276	3213	525	2868	496	1594	6720	4607	4524	290	6045	2053	3199	56123	8996	23759	406	710	8434	5304	1472	9953	10018	9751	4185	3161	7096	8309	10403	6402
P53_DN.V2_UP	M2694		15892871	Elkon R,Rashi-Elkeles S,Lerenthal Y,Linhart C,Tenne T,Amariglio N,Rechavi G,Shamir R,Shiloh Y	GSE1676	p53_siRNA vs controls; top 150 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in HEK293 cells (kidney fibroblasts) upon knockdown of TP53 [Gene ID=7157] gene by RNAi.	Expression profiling of cells knocked-down for p53 and control un-infected cells and cells infected with siRNA against LacZ.					6364	2920	4359	5971	7128	3576	6690	80833	3604	3635	6503	56981	51267	55367	10223	6097	54101	6853	5450	7023	4763	8870	64377	2584	3010	9308	8538	1586	3641	9033	81027	5697	29948	4784	8153	2359	241	969	1565	79057	9023	4792	6372	51086	1558	3906	10991	7143	1493	554	51438	51557	5197	6007	5657	6702	3000	27329	10320	6351	4340	5806	9563	8419	5032	5990	2128	3640	7179	8326	51129	3557	80352	54739	968	2919	11141	5581	1807	256364	6699	3071	79368	4322	7473	671	5463	27006	54363	1757	2355	5097	4923	6374	7157	5031	479	5132	8335	10873	23529	761	10739	722	734	2928	9122	2185	56142	6387	9956	4314	3861	10369	1048	265	57053	11199	5475	4495	2119	922	2123	1750	9125	4916	26532	2994	6565	1002	8193	2615	3881	3354	2814	1553	668	5995	3779	3777	11022	8038	581	4326	9452	6385	57282	27179
RELA_DN.V1_DN	M2695		15892871	Elkon R,Rashi-Elkeles S,Lerenthal Y,Linhart C,Tenne T,Amariglio N,Rechavi G,Shamir R,Shiloh Y	GSE1676	RELA shRNA vs WT; bottom 150 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in HEK293 cells (kidney fibroblasts) upon knockdown of RELA [Gene ID=5970] gene by RNAi.	Expression profiling of cells knocked-down for RelA and control un-infected cells and cells infected with siRNA against LacZ.					658	4653	8736	57468	3772	50937	5639	399	10911	4486	26239	2330	6910	7472	9177	50632	9074	7031	3758	7185	9172	4778	6870	5818	5764	81501	9734	27286	3232	5652	3012	2015	10267	1788	4325	50506	51213	2650	8366	5650	3737	711	768	10841	10734	8368	10753	2165	8399	3575	6553	8200	4070	5091	2833	5778	7137	5020	9595	3036	11012	5003	4585	8000	7424	10371	81563	1830	1469	6884	2827	55540	8812	8788	3627	8029	10741	3425	81848	3897	3292	26539	3848	9369	8645	2944	146	55365	5540	22797	80896	10150	5313	963	27232	9023	7180	4158	51190	29103	5990	3053	9148	3359	2122	27288	51270	9427	10587	730	27202	1118	27314	8778	57082	3270	943	7008	22821	2797	25975	6373	2852	7179	919	11279	3561	50617	5662	551	325	1180	5947	7512	23544	2575	5031	4826	3960	6756	6691
RELA_DN.V1_UP	M2696		15892871	Elkon R,Rashi-Elkeles S,Lerenthal Y,Linhart C,Tenne T,Amariglio N,Rechavi G,Shamir R,Shiloh Y	GSE1676	RELA shRNA vs WT; top 150 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in HEK293 cells (kidney fibroblasts) upon knockdown of RELA [Gene ID=5970] gene by RNAi.	Expression profiling of cells knocked-down for RelA and control un-infected cells and cells infected with siRNA against LacZ.					2353	1958	2705	5743	56895	25799	11067	10249	1850	8326	4117	2152	57335	8061	7056	3736	1473	3355	10903	7172	8291	1316	1880	27334	24146	2247	8552	8976	8654	5229	64320	3726	27165	11093	3604	7421	2354	8284	23409	3973	79166	1489	3749	4616	56342	2796	7538	1960	5049	932	467	9457	64092	10010	2571	8737	1057	6375	8287	3371	741	1672	7539	23431	274	53822	5032	3725	5190	26512	3553	487	56155	5641	8534	50863	11254	8822	8564	10475	5163	4857	3773	10326	53841	338	5304	4159	4782	9229	23645	53630	9162	7718	23769	8522	7422	10750	8941	7071	80352	51701	321	10380	6447	51761	10847	54329	6615	4225	56981	6617	5592	4607	2875	9132	6347	2691	1942	56603	28965	11082	4115	3195	80328	51361	8085	4008	4922	11277	23418	50512	7673	3918	677	29947	8715	27071	2158	7423	2110	952	509	56897	1030	5407	6541	1418	1195
P53_DN.V1_DN	M2697		16199517	Subramanian A,Tamayo P,Mootha VK,Mukherjee S,Ebert BL,Gillette MA,Paulovich A,Pomeroy SL,Golub TR,Lander ES,Mesirov JP		p53 mutant vs wt panel of NCI-60 cell lines; bottom 200 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in NCI-60 panel of cell lines with mutated TP53 [Gene ID=7157].	We examined gene expression patterns from the NCI-60 collection of cancer cell lines. We sought to use these data to identify targets of the transcription factor p53, which regulates gene expression in response to various signals of cellular stress. The mutational status of the p53 gene has been reported for 50 of the NCI-60 cell lines, with 17 being classified as normal and 33 as carrying mutations in the gene.					59	23532	6696	9122	23136	10154	9687	26999	3428	9770	3081	1462	54898	5797	3662	8744	9514	7425	3234	4286	3897	2919	1244	1026	597	55117	25900	4948	83988	2171	4897	10457	283652	23643	1638	216	7436	23150	1836	7102	25797	10516	27040	259217	2731	5142	6490	1410	7107	27065	57476	7832	3702	123	6271	2040	1893	10346	1593	6192	107	9920	55966	54504	3676	26240	8601	590	6778	4118	4814	1643	919	7980	4935	8535	10752	3485	10329	6775	825	9021	834	486	51704	2244	56271	10584	152	5172	9618	23111	6663	5783	341	1794	4692	10475	7431	1373	7364	581	2315	9172	344	10135	355	9658	7299	5321	9765	912	2674	4811	8745	8013	6489	4145	10409	89795	3306	27072	2232	57509	8493	28513	2593	3164	1113	23433	5889	231	760	1513	23371	8522	81550	864	3162	84071	8190	100	6285	5973	23189	4747	23574	3560	4316	284217	6446	11343	35	54	1514	2266	8828	9639	4741	25800	999	7056	27112	11082	2629	26330	24	4938	10560	5332	1522	7104	2744	10402	8869	29114	3764	771	3490	11257	3212	8653	4644	1687	9915	6659	5136	146712	8514	3683	3554	201229
P53_DN.V1_UP	M2698		16199517	Subramanian A,Tamayo P,Mootha VK,Mukherjee S,Ebert BL,Gillette MA,Paulovich A,Pomeroy SL,Golub TR,Lander ES,Mesirov JP		p53 mutant vs wt panel of NCI-60 cell lines; top 200 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in NCI-60 panel of cell lines with mutated TP53 [Gene ID=7157].	We examined gene expression patterns from the NCI-60 collection of cancer cell lines. We sought to use these data to identify targets of the transcription factor p53, which regulates gene expression in response to various signals of cellular stress. The mutational status of the p53 gene has been reported for 50 of the NCI-60 cell lines, with 17 being classified as normal and 33 as carrying mutations in the gene.					2152	1029	22943	7001	5646	5645	4232	1948	51710	7025	1009	51599	4016	6567	1278	26053	387590	2202	136	1281	4082	5947	7345	10267	3880	1363	652	374	1525	50486	51232	9762	51196	6662	23086	5307	1308	928	3491	6337	5420	10551	558	4610	7277	3866	202	254531	3429	161291	2952	3875	6286	7103	10529	10413	27074	6038	273	26018	7433	10253	9805	3691	4680	2199	1832	563	1305	5467	6102	7408	23057	4091	57228	1956	100133941	57214	9249	3625	2752	3816	9910	10524	56998	29899	1112	1365	3606	4072	7718	30848	10653	8536	1119	1032	7525	2274	4070	2898	8871	8218	5655	765	27324	7388	1012	22800	115353	10085	6385	5794	3012	5493	23764	10403	10656	2812	126353	27063	2534	1474	329	9984	26994	10874	1824	3659	1266	23002	10497	793	301	133	9734	23213	3489	10232	2000	1404	26509	5754	7045	51308	25999	303	5328	10124	5468	7464	169611	55786	196	5268	3913	7739	725	4212	2011	51100	1268	4052	9353	3628	7857	90338	4217	688	1756	8412	445	7368	11339	7026	10184	4312	23066	847	7162	7080	7398	323	629	8819	3673	9414	5764	8915	4507	22875	23353	90576	10873	8420
BCAT_BILD_ET_AL_DN	M2702		16273092	Bild AH,Yao G,Chang JT,Wang Q,Potti A,Chasse D,Joshi MB,Harpole D,Lancaster JM,Berchuck A,Olson JA Jr,Marks JR,Dressman HK,West M,Nevins JR	GSE3151	activated CTNNB1 vs GFP; bottom 50 genes (mutual information)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in primary epithelial breast cancer cell culture over-expressing activated CTNNB1 [Gene ID=1499] gene.	RNA was extracted from human mammary epithelial cells expressing oncogenes (or GFP control) for gene array analysis. Experiment was performed in replicate.					23167	3556	1195	9462	4090	79101	374868	2730	23370	100132406	114884	55183	5591	90627	55119	3656	1488	57205	5744	285527	284800	51278	6426	6653	23243	9411	79048	4047	64750	23528	9698	3552	6464	55000	2894	55870	5325	4012	23479	7128	1315	10109	57688	9555	5906	7776
BCAT_BILD_ET_AL_UP	M2703		16273092	Bild AH,Yao G,Chang JT,Wang Q,Potti A,Chasse D,Joshi MB,Harpole D,Lancaster JM,Berchuck A,Olson JA Jr,Marks JR,Dressman HK,West M,Nevins JR	GSE3151	activated CTNNB1 vs GFP; top 50 genes (mutual information)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in primary epithelial breast cancer cell culture over-expressing activated CTNNB1 [Gene ID=1499] gene.	RNA was extracted from human mammary epithelial cells expressing oncogenes (or GFP control) for gene array analysis. Experiment was performed in replicate.					1591	94234	1938	80139	8313	977	828	6168	10398	81	81872	54873	6813	6195	652	811	11001	2683	3146	1509	80311	7087	113878	653605	837	126536	6157	6929	85462	10421	4849	93185	1602	55062	6876	140885	132989	51006	93429	23788	91663	55362	648470	79823	10610	65009	100288594	113178	84062
E2F3_UP.V1_DN	M2704		16273092	Bild AH,Yao G,Chang JT,Wang Q,Potti A,Chasse D,Joshi MB,Harpole D,Lancaster JM,Berchuck A,Olson JA Jr,Marks JR,Dressman HK,West M,Nevins JR	GSE3151	E2F3 vs GFP; bottom 200 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in primary epithelial breast cancer cell culture over-expressing E2F3 [Gene ID=1871] gene.	RNA was extracted from human mammary epithelial cells expressing oncogenes (or GFP control) for gene array analysis. Experiment was performed in replicate.					9333	10940	27076	645238	728689	2837	79924	56269	705	79015	5906	5327	26468	83875	85373	79413	84879	6710	260429	624	2649	3569	4312	643650	2894	51352	93663	5091	144501	25885	284618	126433	643314	246176	3293	55525	6699	55096	148189	647357	2117	60489	3976	114224	7052	1630	54620	158431	123591	1013	2011	200232	3955	732	645352	677811	54622	54436	441951	1992	11335	442117	5914	338376	57523	201305	6286	9047	11254	5936	647135	1953	9875	643396	6656	56131	3310	4901	81854	100287569	414899	6621	80776	339122	56986	399909	11182	55183	101	2069	4261	25896	3656	7551	3447	285456	750	9515	9052	54813	5467	3221	128308	7694	27099	404037	374666	389834	157848	642441	11309	392459	4314	2696	642645	158160	55680	8939	401588	653423	10439	84186	9238	56342	100133091	285489	30817	80100	6804	164656	266977	8420	10984	642398	90784	81492	30833	26151	730394	285181	83931	145474	23624	404550	3805	8148	91370	80131	255738	64581	100421561	5820	166793	440157	51575	81872	55110	200312	7097	138151	90529	51101	54209	2709	643210	3071	7056	10331	643328	54094	8312	116829	157567	125476	196483	23581	642826	342909	127435	5366	9818	9726	135946
E2F3_UP.V1_UP	M2706		16273092	Bild AH,Yao G,Chang JT,Wang Q,Potti A,Chasse D,Joshi MB,Harpole D,Lancaster JM,Berchuck A,Olson JA Jr,Marks JR,Dressman HK,West M,Nevins JR	GSE3151	E2F3 vs GFP; top 200 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in primary epithelial breast cancer cell culture over-expressing E2F3 [Gene ID=1871] gene.	RNA was extracted from human mammary epithelial cells expressing oncogenes (or GFP control) for gene array analysis. Experiment was performed in replicate.					2026	388228	9134	132332	4324	1031	23336	9308	116236	254887	148398	4602	898	58528	158399	1050	84553	53346	134111	84634	195828	25907	400954	2261	2643	2254	129607	11076	285016	4091	9429	57026	80139	576	5827	10675	56548	85358	84915	79683	5727	29767	144455	29887	29901	1028	51209	253152	84733	51176	8739	23462	80757	79022	55540	9118	53820	4747	1592	11000	3110	3040	339983	163933	51734	9401	26996	84885	2571	195977	7374	137392	84206	3790	2297	1633	202451	7546	23576	3625	149175	55964	11001	3248	7782	1122	10194	10125	81928	140707	80318	387763	1407	9143	1917	23089	5426	65055	401034	9738	7368	8534	65078	27106	5111	22835	23493	4277	253650	23129	7074	10656	23136	4884	4861	90378	25884	26033	64858	1959	51016	84304	2237	84456	64130	5427	7025	25837	92610	5300	51514	64714	166979	140688	9837	6877	4005	2527	286336	56704	2175	3205	81575	10098	6530	84451	90313	84302	646762	92659	57088	4038	3306	6261	54583	146760	29028	80712	51655	84771	147015	134548	116238	23097	56935	9435	154141	645030	440829	8851	7089	23221	147912	199953	5726	79622	283454	283658	83855	6450	3742	26577	158062	10278	201255	9258	146330	283554	25791	6508	529	146822	7483	79929	6853	27346
MYC_UP.V1_DN	M2708		16273092	Bild AH,Yao G,Chang JT,Wang Q,Potti A,Chasse D,Joshi MB,Harpole D,Lancaster JM,Berchuck A,Olson JA Jr,Marks JR,Dressman HK,West M,Nevins JR	GSE3151	MYC vs GFP; bottom 200 genes			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in primary epithelial breast cancer cell culture over-expressing MYC [Gene ID=4609] gene.	RNA was extracted from human mammary epithelial cells expressing oncogenes (or GFP control) for gene array analysis. Experiment was performed in replicate.					7776	27076	9333	9052	64857	5906	8334	4312	406	51129	6699	56269	2837	4909	83875	6280	221472	22802	646014	79413	126520	221184	8829	64780	23762	1953	246176	65065	7097	84709	4330	692247	6710	1992	91370	90853	401427	5327	80714	171586	79686	5091	404550	29841	3569	4804	266977	54991	260429	56970	7052	4314	9762	137872	84542	5164	127435	201305	645238	150290	79703	9064	284618	9985	2894	57523	11223	9929	7846	2921	2069	80776	3221	100128998	7127	9867	11067	6843	79630	497634	5347	653464	2649	912	94241	22795	84719	100505621	126433	84895	3656	392459	57493	145567	100287569	23126	59339	140836	81872	79780	192670	51062	29893	114769	84803	114224	6279	39	643650	11254	442117	647135	2709	55384	55143	54933	10903	81029	642441	2185	65998	55785	7011	6498	25897	6038	3554	4318	54094	2635	53916	6529	54795	7483	84189	1828	9837	195814	2847	607	9746	55616	220441	57154	3606	168544	177	145945	114783	9564	22911	144501	55713	5791	7461	8644	57561	285989	766	6792	5063	285181	5090	56131	90529	3092	147699	2593	6857	23037	84056	84330	8085	5467	126353	81844	112476	11278	79015	3212	54809	6364
MYC_UP.V1_UP	M2711		16273092	Bild AH,Yao G,Chang JT,Wang Q,Potti A,Chasse D,Joshi MB,Harpole D,Lancaster JM,Berchuck A,Olson JA Jr,Marks JR,Dressman HK,West M,Nevins JR	GSE3151	MYC vs GFP; top 200 genes			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in primary epithelial breast cancer cell culture over-expressing MYC [Gene ID=4609] gene.	RNA was extracted from human mammary epithelial cells expressing oncogenes (or GFP control) for gene array analysis. Experiment was performed in replicate.					3310	199953	9136	25929	1844	23223	29914	56997	80742	83855	10534	5026	51218	115286	9718	9392	10813	84649	284098	6975	124093	56894	100288413	56652	201164	1119	10849	56704	10322	7762	144577	56915	286042	10799	23171	11040	221143	6573	84798	23481	29078	10609	80758	9605	5321	27346	401260	10199	2527	116447	6877	79751	10078	29902	55117	26577	64425	400916	11001	4234	23671	27165	29901	5373	90161	79961	10056	2353	118491	51042	126668	10166	10598	115752	51154	26468	54475	9521	53342	10257	79050	63934	51293	84135	54517	4325	7374	79077	94015	3240	220323	130574	51018	9955	80324	79663	55850	1662	30817	64216	222962	79823	10195	6652	26094	57101	645030	57521	346689	26664	10102	65999	8602	54660	64386	152579	100289019	91860	81890	10785	84292	10196	389336	55536	6875	3131	7087	4335	439962	729993	200403	146712	337	10669	118471	8527	80020	153364	127841	256051	51001	3069	8909	169714	3708	6496	2813	83480	56896	23160	84221	29952	10683	65083	90025	162540	653605	54976	26539	730013	149018	51537	114795	81887	79711	23082	10650	79763	51575	3336	51388	126382	271	54952	115098	828	29803	5393	83448	84315	55566	84881	542767	147923	4744	55621
SRC_UP.V1_DN	M2713		16273092	Bild AH,Yao G,Chang JT,Wang Q,Potti A,Chasse D,Joshi MB,Harpole D,Lancaster JM,Berchuck A,Olson JA Jr,Marks JR,Dressman HK,West M,Nevins JR	GSE3151	SRC vs GFP; bottom 200 genes			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in primary epithelial breast cancer cell culture over-expressing SRC [Gene ID=6714] gene.	RNA was extracted from human mammary epithelial cells expressing oncogenes (or GFP control) for gene array analysis. Experiment was performed in replicate.					5327	2837	29128	645238	3955	4312	5287	79159	11067	11182	51352	9333	10804	4319	79413	51645	3656	5906	22802	728689	4794	100	6280	643650	27076	1953	79642	4174	2966	10733	23242	22795	57523	124773	284338	375298	3978	84709	7111	2182	3575	79153	2537	170960	5091	6646	171586	27094	86	127	100505621	6374	90784	7694	644337	55783	375593	84315	647589	57709	64946	1806	147968	57561	3212	114803	9837	201305	84816	25885	57526	5914	8829	9150	2894	642771	402778	442117	3713	494143	158431	85373	10331	29028	83879	2069	2015	134145	26036	644295	9064	79733	7551	25786	127391	56269	5055	4173	378708	133418	58155	285596	51380	56986	6857	79723	55120	1903	79628	1295	732	85455	2676	260429	138199	766	55182	4889	80818	51117	340205	4330	7262	56131	9262	80157	6699	9955	1102	4172	29127	84542	84520	554174	285181	9094	5063	10501	54622	151613	374666	3434	80067	89887	29099	50636	54991	83452	55313	65065	643314	407975	5318	10948	5288	4314	54700	10940	114769	266977	984	10265	27185	57468	285955	51633	285989	165918	254122	8128	23150	5734	23180	401131	90507	126205	2146	83849	28978
SRC_UP.V1_UP	M2714		16273092	Bild AH,Yao G,Chang JT,Wang Q,Potti A,Chasse D,Joshi MB,Harpole D,Lancaster JM,Berchuck A,Olson JA Jr,Marks JR,Dressman HK,West M,Nevins JR	GSE3151	SRC vs GFP; top 200 genes			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in primary epithelial breast cancer cell culture over-expressing SRC [Gene ID=6714] gene.	RNA was extracted from human mammary epithelial cells expressing oncogenes (or GFP control) for gene array analysis. Experiment was performed in replicate.					2353	23671	4796	6714	6450	644951	56776	162540	9080	440672	405753	653605	56894	27324	529	56971	54089	85026	339457	60506	100288594	1286	55566	4145	25790	51659	55539	339483	27074	8074	56475	126374	254896	100506127	10861	574432	155382	79955	163175	27231	84279	341880	158056	2527	283854	51513	6608	339983	6725	642926	131375	80742	5121	23416	3263	283385	257357	51085	65993	9032	8798	113878	6035	7087	129852	4303	91703	55586	54814	651803	348013	22893	503538	374969	317701	3394	475	5300	6853	2584	92162	2880	221476	83697	283475	85478	828	79751	7036	2242	84701	728882	246329	441058	84777	157848	83743	55150	10814	116519	149018	85509	84246	54752	5454	25999	8834	2199	126536	64838	3069	83590	8086	4325	136227	8651	79962	221823	200403	2813	89870	9937	93611	9356	80325	644165	199223	643365	29881	83854	9447	83538	55118	90427	55576	596	4992	10683	4987	9087	9290	146822	91179	23542	4758	79058	79783	25830	8625	23533	79022	4025	283194	127841	970	2838	139285	51761	54777	2100	10319	10004	79660	5864	29763	9744	29914	320	3483	85012	10894	100289650	10297	400916	3166	13	5920	389170	51806	83860	84648	5207	79085	7007	90701	51475	219537	90522
CAMP_UP.V1_DN	M2719		16381821	van Staveren WC,Solis DW,Delys L,Venet D,Cappello M,Andry G,Dumont JE,Libert F,Detours V,Maenhaut C		cAMP vs WT; bottom 150 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in primary thyrocyte cultures in response to cAMP signaling pathway activation by thyrotropin (TSH).						9920	6515	6236	2114	11031	114569	3094	10069	8848	3301	51363	2026	10659	57602	8853	4133	26289	667	894	55536	6894	8303	5341	5047	5210	5569	9590	9208	4049	3720	55190	493	2669	221981	80727	54758	3638	23621	7077	3312	26115	5063	8655	11167	6453	1195	10000	10129	4645	4688	5911	2530	134111	4199	330	10803	196264	9435	6599	8932	7277	7220	3783	4628	23187	23786	10079	3398	1975	4790	23365	7114	10712	9689	23022	51444	114614	26022	66036	9520	989	23208	7325	57515	2739	253959	1809	7343	1977	473	9231	27445	10250	23174	4942	22881	4773	6565	23481	57578	3566	39	65009	9644	57523	9448	50863	65018	10397	267004	9308	27334	6856	26220	64407	5996	10381	7082	9806	4673	3983	3423	394	80022	10098	338799	23136	6447	3320	6427	55669	55827	3488	60468	83660	6626	51062	9906	5358	55970	57030	1112	26266	5594	8927	7430	79987	23344	1605	89792	7538	801	3575	5066	9991	6129	490	7917	4674	2744	113802	29079	64327	162427	92181	840	162989	56978	84640	57178	147968	3704	817	124152	10383	639	2354	5788	6767	5055	100216479	6812	301	78991	2776	11126	55752	613	26059	347733	10396	23551	23576	27346	3303	64231	23231	5789	64114	57162
CAMP_UP.V1_UP	M2720		16381821	van Staveren WC,Solis DW,Delys L,Venet D,Cappello M,Andry G,Dumont JE,Libert F,Detours V,Maenhaut C		cAMP vs WT; top 150 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in primary thyrocyte cultures in response to cAMP signaling pathway activation by thyrotropin (TSH).						81788	83667	10193	3148	10797	3475	25875	468	10904	3433	8607	16	3309	1054	25898	8405	7503	29926	51310	3576	23007	6396	55153	51569	92973	2119	55062	949	4720	9361	5479	23563	972	7378	375	3276	8209	552889	64374	57447	11316	9674	8402	23559	3127	1890	476	1351	1535	4723	50	55748	54732	4141	9575	22818	8519	2923	5036	4085	57763	6184	506	7818	55168	23645	55829	517	5193	9812	92335	5018	5366	4835	51011	115098	29927	284058	3192	548596	6775	26580	80017	10410	10475	171568	374666	63899	26996	7045	254887	54899	58486	51295	195828	23063	64745	5034	60674	2745	84219	10036	10456	8086	10768	595101	84134	10322	11190	51582	89894	81565	54987	404734	5557	3608	6352	3987	1209	9472	4191	8674	9798	89941	122769	9500	92399	80315	8818	6732	7980	55683	226	11059	80023	115294	22938	10211	10524	1431	90007	221294	25946	124454	23043	23640	498	115708	27350	7184	252839	94005	112483	4502	3313	79101	1798	4830	9659	10296	3069	57609	4116	9416	54494	29088	1381	64786	5359	95681	4799	4711	8991	113829	211	57511	1293	22861	6747	54455	2006	5875	100132476	26574	4609	81605	29920	79711	10625	6142	23321	9693	23070	2353	292	10616	8891	2182	9844	54940
LTE2_UP.V1_DN	M2721		16585219	Creighton CJ,Hilger AM,Murthy S,Rae JM,Chinnaiyan AM,El-Ashry D	GSE3542	long term E2 growth vs Controls; top 200 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in MCF-7 cells (breast cancer) positive for ESR1 [Gene ID=2099] MCF-7 cells (breast cancer) and long-term adapted for estrogen-independent growth.	Profiling of control vector transfected cells (coMCF-7) and control vector transfected cells long-term adapted for estrogen-independent growth (coMCF-7/lt-E2).					4886	3434	3429	684	11254	2537	10561	64135	3956	23586	10964	9687	55008	3665	4938	2274	4940	55601	2852	64761	7980	3431	9246	8839	24138	10379	8519	1381	2674	3430	9636	120	6672	857	9830	3959	429	4192	4277	23424	51427	4939	1299	5366	5698	10395	3480	3717	467	6658	841	11274	9111	6890	8357	2887	23255	25801	5174	7020	25939	11098	7504	54981	1475	794	22843	799	3437	6566	8638	23314	54809	4256	89927	51083	1123	8365	9926	54898	7456	29761	3547	3475	1837	5610	1054	51191	55034	2000	27295	26046	58155	5577	306	54737	3397	79365	79982	7594	5046	11009	89797	22876	9536	7357	79068	23657	57419	7699	10813	7637	6505	25913	4686	6840	3280	9317	4071	23236	10018	4147	10950	94134	596	1024	8829	8334	6197	5359	6883	55714	185	8339	11201	6049	2669	8614	347902	55366	79868	10443	51765	51131	8204	771	55269	79872	1265	863	182	23279	29919	23254	2618	10795	51761	2037	9949	1960	2218	2202	1844	23089	4783	9612	706	55183	221037	54700	22836	29968	1647	54843	8969	4851	9194	6782	23283	3909	27074	64860	10486	9314	9107	5796	1826	9818	1105	55159	4651	11031	51388	2969	7750	10793
LTE2_UP.V1_UP	M2723		16585219	Creighton CJ,Hilger AM,Murthy S,Rae JM,Chinnaiyan AM,El-Ashry D	GSE3542	long term E2 growth vs Controls; top 200 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in MCF-7 cells (breast cancer) positive for ESR1 [Gene ID=2099] MCF-7 cells (breast cancer) and long-term adapted for estrogen-independent growth.	Profiling of control vector transfected cells (coMCF-7) and control vector transfected cells long-term adapted for estrogen-independent growth (coMCF-7/lt-E2).					4982	4680	79695	2575	2579	81537	79679	316	5265	2264	2001	10974	2034	50515	23180	4128	7138	26298	11320	6386	1906	5236	655	23596	5121	55332	50617	10979	65124	444	3554	8714	151011	1601	54453	79789	10966	10577	1545	22944	4082	23328	5325	6653	1827	10090	5283	6646	80129	4155	51	4217	51280	1846	29844	10479	134	72	8564	8612	1836	7852	9022	23475	309	55005	8836	11104	23074	55040	25825	1730	10455	3488	10957	5507	665	81031	7804	23433	79762	9252	2878	65055	58528	5332	5101	55556	5304	51635	8543	9050	89910	64764	53635	79152	4318	94009	57214	10668	26999	64759	93129	5427	81558	9429	51606	11138	54869	80328	23303	30845	8309	51141	79712	5631	2954	9728	8659	2631	6019	8974	90141	7083	55198	6558	57037	5627	51435	2052	5734	9590	8560	51806	27067	10497	1033	51171	4212	8934	5867	51760	57553	11322	2650	83752	80028	694	10484	55790	5025	9749	51228	11163	6652	1808	7390	8541	3265	5873	253190	5151	360	55872	23588	54855	3157	1824	79959	9867	4857	4925	8650	9630	4644	9334	348995	9936	2036	80150	26517	7263	55286	222	25764	28998	9517	3158	2730	5583
MEK_UP.V1_DN	M2724		16585219	Creighton CJ,Hilger AM,Murthy S,Rae JM,Chinnaiyan AM,El-Ashry D	GSE3542	MEK vs Controls; bottom 200 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in MCF-7 cells (breast cancer) positive for ESR1 [Gene ID=2099] MCF-7 cells (breast cancer) stably over-expressing constitutively active MAP2K1 [Gene ID=5604] gene.	Profiling of MCF-7 cell lines stably overexpressing constitutively active MEK as a model of overexpressed growth factor signaling, as well as control vector transfected cells (coMCF-7).					4886	5174	3434	4256	9687	2674	4071	3429	26353	51133	23586	8334	684	10395	11254	22836	5577	9246	10561	1960	2537	4602	1836	64135	26018	3431	10964	6445	55197	55008	4477	3398	26053	2852	4938	55601	57535	3800	3006	596	8357	8339	3665	23314	8839	445	51309	11274	323	79068	51566	4940	4638	9636	54981	178	8345	51427	6814	55034	84909	7035	4603	9039	6744	24138	57698	6947	10924	11201	8204	55119	645619	4609	58155	26154	8344	57234	466	79675	23015	3983	89927	3430	23475	4092	8416	8365	55005	22996	347902	29919	8777	429	56603	4939	3480	29887	55035	6279	7699	3717	10388	1475	54995	10379	8519	55032	54894	27250	5378	9871	4528	794	79868	9317	79071	60481	5723	23424	9120	1123	8934	22824	2803	22876	29889	9315	2161	55327	64860	22834	51690	55827	84869	7290	29994	55081	7155	8969	9935	10125	7980	79887	65986	7637	4338	26046	55768	9665	8346	51012	29760	467	23255	5205	284064	64431	6672	5121	841	54665	9926	56339	7594	3375	8821	25913	253959	10813	51141	799	8638	5241	9562	25939	6873	221037	90806	2581	1070	10905	9716	1299	3012	6938	7456	6890	9830	8343	6658	10196	9520	2218	54332	51103
MEK_UP.V1_UP	M2725		16585219	Creighton CJ,Hilger AM,Murthy S,Rae JM,Chinnaiyan AM,El-Ashry D	GSE3542	MEK vs Controls; top 200 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in MCF-7 cells (breast cancer) positive for ESR1 [Gene ID=2099] MCF-7 cells (breast cancer) stably over-expressing constitutively active MAP2K1 [Gene ID=5604] gene.	Profiling of MCF-7 cell lines stably overexpressing constitutively active MEK as a model of overexpressed growth factor signaling, as well as control vector transfected cells (coMCF-7).					1543	1048	57016	54491	57214	1290	81537	220	1545	80761	6277	7379	4208	2034	4680	218	2261	6286	79789	444	5734	1846	81031	1525	27242	5468	10186	4016	25825	79695	3887	5569	7045	112399	8611	1969	11138	23596	6310	23266	9568	5166	824	2026	6767	5791	56904	7804	10644	9415	3855	5763	7852	10257	93664	360	8644	55861	6533	10020	397	22998	7851	79616	7481	23508	55765	4642	10479	6712	10742	64759	4041	56649	8910	55790	2150	65983	9080	4293	6558	6386	9619	51097	6653	11182	2878	868	4982	4121	4059	10979	8714	8061	4128	8659	23406	10331	10205	2119	7077	26064	726	1646	10577	23650	64943	5097	2052	602	3691	655	1906	7280	5101	51280	10736	55690	2180	5878	9260	9518	10610	10076	9244	2244	51762	2041	3915	11151	22978	79007	2877	79762	2650	1119	55450	29763	9314	7408	10123	22936	51129	55640	3566	5754	9578	23034	23089	23657	25816	347	5583	11045	116987	23180	7041	404093	3730	4644	65998	79180	1384	25849	3897	8650	254102	9537	4739	30001	133	80328	2983	6484	2273	439921	4833	9517	6674	23368	51083	29888	3783	64856	51337	9645	9870	29094	53635	151011	5447	1364	5328	408	50515	113178
RAF_UP.V1_DN	M2726		16585219	Creighton CJ,Hilger AM,Murthy S,Rae JM,Chinnaiyan AM,El-Ashry D	GSE3542	Raf-1 vs Controls; bottom 200 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in MCF-7 cells (breast cancer) positive for ESR1 [Gene ID=2099] MCF-7 cells (breast cancer) stably over-expressing constitutively active RAF1 [Gene ID=5894] gene.	Profiling of MCF-7 cell lines stably overexpressing constitutively active Raf-1 as a model of overexpressed growth factor signaling, as well as control vector transfected cells (coMCF-7).					57007	9531	4886	5174	22943	2674	6451	3398	9687	10551	26018	5376	595	8991	3667	7031	9926	6542	10395	4256	1960	57758	4477	10099	11254	55740	4071	8706	6445	4277	26053	202	80129	771	4192	7033	7035	9022	8821	10810	9289	54847	56521	10265	214	2852	22876	7837	1363	18	596	5157	54843	22882	323	4602	2581	84909	10769	26353	4254	23327	3488	10950	1381	203197	3485	22903	51454	3480	4651	125058	10560	863	8777	8839	4603	26154	645619	57535	6938	205	794	23389	22996	12	857	50810	3487	3717	57402	28952	89927	23314	390	4638	65986	8365	4092	116039	3397	4601	1955	429	8727	5507	55081	5332	9935	6947	4430	3983	25805	57419	64116	7227	27250	8030	8502	5046	1475	6091	8773	23283	6505	9231	5357	54898	64699	1831	799	54332	60436	22836	55105	1948	6566	10451	80210	2969	10125	55164	403	5165	1952	29902	79068	9915	55327	22843	51340	10336	7358	357	6658	5241	23236	2239	54541	1299	2037	23329	2690	1968	57613	11009	6659	23022	7580	10927	5366	9562	221037	23401	6662	51363	58155	2188	2820	8942	26130	8614	8573	7403	63892	2353	11083	54700	7020	24140	6383	54566	7042	28962
RAF_UP.V1_UP	M2728		16585219	Creighton CJ,Hilger AM,Murthy S,Rae JM,Chinnaiyan AM,El-Ashry D	GSE3542	Raf-1 vs Controls; top 200 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in MCF-7 cells (breast cancer) positive for ESR1 [Gene ID=2099] MCF-7 cells (breast cancer) stably over-expressing constitutively active RAF1 [Gene ID=5894] gene.	Profiling of MCF-7 cell lines stably overexpressing constitutively active Raf-1 as a model of overexpressed growth factor signaling, as well as control vector transfected cells (coMCF-7).					2028	6280	51442	3283	5468	55790	56892	23554	8910	29760	2034	827	3248	22881	4610	5836	9603	2861	5274	65983	2745	64131	115207	23406	250	1081	25816	2534	1839	2770	3655	23596	55214	412	9076	81537	10874	91543	55286	9645	1316	7368	114876	221749	56913	7003	9873	10133	10602	6286	50650	7980	211	7138	7448	5264	2702	10656	100288413	6279	65997	25825	669	824	27242	81553	7379	55975	1545	5311	5734	3694	55742	7280	10020	151011	444	8850	4488	51191	6707	26256	64781	58494	7089	960	4041	9891	1318	79679	83716	1956	4121	2760	5144	7378	25797	9781	1824	23089	3904	10205	3915	3897	57037	10903	11151	5236	401034	3783	51	9200	1846	89797	10257	2246	57493	1052	2119	5698	9568	9111	4217	8863	2182	1230	22848	286527	10979	8013	8714	80896	55357	9317	5129	11138	5358	1827	23157	10331	2624	51129	97	79695	64762	64764	10892	10403	26273	23224	3613	6303	8935	2887	57228	55861	653127	51752	55422	7857	123803	79789	5763	3306	10144	6386	4200	55526	11182	10577	51435	5699	51232	8898	80321	51635	8835	2180	51170	57406	831	9397	22800	7855	79710	51097	55450	65981	10982	5631	4734	23102	23092	26136	2730	5583
PRC1_BMI_UP.V1_DN	M2730		16618801	Bracken AP,Dietrich N,Pasini D,Hansen KH,Helin K	GSE6015	ko vs control; bottom 200 genes			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in TIG3 cells (fibroblasts) upon knockdown of BMI1 [Gene ID=648] gene.	The identification of gene expression changes in human embryonic fibroblast cells depleted of BMI-1.					56937	56521	55613	29948	54101	643326	79932	922	6590	81602	375057	4634	284244	904	55799	26105	7512	1179	23627	57162	3394	27129	23743	12	51291	330	26287	10686	116986	1959	2982	9628	566	8431	51213	2572	90586	1300	56124	28231	2140	9949	1555	9047	114625	157567	9625	5676	64854	78989	65095	3627	54848	4661	56001	3620	2257	390940	7089	54923	3576	482	6362	89919	2785	8174	79772	167227	63974	80207	2623	64405	51199	27123	26499	10418	27086	5936	1636	1259	2912	6004	10123	79661	5145	54808	63923	7975	54937	894	155060	23569	199870	6754	23149	10560	6506	27329	1962	6736	81569	9818	79156	6286	26253	8856	5778	55117	1021	7102	8269	2359	64167	51351	4188	114	2905	8354	400961	23507	1800	1756	7644	51086	90204	1365	2591	192670	8643	7128	3848	23090	163590	9654	57161	55636	10912	79608	2557	1232	1906	3040	50514	6344	5244	5079	22807	10806	51087	6493	55258	80060	1305	8356	285596	6355	10739	79640	64386	5080	23566	65986	55803	7738	7299	79782	57626	8843	3567	7225	1844	54813	1238	80305	5730	23119	8372	55199	79846	5128	160518	921	50863	2290	79574	100288594	4250	3798	57115	3805	285203	28461
PRC1_BMI_UP.V1_UP	M2732		16618801	Bracken AP,Dietrich N,Pasini D,Hansen KH,Helin K	GSE6015	ko vs control; top 200 genes			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in TIG3 cells (fibroblasts) upon knockdown of BMI1 [Gene ID=648] gene.	The identification of gene expression changes in human embryonic fibroblast cells depleted of BMI-1.					27113	29943	5959	54714	55057	1121	8435	64838	648	57165	56033	11173	29947	9480	2169	9506	80740	339	5800	3679	3206	29118	54549	3373	130814	8906	63967	23766	4978	117247	5155	11000	9254	750	23430	79085	6045	30848	8346	55282	2243	55924	1593	50944	3237	2053	2584	11317	29763	6317	489	167	4298	23475	1557	2289	542767	115290	92106	2125	80339	758	3754	60484	414	6916	79944	286148	200316	23392	11151	5273	79136	2769	3761	54795	25770	23132	1946	2742	56899	54584	25897	58495	3982	114825	147172	3434	9351	56139	148066	55832	8190	24142	29992	51806	64106	1136	79834	23562	8153	763	27019	23148	11211	79802	23554	29967	64854	2242	15	6712	7139	54212	8085	54842	50939	5652	8468	9771	25802	5639	26082	2312	1880	10319	11045	51761	23550	9437	8735	23113	4261	3804	2302	55073	9356	5626	6692	80039	3062	5365	796	9899	1551	91316	9022	116492	1907	29108	79972	5595	5105	387751	8224	50861	10588	51365	10663	51333	51475	3115	55916	1630	3746	2670	79853	6853	10380	1875	5288	26532	79092	9920	2619	22879	26468	5346	6906	79934	55336	6862	5024	2261	64122	79364	3991	335	10021	50489
PRC2_EED_UP.V1_DN	M2734		16618801	Bracken AP,Dietrich N,Pasini D,Hansen KH,Helin K	GSE6015	ko vs control; bottom 200 genes			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in TIG3 cells (fibroblasts) upon knockdown of EED [Gene ID=8726] gene.	The identification of gene expression changes in human embryonic fibroblast cells depleted of EED.					81890	8325	27113	11145	5210	50809	3070	11182	55643	65009	11151	115290	11194	1464	57523	58189	8793	79792	51005	29763	6319	8189	3728	25789	64780	22994	5347	56112	9394	9900	55143	57513	24137	8438	10868	2068	4957	3707	2889	4171	9258	6494	8318	8726	126353	64794	409	7869	84951	2194	3787	95	8906	8825	51006	25897	8940	1849	55139	9013	55732	2771	7517	23400	4007	8208	55697	5365	7249	55690	80178	5424	9401	79834	57192	7402	5568	23457	54496	10312	10607	64172	79778	2355	55388	81570	5098	10449	8971	6387	2241	55055	5273	3619	26007	3739	3625	59269	10818	3899	54795	2733	8557	10861	790	10295	27037	6813	51294	27254	55663	55723	9828	2584	6667	23113	2185	4597	7046	63967	6853	5822	64429	8190	5364	7407	4047	10919	5959	9064	58525	80339	5261	5129	333	2289	10460	3638	3418	5905	9967	80380	10318	11245	65989	3300	84986	9493	23132	768	79087	23649	3090	23511	9351	2735	5732	4174	26233	22808	4998	4605	81501	10188	55924	10844	55222	2026	11202	25802	9469	80174	79680	23404	3162	80128	9415	64858	11186	1121	5091	3991	5144	64852	55057	701	6835	6560	8737	55727	79447	7410	5598
PRC2_EED_UP.V1_UP	M2736		16618801	Bracken AP,Dietrich N,Pasini D,Hansen KH,Helin K	GSE6015	ko vs control; top 200 genes			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in TIG3 cells (fibroblasts) upon knockdown of EED [Gene ID=8726] gene.	The identification of gene expression changes in human embryonic fibroblast cells depleted of EED.					5055	8347	167227	8334	157567	8349	56937	51129	7769	10123	6310	56911	8269	10443	57016	9818	55117	3006	2591	57088	9033	23162	8200	467	6447	84033	2861	23643	9734	27344	54145	84561	2359	5324	26137	79772	25966	56521	11046	28962	885	9625	114625	57035	54813	11199	8339	8174	26952	9397	22903	11067	643326	6767	7813	10418	4619	25988	1850	81602	55589	2517	6868	1756	57460	3224	8431	5778	441024	10912	5154	51213	56676	3199	3627	23051	10221	51012	1543	6123	3772	11248	8029	219333	58155	152006	11179	4034	2928	8644	921	55231	81563	894	6590	55532	7227	163590	174	5092	50515	93129	10739	2623	23080	6304	1444	8777	7857	26120	765	9910	57380	29994	84869	8792	1997	9154	741	5730	221395	64111	55799	147	9173	51338	51666	54502	23119	3097	3598	27123	6882	6249	11122	55339	6336	7448	54462	22953	8710	56925	83445	1179	57332	57829	64123	23095	2537	7644	9788	51111	1519	116496	6360	7730	284040	6528	51285	10391	27075	1047	29951	5653	256987	571	1149	80031	5980	1028	28511	29948	2262	54825	3785	5168	9744	2940	80163	64854	1259	3394	8492	4306	7286	10966	51744	10336	3592	401630	55258	83478	5995	6344
PRC2_EZH2_UP.V1_DN	M2737		16618801	Bracken AP,Dietrich N,Pasini D,Hansen KH,Helin K	GSE6015	ko vs control; bottom 200 genes			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in TIG3 cells (fibroblasts) upon knockdown of EZH2 [Gene ID=2146] gene.	The identification of gene expression changes in human embryonic fibroblast cells depleted of EZH2.					55117	4923	80323	28984	56937	51129	2861	54829	157567	3601	9818	10123	5569	1305	27075	79932	56521	3570	3673	9314	79669	9173	55432	9976	115207	55640	220	1839	9289	2140	149111	2824	55262	6563	4013	78990	59353	5055	8431	9949	26575	9625	11082	9945	26040	7851	27123	7102	23236	51285	54039	1845	25891	3576	970	6590	2115	669	4862	8462	79772	3897	5101	10391	441024	79846	174	2150	4124	10371	81569	7762	23596	1906	60482	10561	3394	2118	10221	79616	8705	6916	28962	5593	131566	55296	8497	58155	4319	27286	3598	885	650	53826	5519	3423	90865	1756	6004	8942	7277	5646	2048	6480	79693	3805	54544	1287	26146	23539	9955	22926	6715	80228	3737	1232	80207	155060	10763	54852	79905	64866	319	11046	1850	2359	51291	7130	64167	1300	51213	6310	5650	26253	5744	290	81602	2069	54677	84560	58488	23366	8544	9764	54893	79739	2583	51621	85352	4306	3766	29948	3728	2352	4929	22885	7275	8372	10924	23743	40	8854	29881	7350	4857	10560	1955	22884	10584	7447	23452	55273	3736	64208	29954	25799	56172	5787	1012	419	6515	1288	54744	64123	63893	388650	54863	113146	6249	5154	8321	64170	6322	5291
PRC2_EZH2_UP.V1_UP	M2739		16618801	Bracken AP,Dietrich N,Pasini D,Hansen KH,Helin K	GSE6015	ko vs control; top 200 genes			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in TIG3 cells (fibroblasts) upon knockdown of EZH2 [Gene ID=2146] gene.	The identification of gene expression changes in human embryonic fibroblast cells depleted of EZH2.					3625	79075	4803	55663	8825	7517	5368	333	6315	6387	79834	9254	55320	7058	11151	5021	80739	5557	50809	4171	8438	6328	23354	4883	29967	496	4605	55540	54795	3887	6853	2615	4486	2146	3206	55357	79720	7064	5307	4778	3787	11340	51222	3237	51293	6542	730101	6502	7164	3070	55175	6546	3161	1121	25802	2649	9760	54584	9926	56992	1081	28973	2355	8433	9924	9681	653423	2529	4001	29947	8600	57165	64763	7019	1112	54714	27330	55180	23213	23113	80777	3899	65999	55721	11182	4439	2575	9787	5350	814	55388	81501	9468	185	3750	92106	2619	117247	22794	2742	286148	100288903	84722	3045	1643	11096	993	55222	79066	11339	4861	54797	79968	56033	83463	5984	3434	5730	54985	25897	54517	3930	1551	10460	8447	54859	23592	5333	1015	78998	50619	23560	23397	1063	24137	22936	56647	70	8484	3037	1053	79629	8968	348995	9735	22871	1894	7272	4781	5959	9212	29990	6855	79023	81620	10622	8547	282997	5106	25903	4210	8468	5789	23208	2769	5644	8435	4829	2289	55054	2113	55057	79934	3162	64506	9506	55635	2914	23040	23510	1763	2053	699	8778	23259	51765	2977	79682	8318	5723	55355	54891	54860	3963	140710
PRC2_SUZ12_UP.V1_DN	M2740		16618801	Bracken AP,Dietrich N,Pasini D,Hansen KH,Helin K	GSE6015	ko vs control; bottom 200 genes			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in TIG3 cells (fibroblasts) upon knockdown of SUZ12 [Gene ID=23512] gene.	The identification of gene expression changes in human embryonic fibroblast cells depleted of SUZ12.					79932	81602	2687	56521	146691	155060	6123	6344	3887	728448	2352	58	6590	58157	51296	81563	114625	245812	50853	26040	56937	54893	728882	79772	55799	2905	60529	157567	54923	2254	1305	5978	54039	167227	64849	6710	10974	27344	80207	26628	631	10123	51291	1839	116372	3866	6689	9723	6610	81569	26576	904	26253	4634	1602	5936	54477	9617	8812	7629	1906	81617	1636	23149	64167	29122	79446	643326	1690	28231	65095	23492	9744	8808	64854	9023	9046	57380	1149	676	770	55576	57573	9625	3931	51626	9846	651	2196	6041	1991	7512	90586	6362	131566	885	55806	23731	765	3936	305	2572	390892	867	5055	27231	646089	30001	220	8497	50838	84560	5616	26499	6447	29954	6310	2220	390940	5593	25893	2251	3783	7757	7133	26239	55231	2623	50515	55258	79810	9818	147343	29986	27434	162972	1545	6750	4661	57332	2118	79957	5145	55117	3772	4825	970	7225	6536	91860	29798	9033	6776	752	8269	2982	55303	80761	5739	5696	629	1842	9705	2922	2833	11118	192670	79661	200424	8854	26297	5451	7310	78990	5540	7350	51751	25799	28962	7730	66002	26146	10082	3439	91353	1520	26034	23251	3673	7504	8431
PRC2_SUZ12_UP.V1_UP	M2741		16618801	Bracken AP,Dietrich N,Pasini D,Hansen KH,Helin K	GSE6015	ko vs control; top 200 genes			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in TIG3 cells (fibroblasts) upon knockdown of SUZ12 [Gene ID=23512] gene.	The identification of gene expression changes in human embryonic fibroblast cells depleted of SUZ12.					23512	25802	10519	4717	81501	2742	63932	409	8435	9498	28755	286	5075	3206	5730	117247	79370	27113	3117	9920	863	55057	3373	8557	23169	23554	80339	6533	23130	3211	10462	58189	10053	9477	83786	3237	325	65263	8929	64129	26238	2243	5348	155	750	83481	23562	80055	27161	5317	898	23649	84823	8590	6196	10380	27067	4887	6869	51561	10807	6862	2815	7139	8735	6168	9229	919	218	100505593	5196	55054	414	64106	3222	1081	5071	50939	55175	5652	9079	1946	2053	9653	79943	57116	8438	81623	22865	26468	23354	910	54	259	27019	10242	4139	9254	151230	4852	79853	5800	1630	4618	84148	10900	26138	10369	65999	3587	5990	6363	489	9295	6093	59347	6416	79036	22871	57468	6716	2302	1677	60484	4998	257218	912	55225	23538	9480	1111	167	84107	9401	2769	177	118491	100288903	2983	8973	55055	440738	10786	1821	79934	108	8224	2125	442334	28999	94	6482	4161	4978	28875	26476	9057	8260	1641	1124	8997	79888	25770	4137	7486	11026	11151	5232	84934	59344	22797	9099	55727	29970	27237	766	4212	27334	10744	6813	11173	91355	388714	2793	6318	11045	8736	50613	54859	3850	3543	9914	933	3557
JNK_DN.V1_DN	M2745		16648634	Gazel A,Banno T,Walsh R,Blumenberg M	GSE4828	SP600125 experiment CONTROL vs TREATED; top 200 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in JNK inhibitor-treated (SP600125[PubChem=8515]) keratinocytes.	Keratinocytes are grown to ~75% confluence and either treated with 5nM SP600125, or left untreated. Samples are harvested 1, 4, 24 and 48 h post-treatment.					7975	4143	23769	728882	9755	4986	200316	6663	27349	79987	5345	10398	9557	5914	7189	1587	2172	22999	23236	2677	23500	1406	393	9152	10281	7104	7287	4313	50858	11067	6356	340591	11131	23043	24	10231	26145	4900	5304	7424	9815	30816	4093	6604	115653	7310	57447	1428	3835	203510	11330	4886	27290	5424	11065	8170	9478	4881	26138	8266	5155	9715	94	6461	367	5347	27289	23174	56269	7101	9450	57468	9860	2047	9735	4795	7070	8190	6494	256051	283212	1890	10940	135138	695	5024	9727	4131	27063	3560	10524	10214	8318	1946	84179	5149	6514	10435	2701	407	1850	7456	26	4297	51101	2113	27161	10150	2905	607	90362	169522	5101	4857	10636	124222	11057	2835	10018	9899	60682	26140	5371	29909	140901	11037	3425	1543	7804	10107	432	3739	9468	23258	10252	6445	3689	8444	1668	3394	8789	486	1846	4828	4753	489	1305	1411	5768	3636	2650	1033	29799	5333	51560	3839	7408	9027	6004	57338	3630	5198	7869	10100	8515	11040	51760	50486	56950	3764	7216	2241	9119	26659	641	8828	333	26872	710	142684	2642	6714	140710	7503	356	7546	23371	26469	150759	3293	11156
JNK_DN.V1_UP	M2746		16648634	Gazel A,Banno T,Walsh R,Blumenberg M	GSE4828	SP600125 experiment CONTROL vs TREATED; bottom 200 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in JNK inhibitor-treated (SP600125[PubChem=8515]) keratinocytes.	Keratinocytes are grown to ~75% confluence and either treated with 5nM SP600125, or left untreated. Samples are harvested 1, 4, 24 and 48 h post-treatment.					6359	5367	8736	189	8614	9283	1649	65012	10317	3486	10443	864	5142	26212	652068	7374	3576	90627	55806	57007	6346	7633	9056	25787	320	8805	1183	27124	3201	23179	312	1522	3283	2781	5650	3765	3752	8497	2691	8242	7754	8535	5145	6338	6569	343990	10413	655	3221	215	9308	6928	8740	2160	5790	25852	5511	8038	9532	28778	5368	951	29957	7139	242	646621	53358	84140	8912	9969	200424	9508	80303	783	1081	5639	6236	10824	7010	51208	6591	9025	26191	3594	27035	8336	4122	6869	6327	6351	1089	7051	788	3362	22795	23392	11250	860	5175	9750	259217	4193	2643	181	2570	22797	57016	5260	11228	3598	1842	6909	3440	6490	3199	733	5884	11309	660	3008	7366	1669	1609	3762	2853	6367	3787	5305	26707	3587	11021	6999	1400	26099	11074	330	7957	6317	6529	8631	6567	3885	23287	9053	2882	9373	27	716	5165	8688	3782	7247	8330	23345	2139	7134	33	115426	9770	10124	1812	2006	22808	64006	7292	80742	221154	6584	2042	146227	4597	9060	8341	4326	85446	416	339290	4352	152185	3170	931	2568	25999	6373	8644	2043	6093	54475	1901	3857	140883	8858
BRCA1_DN.V1_DN	M2747		16843262	Furuta S,Wang JM,Wei S,Jeng YM,Jiang X,Gu B,Chen PL,Lee EY,Lee WH	GSE4750	BRCA1 KD vs LUC KD; bottom 150 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in MCF10A cells (breast cancer) upon knockdown of BRCA1 [Gene ID=672] gene by RNAi.	MCF10A cells in 3-D culture for 15 h after treatment with BRCA1-RNAi vs Luc-RNAi adenovirus					2760	1809	79792	672	27158	7580	54991	7310	57799	2889	83439	9341	4439	54815	10894	728642	27295	3643	55610	4066	80000	27124	5950	6524	495	6795	8578	3785	10435	29775	5746	6523	25903	56100	64106	51324	8200	442334	647060	3291	100129460	390892	91543	658	941	2797	2859	60506	6608	8366	60686	10800	8292	26032	29097	1870	4900	973	6615	9407	8367	54932	8085	23463	79887	57105	3430	79759	9265	3386	26548	1521	80215	6375	2875	29949	5367	55112	57669	80045	4600	23426	203510	55683	51177	56605	10234	1106	258	2562	443	55260	55733	29930	5645	55607	5629	2254	2768	29068	8677	7187	56242	58189	79850	79810	654434	4223	3699	51364	29944	4160	58190	64232	56848	337	55057	6339	6336	9421	9629	6519	7678	55554	2205	1946	22843	51716	51179	55566	65989	80094	55175	10553	79098	23632	2302	653326	27006	2842	23676	29903	23233
BRCA1_DN.V1_UP	M2748		16843262	Furuta S,Wang JM,Wei S,Jeng YM,Jiang X,Gu B,Chen PL,Lee EY,Lee WH	GSE4750	BRCA1 KD vs LUC KD; top 150 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in MCF10A cells (breast cancer) upon knockdown of BRCA1 [Gene ID=672] gene by RNAi.	MCF10A cells in 3-D culture for 15 h after treatment with BRCA1-RNAi vs Luc-RNAi adenovirus					391703	1103	8929	9312	57333	27296	22829	3965	30012	79958	8808	8287	79845	8091	6495	79781	10942	8552	9120	6770	26468	2575	79015	55224	7079	438	54855	23562	23090	390999	10536	9103	8989	2830	54913	1421	887	9447	79739	79999	915	79846	8501	79446	23498	11202	322	27255	8353	7409	4056	91120	29119	123872	6981	26045	3371	163131	152015	4133	3653	10850	5802	55843	58158	54766	23617	6013	50944	11039	6579	51378	2134	947	57711	3448	3773	399	116828	1493	350	9079	7066	2560	84719	57408	55503	3217	2765	55025	747	90134	116039	79054	5897	3567	4821	23626	6870	6442	283212	64581	55613	1044	91353	79166	8483	29118	4604	6792	8857	8707	8973	5568	26038	113612	5304	4033	1240	7058	3605	11126	80052	7827	2702	51477	1012	7348	3737	6671	9122	1618	9074	8970	652147	64405	5047	25833	57152	63974	2895
CTIP_DN.V1_DN	M2751		16843262	Furuta S,Wang JM,Wei S,Jeng YM,Jiang X,Gu B,Chen PL,Lee EY,Lee WH	GSE4751	CTIP 20 vs LUC 20 KD; bottom 150 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in MCF10A cells (breast cancer) upon knockdown of RBBP8 [Gene ID=RBBP8] gene by RNAi.	MCF10A cells in 3-D culture for 15 h after treatment with CtIP-RNAi vs Luc-RNAi adenovirus.					1014	25897	92106	4129	54941	55924	3002	26049	79780	3933	3746	963	347088	79789	23632	1906	5320	54508	55566	5600	5739	1472	22982	7827	7102	26225	65263	25786	169611	27288	924	7051	57214	56998	9718	22997	9278	79934	80020	64405	5244	1270	8900	79012	26278	80215	2842	5923	7356	23169	22832	50832	26184	273	51050	3903	11112	170680	84448	3557	2615	3092	6701	90134	4619	4059	150967	51384	167	1240	1489	55107	66002	643093	3836	79906	26539	5881	54993	320	29775	399818	9695	79784	84223	51716	3640	51308	5742	55289	79953	3593	24142	25890	9499	6519	54546	23136	7544	25818	3442	79901	864	3827	57000	5803	5078	4051	51363	8786	9818	55065	54855	2330	54209	10734	26140	83714	54551	6376	5272	84786	4435	3112	283345	79990	3860	23269	10021	7225	23564	22797	79734	8751	1028	838	60529	7299	54413	29842	51152
CTIP_DN.V1_UP	M2752		16843262	Furuta S,Wang JM,Wei S,Jeng YM,Jiang X,Gu B,Chen PL,Lee EY,Lee WH	GSE4751	CTIP 20 vs LUC 20 KD; top 150 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in MCF10A cells (breast cancer) upon knockdown of RBBP8 [Gene ID=RBBP8] gene by RNAi.	MCF10A cells in 3-D culture for 15 h after treatment with CtIP-RNAi vs Luc-RNAi adenovirus.					3904	80262	9437	57538	3816	57096	56143	11262	6271	2925	8736	339	9177	27293	9734	3776	2895	54797	6615	9633	440387	138046	9312	26102	611	8749	26291	51226	5004	8863	941	2537	3211	3576	7015	5961	7276	5475	6364	84436	9033	5737	7348	5157	28227	2788	6553	54959	7185	3053	8153	100507249	246100	56033	3982	933	57115	2662	9122	54831	4624	6568	64064	3787	63827	79370	57825	51162	3741	5676	728448	54813	92346	608	5745	7123	10800	80723	57408	3012	79727	5409	4878	1278	3965	3643	4004	348110	84796	2867	443	1493	140578	1649	947	4618	81626	135948	54836	8302	6094	3749	79760	79923	26628	9118	6490	353299	51352	4284	338	7010	81027	25903	6297	10663	8822	8501	9480	7568	54581	23617	10278	147172	23105	643328	56242	285596	8536	30819	1690	1473	9509	58	5645	5149	4317	7287
MTOR_UP.N4.V1_DN	M2756		17010674	Wei G,Twomey D,Lamb J,Schlis K,Agarwal J,Stam RW,Opferman JT,Sallan SE,den Boer ML,Pieters R,Golub TR,Armstrong SA	GSE5821	contol (DMSO) vs 24h of rapamycin treatment; bottom 200 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in CEM-C1 cells (T-CLL) by rapamycin (sirolimus) [PubChem = 6610346], an mTOR pathway inhibitor.	CEM-C1 cells were treated with 10 nM rapamycin or DMSO and harvested for microarray analysis at 24 hours					5896	10628	5897	9975	1791	51306	3280	2124	1901	79684	2123	55320	10516	57730	7832	4778	50852	150759	8334	23401	54876	863	11152	51646	10023	4311	10638	901	4050	3005	23224	57240	55520	474344	283232	913	85373	51111	8357	79870	83752	130872	56985	5334	1602	220972	55758	911	22838	135	11179	25901	1195	85375	27250	80035	84124	51170	3204	10252	22807	79663	1043	9705	910	79800	57396	25949	10957	63920	55450	55073	643314	647357	54585	51351	1571	51809	80778	85459	7957	51752	11078	11226	9541	349152	54014	55525	23177	4361	283131	9662	1203	23492	83990	1523	140710	84159	29896	9884	909	26959	55179	23380	7903	2348	80003	7678	9665	26235	26511	91120	7716	55634	81698	6262	65998	9962	50861	9742	10224	81627	55251	593	90806	4335	51185	3476	10778	55268	9794	6234	64131	308	7561	10795	10608	7169	54880	8850	84820	11147	65244	79364	23112	51411	90120	23169	9648	54946	57337	645644	57326	7552	55729	1998	1200	26137	66035	1657	54916	114327	6328	5966	5890	285203	27300	7733	85236	7704	54964	5790	6655	466	10223	51768	93973	8336	5429	582	7035	373	55512	8875	534	898	55733	54737	7741	26054	9710	56257	51147
MTOR_UP.N4.V1_UP	M2757		17010674	Wei G,Twomey D,Lamb J,Schlis K,Agarwal J,Stam RW,Opferman JT,Sallan SE,den Boer ML,Pieters R,Golub TR,Armstrong SA	GSE5821	contol (DMSO) vs 24h of rapamycin treatment; top 200 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in CEM-C1 cells (T-CLL) by rapamycin (sirolimus) [PubChem = 6610346], an mTOR pathway inhibitor.	CEM-C1 cells were treated with 10 nM rapamycin or DMSO and harvested for microarray analysis at 24 hours					79094	440	1511	23657	7436	5106	23046	590	467	53346	4239	54360	8553	25932	586	50615	306	9871	23596	6520	51128	3475	1978	8566	7280	79071	3949	1717	8477	5831	10301	9238	9933	3575	8544	23223	4130	6536	445	2805	91860	1649	58472	5723	10437	55975	10469	23516	23395	10634	1051	55630	9783	7422	10124	2582	11320	9709	6016	10969	54187	974	5641	26973	55003	883	6510	10622	355	81570	54541	833	80347	51018	9136	1054	2982	55840	57406	384	5796	79648	8754	80830	4969	3417	133	80329	10538	57761	5175	23236	2673	6307	2632	54836	1317	7357	55500	29097	51303	27235	29844	79763	1875	2585	54148	5213	2713	116496	4783	8140	403	5127	732	51008	79080	26015	1831	8891	31	10244	79646	10758	2912	8882	10281	23109	1147	51474	1789	1627	6301	1352	9694	55890	9631	4835	254531	5805	5095	3702	9749	7407	104	8501	9046	253982	55815	2246	2961	51542	140803	23139	2688	4987	4141	2710	79991	51022	2184	81034	2643	8372	6533	26276	5357	664	6752	51076	22950	65084	6810	79693	11346	3419	26227	3708	64219	4978	374286	10083	6720	200734	4285	55131	9355	3396	79012	29922	846	28231	23753	1876	29093	8050
PTEN_DN.V2_DN	M2758		17060456	Kim JS,Lee C,Bonifant CL,Ressom H,Waldman T	GSE6263	 PTEN ko vs control; bottom 300 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in HCT116 cells (colon carcinoma) upon knockdown of PTEN [Gene ID=5728] by RNAi.	Two HCT116 PTEN+/+ cell lines (parental cells and a clone with random integration of the targeting vector) and three independently-derived HCT116 PTEN-/- cell lines were studied					6192	6414	652	2172	55753	79981	10590	27158	29092	10610	8653	7456	2242	1050	2827	5997	9094	23269	4756	1585	4281	25803	5936	27344	55110	55509	57597	79873	4931	64763	56156	85476	51226	54518	10481	643224	3059	7186	113177	5728	3855	22809	4929	57404	8928	64794	8367	23200	3222	10391	11199	440193	8798	6014	51185	51019	4902	8538	81575	9179	4499	55610	7287	25805	3925	83463	6446	9185	54880	871	55890	6755	81027	6926	54795	9495	51337	5595	9902	64581	23492	25984	26150	7352	55663	57089	8877	22821	51177	4092	1991	54496	54908	55194	9315	10202	55175	5324	140460	7975	57185	7678	10579	8085	4846	26716	866	3040	8507	1746	56997	84448	130872	4217	580	9401	8906	10023	1954	2175	8471	25945	115703	4016	645340	59269	2204	8351	2261	7544	7045	91316	55365	23322	6927	55701	55367	7015	1397	55501	1409	79608	9328	9992
PTEN_DN.V2_UP	M2759		17060456	Kim JS,Lee C,Bonifant CL,Ressom H,Waldman T	GSE6263	 PTEN ko vs control; top 300 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in HCT116 cells (colon carcinoma) upon knockdown of PTEN [Gene ID=5728] by RNAi.	Two HCT116 PTEN+/+ cell lines (parental cells and a clone with random integration of the targeting vector) and three independently-derived HCT116 PTEN-/- cell lines were studied					9235	26298	27113	27147	51200	2012	29948	8644	93408	3605	51291	28951	8896	647835	53836	6360	3866	89795	9388	421	79759	95681	81570	26353	5268	7252	397	6304	491	55654	6695	3934	256051	220	10595	56895	5616	5091	51129	404093	3909	23034	9630	89919	4826	64285	56998	3760	54813	7379	1305	22795	9159	78990	5655	5104	81623	330	6450	8715	837	4017	28234	3566	5730	6677	9540	57101	64393	79745	306	7060	50486	91851	84981	2533	5328	26529	2823	6689	11238	2713	79094	116492	387751	22865	9119	3553	1132	2742	8793	3725	25786	3981	2998	25822	7402	5016	2895	1880	6484	130814	27289	51352	5743	10791	6910	54832	6517	51327	10003	6398	942	4358	90273	8854	3576	22879	3590	8794	8613	10123	6507	27129	54986	80833	22824	4159	90133	7984	51281	6252	3351	57103	54796	3575	57016	55954	3882	5029	4046	1435	440895
DCA_UP.V1_DN	M2760		17222789	Bonnet S,Archer SL,Allalunis-Turner J,Haromy A,Beaulieu C,Thompson R,Lee CT,Lopaschuk GD,Puttagunta L,Bonnet S,Harry G,Hashimoto K,Porter CJ,Andrade MA,Thebaud B,Michelakis ED	GSE6014	DCA vs Controls; bottom 200 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in A549 lung carcinoma and M059K glioblastoma cells treated with dichloroacetate [PubChem=6597].	Analysis of A549 lung carcinoma and M059K glioblastoma cells treated with dichloroacetate (DCA), an inhibitor of the mitochondrial pyruvate dehydrogenase kinase. DCA shifts metabolism from glycolysis to glucose oxidation and decreases mitochondrial membrane potential in cancer cells.					126321	339044	200081	55035	93408	79924	9439	8530	10312	9392	79000	5793	1361	55190	11136	10734	57626	9284	91355	6620	56001	5300	643326	3852	23368	6698	5145	54093	9929	11045	117247	80223	2766	643328	9617	8085	53405	112939	6293	51257	2027	4660	79768	29062	4114	2516	79684	60490	9623	653326	10991	90957	474170	60625	26040	26034	84629	6478	79792	51776	57209	8605	5824	10443	4439	5164	1263	80067	2254	25844	25879	27040	27251	23636	5447	51310	57205	7107	50937	11200	55315	2842	6474	28986	3458	9435	57140	64850	5261	7038	8995	83752	6533	9684	54978	23461	26287	84851	57405	23481	6376	387032	219654	64130	8785	3442	6247	55843	6317	22833	6470	51135	388677	192666	51133	10432	7580	2875	11070	2268	5310	116986	83937	22834	1014	57335	55731	6498	55119	3909	26531	10393	81578	763	23229	259266	23151	23114	10633	57402	8115	3848	5317	63877	221395	30848	10022	8650	152100	22985	238	84789	8484	4240	79363	256227	140803	8941	51450	8351	8558	28831	10326	26148	646541	55056	28966	6911	4331	93349	9013	51447	3587	10948	779	9020	55515	54875	55565	10842	56983	2525	5900	2895	23424	54955	26504	9854	3164	157567	7637	79772	26145
DCA_UP.V1_UP	M2762		17222789	Bonnet S,Archer SL,Allalunis-Turner J,Haromy A,Beaulieu C,Thompson R,Lee CT,Lopaschuk GD,Puttagunta L,Bonnet S,Harry G,Hashimoto K,Porter CJ,Andrade MA,Thebaud B,Michelakis ED	GSE6014	DCA vs Controls; top 200 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in A549 lung carcinoma and M059K glioblastoma cells treated with dichloroacetate [PubChem=6597].	Analysis of A549 lung carcinoma and M059K glioblastoma cells treated with dichloroacetate (DCA), an inhibitor of the mitochondrial pyruvate dehydrogenase kinase. DCA shifts metabolism from glycolysis to glucose oxidation and decreases mitochondrial membrane potential in cancer cells.					28815	56269	3433	11039	118491	23542	51351	4192	92346	2561	79998	1556	1397	29881	9154	23263	79820	23566	1325	8292	26249	3732	1996	10319	10255	10126	23187	26	7472	710	55415	11119	10743	4917	1511	482	57663	51193	9753	11122	9379	1181	10223	2906	3446	91977	81570	8029	8318	55784	28875	3963	8346	7739	26140	54466	51327	64600	79755	9764	645619	84951	79446	3860	2251	63978	9389	5265	10278	11250	56156	90204	9699	80168	9212	27165	2890	8840	150160	8976	27091	79153	9373	25770	23591	765	1757	7439	3362	23341	388714	26525	2147	398	2696	4995	64064	5737	9712	51561	81626	2915	7644	3820	84253	54941	64925	1419	5016	26289	939	6870	55003	57576	3576	55650	51384	54982	9784	79414	60385	80177	83444	56475	54	7392	660	79056	910	6041	23242	54714	79686	23285	3559	54943	8516	1804	835	5267	64789	91695	3806	644974	51226	1470	83880	7301	8728	631	970	2245	4599	23339	23523	26958	105	79999	8994	64581	79412	3640	1068	55653	2051	7712	22926	51181	10086	2139	50805	9586	64816	3222	27063	130814	55231	5409	51224	81571	7139	11131	11067	6121	199	27006	22844	5599	3346	6495	6655
ALK_DN.V1_DN	M2773		17452456	Wiederschain D,Chen L,Johnson B,Bettano K	GSE7578	Alk shRNA vs Wild Type; bottom 150 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in DAOY cells (medulloblastoma) upon knockdown of ALK [Gene ID=238] gene by RNAi.	Analysis of DAOY medulloblastoma cells following RNAi knockdown of Alk.					3429	6010	8482	5100	2537	11330	25975	3263	2912	80303	57242	10273	3783	10296	23057	79575	6710	10964	10	93408	815	27239	56157	2353	10223	10650	5697	170679	4991	1472	51190	5345	5075	9153	10379	79875	360	3489	95681	1489	1237	1132	4599	5630	100288594	3169	1800	26047	51127	8549	5276	9228	4619	5179	11061	53630	9914	10871	157627	140	26105	4680	2996	8858	79930	80178	9170	83445	9734	145678	23503	6953	9729	79720	7404	5803	10562	8448	11317	23591	1299	57447	53826	9723	81622	10875	64854	181	8190	6258	1410	1087	3765	51046	7074	2886	10218	3305	2646	5792	84789	753	4938	26476	22953	7409	7410	3933	23254	5518	1734	1775	1179	6503	108	8325	80163	63978	2566	5625	79413	55020	1943	10620	2185	118433	27141	1240	2877	55051	23152	4985	100288903	54845	8906	4018	55466	3698	60494	11250	3635	64108	6554	79168	84719	3748	845	4524
ALK_DN.V1_UP	M2774		17452456	Wiederschain D,Chen L,Johnson B,Bettano K	GSE7578	Alk shRNA vs Wild Type; top 150 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in DAOY cells (medulloblastoma) upon knockdown of ALK [Gene ID=238] gene by RNAi.	Analysis of DAOY medulloblastoma cells following RNAi knockdown of Alk.					54541	23657	83729	26291	8875	2911	57761	1491	196740	79094	2925	4914	54210	8140	1758	6702	1418	6696	29968	56944	1750	23025	3109	5294	10863	8942	4056	24147	2069	7422	79955	57828	393	26063	7424	3887	6335	26150	23615	51193	8614	9023	1054	9518	84991	1080	148066	761	83887	90326	23209	624	4795	56892	128872	22808	2169	6364	5834	266	6237	90665	5106	1236	956	10797	51716	2034	2115	6363	26532	80013	79927	79727	6374	79689	4066	55640	5368	64170	199	6323	639	57596	5024	84561	2326	8812	2191	2780	7850	4826	364	643	64127	50943	50613	646452	440387	650610	58503	11075	3543	658	3569	55336	23676	63967	51412	51129	2769	22797	6999	1116	9366	26226	8705	6507	8038	440792	6510	8200	83880	4496	366	6909	7494	6288	8290	64377	683	80188	4010	5168	875	57823	6536	81833	285	4353	2584	1475	440	10648	760
BMI1_DN_MEL18_DN.V1_DN	M2775		17452456	Wiederschain D,Chen L,Johnson B,Bettano K,Jackson D,Taraszka J,Wang YK,Jones MD,Morrissey M,Deeds J,Mosher R,Fordjour P,Lengauer C,Benson JD	GSE7578	Bmi1 Mel18 shRNA vs Wild Type; bottom 150 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in DAOY cells (medulloblastoma) upon knockdown of BMI1 and PCGF2 [Gene ID=648, 7703] genes by RNAi.	Analysis of DAOY medulloblastoma cells following RNAi knockdown of Bmi-1 and Mel-18.					57084	5100	3429	3773	5179	28959	3400	1008	2	80303	5121	2620	9723	2353	6590	11061	6337	8190	55365	348	55601	360	886	5122	3554	2537	9122	3398	6414	23321	9547	2070	684	4061	8519	9023	2043	25999	55776	27250	2878	203	29105	3417	79667	79630	25840	28985	11036	648	6398	140597	4905	8654	8522	8082	79158	1806	11037	5178	283131	10562	8835	11275	9053	9244	54344	10379	1299	55885	55848	54360	55683	25878	1844	55228	7373	6919	10406	6692	27246	760	6990	27115	10752	24	7101	7111	1908	51308	7107	23316	9246	10451	1833	8539	2072	8309	2217	1962	8842	1512	6657	27012	5139	10611	10653	6275	7001	55753	414	55816	23057	22921	8633	7813	5274	114884	5142	3953	8788	4129	10891	10102	10103	23090	25956	8671	3679	10879	8349	54112	4744	9219	9077	54845	23548	253982	23556	29092	8800	53343	79582	3229	1390	2109	5950
BMI1_DN_MEL18_DN.V1_UP	M2779		17452456	Wiederschain D,Chen L,Johnson B,Bettano K,Jackson D,Taraszka J,Wang YK,Jones MD,Morrissey M,Deeds J,Mosher R,Fordjour P,Lengauer C,Benson JD	GSE7578	Bmi1 Mel18 shRNA vs Wild Type; top 150 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in DAOY cells (medulloblastoma) upon knockdown of BMI1 and PCGF2 [Gene ID=648, 7703] genes by RNAi.	Analysis of DAOY medulloblastoma cells following RNAi knockdown of Bmi-1 and Mel-18.					1437	51200	1906	595	83729	5744	3936	9945	8038	8614	51083	5069	7010	3678	3696	89797	3914	154	2191	9076	56892	80380	26585	3624	3782	133	8140	24147	5327	4045	10123	444	1839	56911	3604	1647	8061	7042	4316	3676	10184	182	1307	8744	1464	2919	23657	3575	80149	50515	8828	23400	1012	8728	976	3675	9846	9119	1435	7424	23359	22885	3352	131578	3976	22797	50863	4297	19	8876	6509	1404	26291	79931	150094	23046	85377	7130	7078	8200	25966	5329	100507436	4907	683	1294	7286	5292	9853	2152	3694	3037	719	7204	6804	51177	79747	3995	943	4879	8712	57761	3552	115123	467	9469	9780	11343	323	79570	5294	6876	6583	330	55092	6870	81029	7436	51193	653	10435	3576	29968	3783	4494	1305	6536	306	56937	6573	10124	79924	5420	56938	79627	7422	83716	10938	9839	7465	11221	5026	9854	10389	8609
BMI1_DN.V1_DN	M2781		17452456	Wiederschain D,Chen L,Johnson B,Bettano K,Jackson D,Taraszka J,Wang YK,Jones MD,Morrissey M,Deeds J,Mosher R,Fordjour P,Lengauer C,Benson JD	GSE7578	Bmi-1 shRNA vs Wild Type; bottom 150 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in DAOY cells (medulloblastoma) upon knockdown of BMI1 [Gene ID=648] gene by RNAi.	Analysis of DAOY medulloblastoma cells following RNAi knockdown of Bmi-1.					57084	28959	80303	3773	2353	6414	2620	8539	3417	3429	886	645644	6990	57664	3400	1806	9723	94081	23057	11037	25999	7032	1583	27250	645	79630	5121	23090	79575	2109	5100	8654	10451	6657	55601	55365	1390	7001	10481	8082	64405	28999	10103	8835	23548	3554	2878	9961	8519	684	55022	10758	8522	4435	27239	6451	6492	4129	23321	51015	8626	23171	5630	54845	8365	10686	760	55683	57447	2043	6590	140597	23635	440992	1962	8349	1066	56998	84789	55843	7227	6258	55885	6615	4488	6337	1299	29937	25978	8735	10406	8801	94134	2537	2969	54785	10964	55228	54112	1917	51384	11036	60529	5142	8355	51719	9394	5357	56521	1975	8723	2115	55816	56155	8503	10314	6648	1958	24148	1891	11240	10087	22921	246100	79090	7141	10671	347544	191585	7138	79184	10891	5178	7020	11061	199870	9170	6275	10752	79446	25840	648	706	29798
BMI1_DN.V1_UP	M2782		17452456	Wiederschain D,Chen L,Johnson B,Bettano K,Jackson D,Taraszka J,Wang YK,Jones MD,Morrissey M,Deeds J,Mosher R,Fordjour P,Lengauer C,Benson JD	GSE7578	Bmi-1 shRNA vs Wild Type; top 150 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in DAOY cells (medulloblastoma) upon knockdown of BMI1 [Gene ID=648] gene by RNAi.	Analysis of DAOY medulloblastoma cells following RNAi knockdown of Bmi-1.					5744	1906	1404	3678	2191	4045	8038	24147	1305	6876	6578	51200	11182	154	3914	9076	23400	26585	7010	8140	9052	3676	3624	3604	4316	2030	1464	9945	976	10184	59	9780	1307	51083	652	1839	83716	1437	182	1435	80380	56892	8828	3575	7042	3936	28231	5327	7130	6573	6804	4314	1969	7078	79147	8076	8744	5673	8200	1520	22943	6509	653	8425	7075	56920	140885	26291	3177	3995	3696	4297	306	27286	8876	290	9469	3514	19	7424	50515	100507436	9249	4240	79850	375790	6890	83729	80021	2919	2152	7436	3694	2564	6513	3037	131578	6364	24145	50943	5362	1497	7204	6510	5045	2317	3749	5626	444	2242	4277	1294	3675	55092	8614	63967	624	719	64866	29954	595	57007	9854	3732	4324	10675	5420	26018	4907	683	4856	7855	2583	8884	3976	2260	5069	79581	22926	115123	3872	3211	56937	943	4041	81839	10536
MEL18_DN.V1_DN	M2783		17452456	Wiederschain D,Chen L,Johnson B,Bettano K,Jackson D,Taraszka J,Wang YK,Jones MD,Morrissey M,Deeds J,Mosher R,Fordjour P,Lengauer C,Benson JD	GSE7578	Mel-18 vs Controls; bottom 150 genes			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in DAOY cells (medulloblastoma) upon knockdown of PCGF2 [Gene ID=7703] gene by RNAi.	Analysis of DAOY medulloblastoma cells following RNAi knockdown of Mel-18.					5100	3429	57084	5179	80303	2353	28959	1008	5121	9723	360	11061	3400	11037	9547	3773	684	6414	8522	203	8835	29105	23321	2620	7373	348	23213	8190	886	4129	1958	51454	5350	55365	760	114884	55601	3554	27087	10103	64641	10879	2537	8654	4061	1806	1844	1917	40	55848	4094	79090	9246	7107	2	10891	7111	57664	10451	9053	27115	55228	140597	7703	3433	23136	8519	55022	10562	5178	1396	25999	6590	3728	10102	3434	6337	28985	2070	23316	55816	4922	1381	9077	25975	1299	5997	2188	8633	8365	10406	55603	54112	2969	79870	9122	23236	79630	7020	4938	10481	1734	5950	1644	9317	6492	219654	23150	9531	4329	10379	54845	23171	64405	3398	9627	4287	29760	6657	1756	2042	10611	8935	9961	5274	1390	1124	51760	11036	5318	9747	744	57447	55683	5142	84789	23057	24148	2788	1382	9262	6451	5287	27165	23355	5264	8788	8842
MEL18_DN.V1_UP	M2784		17452456	Wiederschain D,Chen L,Johnson B,Bettano K,Jackson D,Taraszka J,Wang YK,Jones MD,Morrissey M,Deeds J,Mosher R,Fordjour P,Lengauer C,Benson JD	GSE7578	Mel-18 vs Controls; top 150 genes			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in DAOY cells (medulloblastoma) upon knockdown of PCGF2 [Gene ID=7703] gene by RNAi.	Analysis of DAOY medulloblastoma cells following RNAi knockdown of Mel-18.					83729	23657	51200	8140	8038	5744	1437	7130	51083	24147	23046	595	8425	3678	182	3782	1906	8614	7424	6509	4297	5069	3914	444	3976	1435	9945	22797	1969	8728	3624	6804	1839	8829	3575	26291	56937	81029	719	1294	624	80380	3037	1307	7010	4222	10536	8200	5045	5327	10123	5329	25966	83716	943	23400	3604	4316	8828	5026	2919	6573	6696	11182	4324	50515	50863	7075	9780	8061	2191	27286	771	3696	8744	6578	79669	375790	7049	28231	1520	55092	6536	4907	133	10184	6510	3675	1012	3676	3995	9120	4494	976	150094	2152	2827	3117	7436	6890	30001	5834	100507436	22885	54541	5361	7042	9076	9854	7422	1464	3710	2030	64866	8323	80149	9435	25777	8876	1663	3772	10057	6583	2784	1893	55240	4277	7301	26585	9308	3936	1305	26018	8840	63967	4023	9955	955	27099	9469	27092
PTEN_DN.V1_DN	M2786		17560336	Vivanco I,Palaskas N,Tran C,Finn SP,Getz G,Kennedy NJ,Jiao J,Rose J,Xie W,Loda M,Golub T,Mellinghoff IK,Davis RJ,Wu H,Sawyers CL	GSE7562	 PTEN ko vs control; bottom 200 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated upon knockdown of PTEN [Gene ID=5728] by RNAi.	A431, HCC827 and SKBR-3 cells were retrovirally and stably transduced with a small hairpin RNA targeting human PTEN. PTEN knockdown was confirmed at the protein level by western blot to be approximately 90%. PTEN-deficient sublines were named by adding the suffix PR(for PTEN RNAi) at the end of each of the parental cell line names. For example, PTEN deficient A431 cells are called A431-PR. RNA was extracted from each of the parental and PTEN-deificient lines. Each sample was done in duplicate (ie two chips per sample) for a total of twelve samples.					5055	5728	3887	79585	3113	25984	3115	23180	29944	6373	752	51046	7143	50839	5613	11191	92552	10507	23251	9348	5646	79366	7367	27231	1775	10468	1607	29108	29949	79816	51326	2791	6451	915	114897	8309	9739	79783	8838	9899	79623	89927	6527	3157	4703	5288	9934	51440	5053	3123	2268	117	6336	3452	51673	5645	3936	1116	10663	6317	646541	5446	51299	80329	2352	6019	10740	4988	84786	7368	5657	3211	4879	29021	6702	81616	3122	23460	51438	7310	1036	51156	23066	10046	8910	5270	2583	9855	1758	6926	3699	4148	2823	401466	23281	1008	79998	4160	164656	9071	4306	57834	4488	765	3126	64975	54813	3605	8825	2560	148229	8061	2515	5003	6563	434	1009	24147	2315	7431	378805	150160	7504	63934	79168	7039	189	5918	3766	6899	50506	22987	57118	64405	5629	3108	7691	115290	27156	3861	9957	7102	2014	80032	79954	30820	8807	84694	55054	976	80323	3824	5132	51384	9173	2119	722	9486	23562	643376	56548	3761	79934	23498	27094	55714	6402	5790	3119	8536	9086	1669	10317	8547	9808	5698	390616	4060	8360	26508	8821	399904	6360	10814	257	10439	7291
PTEN_DN.V1_UP	M2787		17560336	Vivanco I,Palaskas N,Tran C,Finn SP,Getz G,Kennedy NJ,Jiao J,Rose J,Xie W,Loda M,Golub T,Mellinghoff IK,Davis RJ,Wu H,Sawyers CL	GSE7562	 PTEN ko vs control; top 200 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated upon knockdown of PTEN [Gene ID=5728] by RNAi.	A431, HCC827 and SKBR-3 cells were retrovirally and stably transduced with a small hairpin RNA targeting human PTEN. PTEN knockdown was confirmed at the protein level by western blot to be approximately 90%. PTEN-deficient sublines were named by adding the suffix PR(for PTEN RNAi) at the end of each of the parental cell line names. For example, PTEN deficient A431 cells are called A431-PR. RNA was extracted from each of the parental and PTEN-deificient lines. Each sample was done in duplicate (ie two chips per sample) for a total of twelve samples.					1917	3625	4762	29965	1761	55816	51334	259217	79839	27087	79898	3443	8190	241	658	3346	65986	4121	9127	116372	51285	55506	55532	7062	3358	8796	5803	23261	5577	83468	2043	2207	57523	3212	1670	100507249	9132	5949	11131	441151	29124	6695	79370	7025	23635	2246	3224	6414	566	54874	9315	1208	79760	10912	79935	3010	56124	2558	6529	1584	3441	10100	25759	4118	9890	2123	1443	51196	3641	83439	9499	5241	1592	8484	54829	5723	9834	10319	347733	79812	56673	8839	4604	7345	63978	398	27240	27302	576	152	91227	55217	2775	5071	51700	7570	56143	83700	81553	136227	4675	939	9953	913	3689	23114	1906	3451	3231	91543	54504	1830	26189	2662	8999	51168	9806	54855	9194	5210	3250	9355	90134	10379	5172	1269	5795	727	6708	54996	256949	5997	29065	64922	57165	7412	717	1672	4210	8013	51266	525	5915	9242	51302	1949	10394	10639	2852	1140	90865	1952	4477	10628	64108	644872	6549	26958	3805	3351	4796	7140	7049	29122	8218	79611	11202	58157	4600	182	8302	4217	23143	1306	8997	150	8470	7991	627	5174	9506	22854	642733	5077	655	9514	29948	358	1630	10011	7088
NOTCH_DN.V1_DN	M2788		17560996	Dohda T,Maljukova A,Liu L,Heyman M,Grander D,Brodin D,Sangfelt O,Lendahl U	GSE6495	Control vs DAPT; top 200 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in MOLT4 cells (T-ALL) by DAPT [PubChem=16219261], an inhibitor of NOTCH signaling pathway.	NOTCH signaling in T-ALL cell lines. Three independent cultures of the MOLT4 cell line before and 48 hours after addition of the gamma-secretase inhibitor DAPT (5 uM).					1380	3397	3280	8111	4854	6590	54514	414	4613	1392	83446	23457	81848	8497	79136	79922	19	2219	10458	2525	23746	59349	5623	11197	10365	11228	84909	2217	162461	22853	7704	3679	25759	55061	54972	939	64663	51151	6588	767	10161	54714	8534	3732	54585	1469	9746	3680	762	51421	3002	2854	9362	4642	54436	3200	391427	4643	6926	55821	3589	10266	27141	9834	1102	26083	2196	55503	339524	4640	347733	64078	8477	6407	3753	11262	3741	3575	29802	30835	64386	79853	139081	3857	164656	1144	1395	80740	10526	26468	51161	5603	28999	29851	8875	4967	57191	64097	58503	3538	80228	346562	79149	9420	6981	760	6010	7638	8433	221078	26716	7625	10272	8448	3060	2833	8424	9593	57399	1193	6701	5004	3736	116832	943	1400	3960	80149	11132	2982	8529	3400	5866	10891	2277	1870	7222	2980	8993	4121	2838	57007	55332	7539	29007	4648	6337	8537	171558	59351	55179	3780	5054	6401	8743	5327	84830	5611	2567	55801	92086	5260	148229	64342	27159	114793	1734	8788	166614	79983	7980	4038	10437	4811	33	25992	60494	9033	79934	728448	55095	3122	3642	395	55389	81626	8812	719	1056
NOTCH_DN.V1_UP	M2789		17560996	Dohda T,Maljukova A,Liu L,Heyman M,Grander D,Brodin D,Sangfelt O,Lendahl U	GSE6495	Controls vs DAPT; bottom 200 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in MOLT4 cells (T-ALL) by DAPT [PubChem=16219261], an inhibitor of NOTCH signaling pathway.	NOTCH signaling in T-ALL cell lines. Three independent cultures of the MOLT4 cell line before and 48 hours after addition of the gamma-secretase inhibitor DAPT (5 uM).					5896	9855	56172	55765	9510	4210	23380	92211	23500	1026	2902	5470	3757	7773	11076	273	3434	7137	2649	6773	6006	3973	79935	80112	1420	1396	64288	11328	8900	4330	23434	29113	51270	2569	6527	6344	283871	652147	1137	25841	63910	3783	7771	5988	9162	5624	55714	8538	80352	305	10218	55295	6236	23467	1282	4888	4617	400961	5024	54825	64377	84679	54842	2533	2791	8436	3303	23303	51733	57000	10401	6712	80823	5997	9328	23335	3628	26239	3750	10848	51715	1358	440334	9754	3998	1428	3162	5959	793	643224	10536	91683	732	11238	51378	55885	5897	57513	57825	8986	1489	651803	3195	5592	10343	55664	79809	10125	6334	55721	2940	3346	9903	9229	9937	90133	79789	22849	1944	23641	3824	92170	2322	11148	3875	7046	10746	50943	80339	5197	1805	6102	2979	55532	2668	22927	50674	6279	51440	64850	10686	55057	9150	7941	5566	11033	7145	9289	8844	55760	8823	51087	79891	26532	79738	8814	10518	80271	25789	860	2258	8526	54901	29122	29044	4759	11254	4214	79740	6523	8382	7041	11040	23591	482	56660	9739	55321	22847	55630	57523	4884	5028	1360	944	11082	55040	54961	24142	10396	140462	64901	7832
EIF4E_DN	M2790		17638893	Larsson O,Li S,Issaenko OA,Avdulov S,Peterson M,Smith K,Bitterman PB,Polunovsky VA	GSE6043	overexpression of eIFGI vs control; top 100 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in HMEC cells (primary mammary epithelium) upon over-expression of EIF4E [Gene ID=1977] gene.	Translation initiation factor 4E confers primary human cells with neoplastic properties. A comparison of HMEC/hTERT and HMEC/hTERT/eIF4E cells using both total and polyribosoaml associated RNA.					987	6840	137075	7163	9903	54845	5743	4628	55586	9321	355	7318	85450	57703	64778	1075	54832	6617	26751	55749	10513	7976	10087	9317	9520	3840	57609	8087	9522	54749	55342	1545	7159	843	9897	9685	25966	5328	222698	135112	23387	154043	26019	79961	23150	4318	1213	55023	91107	8481	23215	2517	6272	10507	7158	51164	23054	79648	4016	57212	195814	6291	8826	57496	58472	5166	10549	4651	718	51244	7105	11227	56300	51742	90826	1102	80216	23327	8754	283537	23001	6776	79668	9743	93627	54477	1793	10724	55031	1604	57700	10318	51129	4008	2627	4217	130367	6288	5903	57634
EIF4E_UP	M2791		17638893	Larsson O,Li S,Issaenko OA,Avdulov S,Peterson M,Smith K,Bitterman PB,Polunovsky VA	GSE6043	overexpression of eIFGI vs control; top 100 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in HMEC cells (primary mammary epithelium) upon over-expression of EIF4E [Gene ID=1977] gene.	Translation initiation factor 4E confers primary human cells with neoplastic properties. A comparison of HMEC/hTERT and HMEC/hTERT/eIF4E cells using both total and polyribosoaml associated RNA.					25822	79717	6888	10397	26272	60488	10319	201254	8834	222235	3747	55559	9607	5202	79177	3417	10598	79413	6641	10651	285555	79622	399693	29058	79672	84315	10360	283951	63875	5606	30851	10534	79763	2173	134492	140809	6944	84661	2306	400931	1797	114884	9479	9551	5805	54522	9775	1160	79447	29886	51160	9191	7263	51027	26257	56902	4234	152330	7284	3078	7390	148229	94032	8266	55316	441150	140876	11279	7347	51263	7940	79833	65265	9929	97	118487	7434	4191	5373	257194	4624	51491	651	931	3606	9537	84284	10591	3705	5644	26998	5998	56061	404672	784	253512	2281	85007	6882	81558
RPS14_DN.V1_DN	M2812		18202658	Ebert BL,Pretz J,Bosco J,Chang CY	GSE9487	RPS14 shRNA KD vs control; bottom 200 genes			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in CD34+ hematopoietic progenitor cells after knockdown of RPS14 [Gene ID=6208] by RNAi.	We performed genome-wide expression profiling of cells infected with control or RPS14 shRNAs.					761	420	11013	23348	29968	116987	79767	440	875	3397	55872	119	8706	8490	1266	5313	54821	2013	7052	79094	79628	23650	7180	200315	1400	79366	23109	222642	2140	5091	8444	79644	11075	5118	55222	4285	7283	83461	10046	55388	79733	131601	55366	9700	23409	83660	7083	79694	4653	79901	80020	586	4288	2022	79711	9319	8877	3574	5347	51293	3177	3619	283459	4605	6274	9159	56992	89874	5831	7280	9532	54922	29028	2030	6710	4998	4628	3601	705	60558	6723	1621	29116	51083	9824	9156	10534	78989	4744	790	482	10112	25786	7855	56967	9631	3268	730101	741	55466	79723	3798	1894	139322	56652	1062	7021	27079	80179	3860	6470	11004	347733	26271	79696	6182	7407	9055	314	4436	63826	6535	990	5909	1039	55975	210	4072	55055	2742	166647	1317	51337	5424	222658	9531	9133	8501	28992	9787	3196	51236	55635	9238	10196	1183	9493	23397	51116	23395	51154	2068	54475	2639	4194	2035	9185	64318	94009	22795	2941	4174	54865	8078	55240	23212	10874	23563	7625	22837	25959	8891	23481	991	84298	2532	79763	2968	221830	5105	55706	50628	51659	6234	55149	11153	27229
RPS14_DN.V1_UP	M2816		18202658	Ebert BL,Pretz J,Bosco J,Chang CY	GSE9487	RPS14 shRNA KD vs control; top 200 genes			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in CD34+ hematopoietic progenitor cells after knockdown of RPS14 [Gene ID=6208] by RNAi.	We performed genome-wide expression profiling of cells infected with control or RPS14 shRNAs.					6347	27299	27290	1026	793	7941	330	10457	4688	6696	29774	63036	2012	3950	3576	929	59	6328	1960	64581	597	5375	7045	115207	5168	23601	9450	5800	54677	4599	22797	4600	11240	7940	64393	645323	79895	306	5791	1378	4088	55640	23643	23179	7107	7127	3687	822	4352	11174	10346	2201	26999	1991	1368	1520	29969	23312	51554	1088	55521	9976	150	4094	8842	223117	566	55022	9462	1102	8564	6692	5328	10769	10402	3109	10261	64231	8820	6866	79962	196475	3556	7305	9518	81855	3119	1545	25780	151011	9934	1475	8900	50650	55304	1880	6457	7450	5730	3428	9404	1511	56833	11031	309	785	81035	64866	23462	2781	64787	834	4065	2517	388	10129	6653	2123	54502	4082	9938	2672	8013	969	290	5144	9467	3108	3553	2153	9047	199	10602	54212	9920	57103	8876	53346	3689	3490	29992	54440	27063	214	5154	6346	719	1512	56253	100	10800	3128	54453	182	3683	3604	10123	5197	5734	2124	57523	26191	1318	928	5793	27244	10394	10681	5205	8942	4680	604	6385	2162	3055	5657	8794	140885	3684	51816	2697	4818	1634	683	4542	11314	3126	51232	3385	29108	4332	6809
IL15_UP.V1_DN	M2818		18281483	Marzec M,Halasa K,Kasprzycka M,Wysocka M,Liu X,Tobias JW,Baldwin D,Zhang Q,Odum N,Rook AH,Wasik MA	GSE8685	Sez-4 cells starved of IL-2 and activated with IL-15 vs Sez-4 cells starved of IL-2; bottom 200 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in Sez-4 cells (T lymphocyte) that were first starved of IL2 [Gene ID=3558] and then stimulated with IL15 [Gene ID=3600].	Sez-4 cell line was starved of IL2 for 16h, washed twice and placed into 6-well plates in 10ml RPMI (10% FBS) for 2 h followed by addition of IL-15 (20ng/mL) or medium alone for 4 h.					2138	64757	1028	57126	777	3749	10368	6947	6590	3357	1272	51276	23541	7450	1942	7053	971	2535	6019	79843	10396	80215	2859	2123	4638	126353	10077	59353	9509	9976	55204	2668	266	26115	6588	6857	8792	5104	135948	10017	225	4222	4889	6403	64446	5608	54996	50617	80031	5730	79921	3784	2780	83447	253982	4327	3750	26959	57644	80737	283212	79981	84099	10279	79173	64759	55779	64798	5010	88	55357	113791	2116	92558	10043	11086	50835	57097	29068	54831	79999	9495	4033	5449	6568	50834	3565	58985	9639	8328	8513	2524	28815	7127	23553	10123	57115	55857	6274	26238	356	80823	3787	27250	2239	8842	8356	339	80188	284266	27244	1047	1419	56729	7038	80231	5592	56132	151011	6036	2669	8484	6591	6123	2877	9884	57608	23316	957	1482	8038	26059	51560	3849	51339	730101	6665	56981	51285	9886	2059	26333	23120	388699	55805	9407	2312	51700	79847	901	3239	10628	147	116039	6328	728577	2974	10272	10894	54361	63978	1838	55366	56967	100505741	1393	2742	1087	30819	9287	54453	5334	1795	79930	1831	1470	3960	6676	64641	10957	140803	6638	1811	114825	653483	729230	57326	7041	1118	64123
IL15_UP.V1_UP	M2819		18281483	Marzec M,Halasa K,Kasprzycka M,Wysocka M,Liu X,Tobias JW,Baldwin D,Zhang Q,Odum N,Rook AH,Wasik MA	GSE8685	Sez-4 cells starved of IL-2 and activated with IL-15 vs Sez-4 cells starved of IL-2; top 200 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in Sez-4 cells (T lymphocyte) that were first starved of IL2 [Gene ID=3558] and then stimulated with IL15 [Gene ID=3600].	Sez-4 cell line was starved of IL2 for 16h, washed twice and placed into 6-well plates in 10ml RPMI (10% FBS) for 2 h followed by addition of IL-15 (20ng/mL) or medium alone for 4 h.					1958	1959	3586	5008	7098	23764	1848	1960	28984	2527	8061	7293	4616	3596	993	8835	5998	7421	2323	5727	8140	9447	1154	3976	29094	5292	25907	80163	6387	6696	6504	116492	10849	6004	126321	9746	51330	91860	11040	3177	115207	7975	650	11006	57493	1001	6366	5978	27033	54913	11132	8600	164656	51678	9781	55687	3099	4066	3667	5339	84928	3759	333	28231	4056	5619	7804	969	142684	10622	58158	26504	4046	10947	8807	5745	54896	3104	1581	94	50943	80152	57602	80324	79693	1608	388	1746	56924	6510	6579	54923	5409	653423	5645	51341	5672	9816	3726	79850	3552	3224	51308	1846	3993	4094	26145	80223	5373	196	9957	5733	54596	63898	6692	9953	56652	91695	200424	54517	79767	92822	1844	27242	55150	8651	23046	7755	55911	2353	23591	256949	26628	92609	8728	8864	3860	191585	1893	262	51171	357	6351	5778	7762	79175	10253	65263	6695	51200	9249	645619	3567	57050	80256	5075	10447	735	26664	7026	4839	898	57823	25961	11007	57223	51806	25816	50507	11255	10749	8459	79740	2875	80110	3625	55558	5141	2118	645784	3765	10221	9441	3604	55610	56902	390998	10656	6271	388796	3026	7855
IL2_UP.V1_DN	M2820		18281483	Marzec M,Halasa K,Kasprzycka M,Wysocka M,Liu X,Tobias JW,Baldwin D,Zhang Q,Odum N,Rook AH,Wasik MA	GSE8685	Sez-4 cells starved of IL-2 and activated with IL-2 vs Sez-4 cells starved of IL-2; bottom 200 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in Sez-4 cells (T lymphocyte) that were first starved of IL2 [Gene ID=3558] and then stimulated with IL2 [Gene ID=3558].	Sez-4 cell line was starved of IL2 for 16h, washed twice and placed into 6-well plates in 10ml RPMI (10% FBS) for 2 h followed by addition of IL-2 (200U) or medium alone for 4 h.					1028	3357	23586	6857	126353	9751	2138	10586	9886	10686	64759	11126	10368	51146	26959	64757	54453	26503	2123	55663	1179	90362	26115	56906	57116	10279	56001	1962	266	57608	1143	27284	64806	3623	5063	339	25780	79935	9976	3579	79802	6588	79841	6036	55204	8352	1945	5158	225	1056	947	100505741	5087	51285	80031	8292	395	10957	84324	11077	4222	55805	23007	55779	8200	80177	79921	54959	149076	388699	8969	5333	3202	5137	50853	55566	7773	5334	7010	7102	6328	57326	64927	23541	80231	27250	55057	1269	7038	901	7053	79843	253982	27244	54996	64798	55507	2535	80345	6096	92558	6123	9884	326	8856	8842	79087	51276	79932	1114	80201	10014	4674	4638	9671	3670	55766	3787	8484	971	57172	29114	5341	81622	777	579	7140	10690	55220	55	55266	8513	9187	10628	2165	2515	346157	151050	5592	3606	9891	79874	2212	23316	2977	79797	10123	8284	6591	29970	55281	1469	387569	5997	5608	283677	7127	5527	27158	9915	2877	23361	6755	8503	5450	653483	60494	7976	4250	28951	4308	5125	5030	9863	9914	55506	10806	2322	23148	25840	8605	26238	869	283761	10858	80168	26059	10384	3512	4316	6503	10151	9940	11119	7404	79940
IL2_UP.V1_UP	M2822		18281483	Marzec M,Halasa K,Kasprzycka M,Wysocka M,Liu X,Tobias JW,Baldwin D,Zhang Q,Odum N,Rook AH,Wasik MA	GSE8685	Sez-4 cells starved of IL-2 and activated with IL-2 vs Sez-4 cells starved of IL-2; top 200 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in Sez-4 cells (T lymphocyte) that were first starved of IL2 [Gene ID=3558] and then stimulated with IL2 [Gene ID=3558].	Sez-4 cell line was starved of IL2 for 16h, washed twice and placed into 6-well plates in 10ml RPMI (10% FBS) for 2 h followed by addition of IL-2 (200U) or medium alone for 4 h.					1959	1958	3586	5008	23764	28984	7098	1848	1960	2353	7293	3596	4616	8061	7421	8835	5998	993	126321	1154	6504	6004	5292	8140	3976	51330	9447	91860	6387	11006	5727	8600	11132	79175	6696	27033	11040	10849	650	164656	2125	1608	51678	23046	3738	57493	29094	91695	3099	63971	25907	2875	969	9816	23630	2323	27180	8590	7804	8807	7162	26290	11230	80758	9781	80163	54913	2797	57292	80004	54896	7447	79767	55558	80324	388	11007	10749	8612	2321	9625	2151	3552	3625	79850	3467	50858	388796	6510	1844	81492	28231	64866	5304	10221	2128	1001	3680	10622	3177	443	8877	23639	1953	9249	5778	22866	79693	7399	56652	27242	3667	8740	8728	79703	23158	79917	10947	79651	63898	3360	80223	57718	685	347902	1233	115207	1846	8645	56924	6569	8651	3755	23413	22927	96610	7762	84223	196	3604	8676	3726	29935	56676	56254	7855	65263	5580	303	2562	4071	5373	26476	56157	5339	2921	23766	55687	7122	5978	55885	645619	25841	2670	30846	54517	5745	124044	2355	3207	1316	7026	6515	26628	29122	7133	10253	57602	50943	22914	1043	5881	9032	8838	60673	50833	5141	3567	3643	25816	8659	284403
IL21_UP.V1_DN	M2824		18281483	Marzec M,Halasa K,Kasprzycka M,Wysocka M,Liu X,Tobias JW,Baldwin D,Zhang Q,Odum N,Rook AH,Wasik MA	GSE8685	Sez-4 cells starved of IL-2 and activated with IL-21 vs Sez-4 cells starved of IL-2; bottom 200 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in Sez-4 cells (T lymphocyte) that were first starved of IL2 [Gene ID=3558] and then stimulated with IL21 [Gene ID=59067].	Sez-4 cell line was starved of IL2 for 16h, washed twice and placed into 6-well plates in 10ml RPMI (10% FBS) for 2 h followed by addition of IL-21 (100 ng/ml) or medium alone for 4 h.					84099	51146	1114	3934	3891	43	23316	10279	1609	95681	8777	5449	7137	50835	5158	80737	7464	9890	3791	3749	56171	6567	1056	55743	79747	54210	4992	5341	57126	3787	3045	8330	5332	140467	10864	7100	2160	29944	54453	2251	9113	23148	1419	29949	5121	91355	1761	5260	7078	728577	8372	57608	23541	10017	84830	55888	81571	54831	2877	971	2974	162972	135138	7141	3458	5137	10050	79843	5544	55663	5161	6360	23143	6332	5139	54361	56132	29948	4081	388569	2936	51301	2843	25849	5593	83447	92	3218	55805	6658	23641	2165	64123	2244	9378	4543	2242	1149	79746	253982	8383	28815	5592	57335	389856	9287	80201	11274	8448	2668	1240	6369	135948	2719	51471	8823	51298	4018	64129	126353	54769	4223	4037	54581	22903	3655	7038	4908	885	92558	50834	3882	4889	542767	57731	25802	25787	147	5730	9071	9177	5101	26503	9633	7021	326	3673	2059	55691	339457	5506	1946	3592	7711	6671	55103	8756	5629	29984	1577	283927	55799	8120	4747	4638	2707	2239	3034	55220	387569	2979	7102	959	645682	4693	8287	3898	79899	388699	6568	6900	64581	23361	10268	80024	10858	10863
IL21_UP.V1_UP	M2827		18281483	Marzec M,Halasa K,Kasprzycka M,Wysocka M,Liu X,Tobias JW,Baldwin D,Zhang Q,Odum N,Rook AH,Wasik MA	GSE8685	Sez-4 cells starved of IL-2 and activated with IL-21 vs Sez-4 cells starved of IL-2; top 200 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in Sez-4 cells (T lymphocyte) that were first starved of IL2 [Gene ID=3558] and then stimulated with IL21 [Gene ID=59067].	Sez-4 cell line was starved of IL2 for 16h, washed twice and placed into 6-well plates in 10ml RPMI (10% FBS) for 2 h followed by addition of IL-21 (100 ng/ml) or medium alone for 4 h.					7421	4066	9625	654096	58529	9746	84223	2354	1001	5075	116492	11006	51200	5745	10333	126321	2893	79152	55190	4597	25850	65009	9447	23111	26504	3177	5806	5798	81848	886	1511	27074	1959	5645	26298	56157	8612	11132	6833	5292	1608	84107	84179	3854	646621	79957	9743	3748	400961	96610	3902	8807	6335	11245	4843	56123	10610	79814	55259	28984	8482	51257	388567	29930	974	57292	7975	7629	8140	116986	2306	29122	54329	3982	1675	9159	84561	51272	8590	6271	6696	11040	8938	81796	8459	64386	8404	2983	83880	7253	462	7162	22989	6334	666	3360	383	6337	3212	644963	23046	1593	1893	7512	1116	3381	867	22927	7005	91543	2196	1775	9077	4920	9153	80149	7368	27302	1003	4622	10536	4159	10062	8647	6750	7447	10570	4818	91977	2774	7098	10637	2903	79160	6387	7941	5959	5458	8659	3700	9099	83448	80199	7018	11012	604	4582	1306	4987	4359	9934	5837	2696	57493	6579	50833	55687	23460	196993	56311	303	1750	6785	10439	2562	440334	9149	192666	2128	923	23676	54991	11170	2661	51046	1366	55296	4829	152992	81693	54913	58504	729	3008	56143	5800	92106	26257	9074	63970	6692	3976	11272
PDGF_ERK_DN.V1_DN	M2828		18312689	Antipova AA,Stockwell BR,Golub TR	GSE7403	PDGF stimulation after ERL inhibition vs Controls; bottom 300 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in SH-SY5Y cells (neuroblastoma) in response to PDGF [Gene ID=] stimulation after pre-treatment with the ERK inhibitors U0126 and PD98059 [PubChem=3006531, 4713].	To define ERK/PDGFR activation signature, SH-SY5Y cells were grown to confluence and starved overnight in serum-free medium in order to silence any sustained effects from growth factor signaling. Prior to induction with 50ng/ml PDGF, cells were treated with pathway inhibitors 74 mM Apigenin or 50 mM U0126, or with DMSO (carrier) for 60 minutes. Total RNA was isolated 30 minutes after PDGF addition. Experiments were performed in duplicate. The RNA was processed and hybridized with Affymetrix U133A GeneChips.					4792	1848	10253	4609	1843	4613	4081	10221	6903	11070	7071	11232	8915	144699	30850	9587	5514	5187	10957	1944	8772	2959	4189	2535	4744	23764	22992	388	1876	758	11236	694	3726	22870	23357	1850	5156	4092	134728	29901	23625	4245	6520	7841	9673	3660	84975	7746	4052	10279	8445	9997	3694	11039	9450	1051	944	9704	1027	2077	23401	4215	91369	4335	22879	10293	26048	5409	23119	5526	23240	6909	4958	3561	5494	154754	6315	23639	3337	4097	26098	899	5546	9755	23032	4783	64410	10297	133	3575	9925	399665	53615	1958	27237	7862	11064	9854	6817	23515	3725	3425	51491	157627	1164	10755	339044	113878	24144	29781	23761	25972	5595	9275	646	607	25988	901	1948	7050	79441	50999	23181	9600	26240	8929	8834	25799	10263	3860	3670	9529	57215	669	23152	438	2904	6253	23082	678	80028	55631	54498	6821	7753	6621	5141	23239	382
PDGF_ERK_DN.V1_UP	M2830		18312689	Antipova AA,Stockwell BR,Golub TR	GSE7403	PDGF stimulation after ERL inhibition vs Controls; top 300 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in SH-SY5Y cells (neuroblastoma) in response to PDGF [Gene ID=] stimulation after pre-treatment with the ERK inhibitors U0126 and PD98059 [PubChem=3006531, 4713].	To define ERK/PDGFR activation signature, SH-SY5Y cells were grown to confluence and starved overnight in serum-free medium in order to silence any sustained effects from growth factor signaling. Prior to induction with 50ng/ml PDGF, cells were treated with pathway inhibitors 74 mM Apigenin or 50 mM U0126, or with DMSO (carrier) for 60 minutes. Total RNA was isolated 30 minutes after PDGF addition. Experiments were performed in duplicate. The RNA was processed and hybridized with Affymetrix U133A GeneChips.					4351	53820	25770	6898	4692	1021	5394	9976	2742	81691	81887	7922	5730	317662	7915	8804	91754	6883	6634	27099	7739	2923	10825	6480	23595	399979	5480	4043	9410	6311	4524	7188	1069	10615	23070	7139	10098	338645	23105	91860	4133	9920	57515	64963	10391	10141	27232	3812	23593	26027	26610	10428	6314	4948	116492	79719	9924	4829	23016	22994	64149	4128	11199	10454	4107	5376	5935	11340	138046	3069	23262	360	7507	22926	3624	9873	5076	3071	51594	1300	140597	730013	2745	5650	5019	6238	11166	5978	3084	4607	1181	118491	8204	23109	311	2596	84107	8555	22854	4843	22920	9014	3447	8634	57187	2313	5699	55534	4598	310	9738	5917	7262	10867	4643	2591	3998	404672	440992	23339	7637	5055	3594	5586	23279	22934	4034	6910	11200	6370	54	3061	7266	23673	9540	6736	23075	1277	4281	22824	284352	4986	54741	113	4719	3373	1373
PDGF_UP.V1_DN	M2832		18312689	Antipova AA,Stockwell BR,Golub TR	GSE7403	PDGF stimulation vs Controls; bottom 300 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in SH-SY5Y cells (neuroblastoma) in response to PDGF [Gene ID=] stimulation.	To define ERK/PDGFR activation signature, SH-SY5Y cells were grown to confluence and starved overnight in serum-free medium in order to silence any sustained effects from growth factor signaling. Prior to induction with 50ng/ml PDGF, cells were treated with pathway inhibitors 74 mM Apigenin or 50 mM U0126, or with DMSO (carrier) for 60 minutes. Total RNA was isolated 30 minutes after PDGF addition. Experiments were performed in duplicate. The RNA was processed and hybridized with Affymetrix U133A GeneChips.					9450	26952	10279	1287	9154	944	1823	25878	7374	26238	2123	51363	5644	2201	29044	284649	8372	10990	1501	602	6543	1543	6295	5196	5071	3694	4052	23430	2212	3575	650610	5595	23371	1628	4958	157627	717	3860	154754	56267	8029	26538	6549	3984	886	4487	54552	33	1278	2710	11262	3507	3811	80868	146542	51341	5327	669	10661	3010	2863	316	8745	416	5324	6315	6708	1381	7556	9058	5526	6555	3231	304	213	3605	26045	10407	9886	7078	5172	3113	415	8556	8553	643093	28461	27287	651	5883	23268	1418	4036	647070	10512	6357	54581	4157	10293	3012	1410	9730	4070	80086	1950	1576	348035	108	9365	54474	8916	155	904	11221	5002	23032	4065	5051	1908	94	6909	3725	9053	51706	8552	27296	2694	2359	55056	56243	688	8115	10578	3806	1836	57051	496	5100	444	869	7582	1186
PDGF_UP.V1_UP	M2834		18312689	Antipova AA,Stockwell BR,Golub TR	GSE7403	PDGF stimulation vs Controls; top 300 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in SH-SY5Y cells (neuroblastoma) in response to PDGF [Gene ID=] stimulation.	To define ERK/PDGFR activation signature, SH-SY5Y cells were grown to confluence and starved overnight in serum-free medium in order to silence any sustained effects from growth factor signaling. Prior to induction with 50ng/ml PDGF, cells were treated with pathway inhibitors 74 mM Apigenin or 50 mM U0126, or with DMSO (carrier) for 60 minutes. Total RNA was isolated 30 minutes after PDGF addition. Experiments were performed in duplicate. The RNA was processed and hybridized with Affymetrix U133A GeneChips.					2353	23237	7980	1847	1958	4665	11066	127544	1026	898	8720	25907	4043	2791	5209	4999	150094	8061	10294	9277	3306	8941	54898	8560	1021	2109	23279	4435	8140	51031	9410	7071	10794	11021	9841	10472	54541	6634	4326	6311	5702	9920	9672	2230	54454	2286	4692	4893	7188	27099	467	10825	8535	26102	7922	8505	9759	200424	6574	55702	317662	9320	5023	8567	6793	5597	284352	3354	57343	3071	6526	6675	56650	3454	81887	1119	993	22880	4739	22926	1960	84124	28232	1647	310	8754	10966	7430	25940	440915	24145	2794	85458	23339	7403	24144	9414	440423	29899	23299	4719	9929	57187	10447	4633	8800	6047	51594	26953	23545	990	3069	151011	9816	57515	830	22899	26027	5274	65009	60436	54623	5706	2114	5394	9604	26610	64963	55233	3624	407	6370	4660	51103	84733	26212	57050	3777	27257	3267	7779	6883	374	6314	4829	4351
TGFB_UP.V1_DN	M2838		18394990	Padua D,Zhang XH,Wang Q,Nadal C,Gerald WL,Gomis RR,Massagué J	E-TABM-420	stimulation with TGFB vs control; bottom 200 genes			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in a panel of epithelial cell lines by TGFB1 [Gene ID=7040].	A gene expression signature typifying the TGFbeta response in human epithelial cells was obtained from transcriptomic analysis of four human cell lines (Figure 1A, Supplementary Figure 1). These cell lines include HaCaT keratinocytes, HPL1 immortalized lung epithelial cells, MCF10A breast epithelial cells, and MDA-MB-231 breast carcinoma cells. The cells were treated with TGFB1 for 3 h in order to capture direct TGFbeta gene responses .					57007	9792	5362	1282	3433	4092	1027	10370	57089	5997	10214	2251	744	7026	7779	2920	10272	2919	81930	9957	7738	2275	55893	84159	9510	2188	8436	55366	4603	7479	116039	51272	8608	11162	1404	60370	78990	7010	9530	154	84981	6621	1146	6526	10451	51129	1525	55435	330	56300	1571	2123	54795	7100	9451	765	3398	3298	10265	10020	5727	55734	5509	4593	859	23401	64778	26747	55638	10647	9815	80122	5923	2863	23036	624	54502	604	7286	3670	4330	7020	57473	4303	1848	10633	23240	23005	3659	54913	79156	7158	1846	23179	8503	56260	23012	57037	2070	144699	1144	60485	23613	23417	26033	54894	11055	56548	29923	5670	388397	8819	23586	81579	9911	3339	92346	54852	64968	10253	7056	2770	2643	9095	3397	22841	79943	26298	80023	9976	79628	26333	3284	79873	55890	60686	147339	84658	51768	9520	7368	57613	1962	80173	8336	27343	5734	23150	79605	10817	10559	11039	3437	5806	5193	55204	3434	9363	7379	22834	79714	2625	10252	79170	4861	7216	9562	79922	57716	5414	81576	4254	8547	3663	10742	8799	6502	9699	7018	54039	10144	3484	7625	79173	79176	51281	4286	23682	55633	6610	79364	23338
TGFB_UP.V1_UP	M2839		18394990	Padua D,Zhang XH,Wang Q,Nadal C,Gerald WL,Gomis RR,Massagué J	E-TABM-420	stimulation with TGFB vs control; top 200 genes			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in a panel of epithelial cell lines by TGFB1 [Gene ID=7040].	A gene expression signature typifying the TGFbeta response in human epithelial cells was obtained from transcriptomic analysis of four human cell lines (Figure 1A, Supplementary Figure 1). These cell lines include HaCaT keratinocytes, HPL1 immortalized lung epithelial cells, MCF10A breast epithelial cells, and MDA-MB-231 breast carcinoma cells. The cells were treated with TGFB1 for 3 h in order to capture direct TGFbeta gene responses .					55323	8843	286	635	3694	400961	6498	6038	7066	3142	10382	6446	3667	7942	2244	3373	79780	79633	6236	5154	23592	5569	8553	54498	81555	4616	29995	5521	51343	25841	4216	3269	6615	5128	659	8877	9173	56603	838	2324	3726	6926	2114	1474	3976	23187	3589	55602	6876	54520	2043	9267	3783	4142	6578	9935	80176	22877	25816	676	10221	7071	913	5209	79037	23174	4053	80759	50515	1160	23205	57154	10849	4908	8609	1836	100132285	10848	23529	23102	23531	54874	51339	2004	9519	203197	54880	23189	9956	1644	4606	2150	9590	54361	23648	94134	126353	8572	6274	6781	1906	5553	9332	3352	221037	10395	8445	9693	467	9314	56995	64750	6525	28984	9057	3340	116372	3725	53616	7090	9306	9853	7473	5412	4803	1490	23210	6862	57591	23541	65981	29970	221749	55547	4776	55279	3678	9767	388	8631	23135	25786	23186	4091	5467	7476	6002	9617	81626	56937	23333	5376	127544	5155	1436	28815	9612	9388	29949	22936	27042	1030	677	9619	23141	10979	59338	1591	9469	58494	2295	58495	1573	57234	2246	84951	10205	1307	51384	3399	8786	29967	4146	7481	10786	1410	54797	2297	79905	376412	5293	1454
YAP1_DN	M2841		18413746	Zhang J,Smolen GA,Haber DA	GSE10196	YAP1 vs control; bottom 50 genes			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in MCF10A cells (breast cancer) over-expressing YAP1 [Gene ID=10413] gene.	MCF10A cells were infected with retrovirus constructs (vector or YAP) and puromycin was used to select for transduced cells. Cells were split and grown to ~60-75%% confluency at which point they were harvested for RNA. Vector vs. YAP comparison was done in duplicate.					8309	3673	150082	9671	9028	4999	128854	84720	10300	5989	5546	285281	79896	8994	283547	55592	83639	9880	158506	3566	132141	81554	29116	55231	149420	7078	164832	9152	728242	284023	7363	159091	7447	11153	139818	50837	9248	10930	54927	9358	57030	642775	6548	23462	2984	785	4430	352999
YAP1_UP	M2845		18413746	Zhang J,Smolen GA,Haber DA	GSE10196	YAP1 vs control; top 50 genes			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in MCF10A cells (breast cancer) over-expressing YAP1 [Gene ID=10413] gene.	MCF10A cells were infected with retrovirus constructs (vector or YAP) and puromycin was used to select for transduced cells. Cells were split and grown to ~60-75%% confluency at which point they were harvested for RNA. Vector vs. YAP comparison was done in duplicate.					10512	1267	23197	23325	54414	84441	157773	1643	9639	145788	4638	7003	23433	10211	541565	8773	1749	6185	54981	5568	28984	29998	83648	54680	4893	56660	149345	4478	1580	83987	814	4338	10423	5218	404636	3996	84705	128338	23180	7534	64092	57799	1351	114971	63932	54537	51375
SIRNA_EIF4GI_DN	M2846		18426977	Ramirez-Valle F,Braunstein S,Zavadil J,Formenti SC,Schneider RJ	GSE11011	control vs RNAi KD eIFGI; bottom 100 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in MCF10A cells vs knockdown of EIF4G1 [Gene ID=1981] gene by RNAi.	eIF4GI Links Nutrient Sensing by mTOR to Cell Proliferation and Inhibition of Autophagy. Two sets of experiments are presented. First, overall transcriptome changes were determined for control or eIF4GI silenced cells. Next, mRNAs associated with polysomes were compared between control and eIF4GI silenced cells.					3290	51400	93349	4734	11216	8992	8550	55257	80179	11235	728461	29015	25966	10197	1039	9873	80196	6732	171546	10929	8076	55777	1009	378708	23300	140609	5090	1080	8491	56648	1901	6347	51542	3612	4017	57030	51438	1031	65005	84694	10274	10282	2528	3682	29887	8050	4615	55319	990	9699	10190	55093	10389	50813	5915	54851	57415	26128	29893	6747	9319	8350	611	10010	7224	9060	79602	3113	64750	79801	51144	493	11167	7879	8226	55578	10495	97	54942	54360	5147	80008	80122	10644	6675	1846	8767	5376	55254	10617	1317	10671	114897	6882	11049	5861	2689	63901	4122
SIRNA_EIF4GI_UP	M2847		18426977	Ramirez-Valle F,Braunstein S,Zavadil J,Formenti SC,Schneider RJ	GSE11011	control vs RNAi KD eIFGI; top 100 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in MCF10A cells vs knockdown of EIF4G1 [Gene ID=1981] gene by RNAi.	eIF4GI Links Nutrient Sensing by mTOR to Cell Proliferation and Inhibition of Autophagy. Two sets of experiments are presented. First, overall transcriptome changes were determined for control or eIF4GI silenced cells. Next, mRNAs associated with polysomes were compared between control and eIF4GI silenced cells.					25821	7508	3635	2204	678	6579	27429	57402	9869	79783	292	8839	79039	25875	3032	10575	1512	6767	4358	501	10758	5160	4728	1052	4841	9918	427	158	5859	10628	63892	6699	760	23344	23741	64065	3329	5720	79600	6288	1075	54826	23401	23111	6698	51056	9189	445	467	23403	10884	27335	7812	3796	7385	498	79009	23220	8904	3106	476	1434	9782	9061	4043	2937	25813	1632	1728	57175	4733	5349	9512	7138	55726	7324	3482	22980	55005	64110	5660	7832	5783	51016	27065	5836	3315	2746	375056	25777	2838	1605	5250	10939	819
HOXA9_DN.V1_DN	M2848		19056693	Faber J,Krivtsov AV,Stubbs MC,Wright R,Davis TN,van den Heuvel-Eibrink M,Zwaan CM,Kung AL,Armstrong SA	GSE13714	HOXA9sh vs GFPshl; top 200 genes (diff-means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in MOLM-14 cells (AML) with knockdown of HOXA9 [Gene ID=3205] gene by RNAi vs controls.	RNA was purified from t(9;11) MOLM-14 AML cells 44h after transduction in triplicates with 2 of the two most effective HOXA9shRNA constructs (3 x 1F3-HOXA9shRNA; 3 x 2A5-HOXA9shRNA) or GFP-controlshRNA (6x).					8358	10204	64853	5996	6307	133	6004	6696	1849	3177	2213	239	79733	5163	8048	8530	6515	10672	1595	586	51164	3157	55893	4211	6747	27161	1958	7545	23329	230	5925	10477	3485	29044	57228	990	25895	4885	6915	4775	2824	1717	26136	2212	6518	22809	4430	4351	79718	51368	8895	84296	6667	55732	1891	23558	3070	2557	55104	28992	81620	4998	56681	4852	220	55159	10953	81539	10733	9781	8318	4597	55668	9363	64785	79979	2189	1396	5558	7915	4239	2059	4883	55763	8846	3202	3992	10417	113178	55374	55165	55	1749	9582	8864	30001	256987	2887	1690	54345	3087	6576	79071	79022	1299	4833	9103	4277	22836	6470	27141	9918	399664	11168	6542	408	54962	9200	79366	55388	8553	9900	2030	6720	8323	29923	51283	675	8027	4495	875	90480	3693	51497	4221	7504	9415	55120	5198	3205	29028	51336	3310	114044	8971	4900	3998	55756	11161	29780	56915	79066	222658	4047	6713	1831	9824	9837	5325	3156	10276	6510	55544	2289	2713	55215	10162	64395	10535	4853	56154	79047	26050	54441	23239	10253	55086	60485	7423	55076	55765	6875	3676	11314	57761	55073	10849	9317	8812	6619	55706	3008	7936	55975	2037
HOXA9_DN.V1_UP	M2850		19056693	Faber J,Krivtsov AV,Stubbs MC,Wright R,Davis TN,van den Heuvel-Eibrink M,Zwaan CM,Kung AL,Armstrong SA	GSE13714	HOXA9sh vs GFPshl; top 200 genes (diff-means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in MOLM-14 cells (AML) with knockdown of HOXA9 [Gene ID=3205] gene by RNAi vs controls.	RNA was purified from t(9;11) MOLM-14 AML cells 44h after transduction in triplicates with 2 of the two most effective HOXA9shRNA constructs (3 x 1F3-HOXA9shRNA; 3 x 2A5-HOXA9shRNA) or GFP-controlshRNA (6x).					57103	5756	85236	2208	10875	10346	54502	4332	28962	51816	22797	64393	6279	26999	729230	6653	51257	25939	2841	6583	3108	23405	7056	6280	23424	157567	26509	8334	10402	1102	10129	4353	7107	57698	932	6990	27244	10443	1545	3428	51809	54145	5175	3576	55081	26994	355	8503	26234	51278	1514	1462	3017	23678	683	942	8900	8832	23643	11046	8345	9473	5791	1647	9314	3122	7060	27347	50650	9333	26034	9583	10437	9636	29970	29887	3717	64778	1836	80173	283537	59342	22846	54505	148022	22862	54877	5734	10567	59	80762	11257	54480	98	765	55013	1890	51128	9765	2535	10023	10855	9256	10161	10140	64231	3385	7305	9778	7508	55577	2534	3587	10778	5002	8754	30851	57396	2581	26750	51338	1540	25940	30835	80219	57763	6310	55284	51427	23092	1407	57157	9818	10973	9373	8795	2799	9448	64761	64127	2353	79641	23074	26175	11010	9958	3597	1464	3579	5271	2232	2217	55819	1880	1293	11179	27010	26128	2207	51335	4942	581	4688	8522	1024	51734	1456	9518	10123	79042	11160	9759	84124	64170	9595	10769	1147	55757	1116	152559	7779	6715	25800	23673	83716	54491	51111	2517	25900	54795	79647	23287	9540	55213
SINGH_KRAS_DEPENDENCY_SIGNATURE_	M2851		19477428	Singh A,Greninger P,Rhodes D,Koopman L,Violette S,Bardeesy N,Settleman J	GSE15126	Fig. 5B			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes defining the KRAS [Gene ID=3845] dependency signature.	K-ras mutations occur frequently in epithelial cancers. Using short hairpin RNAs to deplete K-Ras in lung and pancreatic cancer cell lines harboring K-ras mutations, two classes were identified-lines that do or do not require K-Ras to maintain viability. Comparing these two classes of cancer cells revealed a gene expression signature in K-Ras-dependent cells, associated with a well-differentiated epithelial phenotype, which was also seen in primary tumors. Several of these genes encode pharmacologically tractable proteins, such as Syk and Ron kinases and integrin beta6, depletion of which induces epithelial-mesenchymal transformation (EMT) and apoptosis specifically in K-Ras-dependent cells. These findings indicate that epithelial differentiation and tumor cell viability are associated, and that EMT regulators in K-Ras-addicted cancers represent candidate therapeutic targets.					7039	120224	101	84985	135398	3909	9982	10045	3918	195814	27071	79098	3898	1366	374	272	4486	4128	64063	10509
STK33_DN	M2853		19490892	Scholl C,Froehling S,Dunn IF,Schinzel AC,Barbie DA,Kim SY,Silver SJ,Tamayo P,Wadlow RC,Ramaswamy S,Doehner K,Bullinger L,Sandy P,Boehm JS,Root DE,Jacks T,Hahn WC,Gilliland DG	GSE15151	control vs KD STK33 in nomo & skm cells; bottom 300 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in NOMO-1 and SKM-1 cells (AML) after knockdown of STK33 [Gene ID=65975] by RNAi.	NOMO-1 and SKM-1 acute myeloid leukemia (AML) cells were stably transduced with different pLKO.1puro lentiviral shRNA vectors targeting STK33 or a nontargeting control shRNA. VSV-G-pseudotyped lentiviral particles were produced by cotransfection of 293T cells with pLKO.1 constructs and the compatible packaging plasmids pMD.G and pCMVR8.91. Virus was harvested 48 and 72 hours after transfection, cells were incubated with lentiviral supernatants for 30 hours, and infected cells were selected with 2ug/ml puromycin. RNA was isolated after 2 days of puromycin selection and isolation of viable cells by density gradient centrifugation, and gene expression was profiled using GeneChip Human Genome U133 Plus 2.0 microarrays (Affymetrix).					10804	4051	387914	151888	23007	56704	660	240	2706	5273	25825	139886	644480	435	1122	652995	79587	419	154807	283663	388969	55529	55190	59350	285758	220930	79656	54996	55076	79762	150763	64757	2823	56154	8501	353189	23363	132720	84836	7164	6770	596	8743	56994	55753	5074	197358	60675	2322	645919	5055	150864	84144	222166	79946	9744	440	57418	109	79070	202	290	79154	3899	4147	4680	79695	134430	10125	3815	4778	126549	114928	978	64064	8309	84106	23314	323	26999	57687	90624	51018	55799	3101	5425	53342	671	221336	11240	3399	65990	392490	642775	95	389362	644295	5723	10380	29098	27143	79071	6004	1432	5157	3983	84842	222553	5357	285957	2232	120892	51449	8676	137196	5004	51236	84707	10602	767	254887	387097	11184	649094	81034	79161	23254	23576	5092	3781	51092	5577	11320	7407	2542	4548	113655	831	403313	84706	10687	55502	7923	5291	157638	2824	92170	55260	284098	55612	7414	79680	26084	6546	54682	214	1671	55609	3001	327	2178	113115	135293	54832	9750	306	5096	932	6319	8658	133308	55916	90625	56898	54947	201305	29953	8218	1802	114112	8614	6419	2620	23129	256435	116843	55686	80854	25893	26115	84451	55316	51205	3932	9645	1024	10384	51011	203547	688	2201	26120	153364	25816	63932	84133	375704	24141	54463	4756	54855	54802	116369	6352	129804	9468	144348	6096	374354	730101	5979	54956	84231	9702	7026	5213	23052	8642	84958	116028	10300	346689	9050	84327	157983	10327	24140	11148	401097	1380	10100	80209	8577	23566	57460	352909	8525	6590	10609	6457	92745	8503	84306	3206	114876	5424	55703	23164	9781	29904	9920	5420	80762	8529	91373	54619	116379	51629	339541	54836	202243	79767	652226	79109	790	84058	389840	387882	2162	27074	51540	90861	10998	1829	7224	6988	404550	56265	29094
STK33_NOMO_DN	M2854		19490892	Scholl C,Froehling S,Dunn IF,Schinzel AC,Barbie DA,Kim SY,Silver SJ,Tamayo P,Wadlow RC,Ramaswamy S,Doehner K,Bullinger L,Sandy P,Boehm JS,Root DE,Jacks T,Hahn WC,Gilliland DG	GSE15151	control vs KD STK33 in nomo cells; bottom 300 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in NOMO-1 cells (AML) after knockdown of STK33 [Gene ID=65975] by RNAi.	NOMO-1 acute myeloid leukemia (AML) cells were stably transduced with different pLKO.1puro lentiviral shRNA vectors targeting STK33 or a nontargeting control shRNA. VSV-G-pseudotyped lentiviral particles were produced by cotransfection of 293T cells with pLKO.1 constructs and the compatible packaging plasmids pMD.G and pCMVR8.91. Virus was harvested 48 and 72 hours after transfection, cells were incubated with lentiviral supernatants for 30 hours, and infected cells were selected with 2ug/ml puromycin. RNA was isolated after 2 days of puromycin selection and isolation of viable cells by density gradient centrifugation, and gene expression was profiled using GeneChip Human Genome U133 Plus 2.0 microarrays (Affymetrix).					10804	2706	419	4051	660	240	435	151888	150763	3001	285758	2823	84106	4680	10125	57687	55190	1122	388969	4147	23007	11148	8676	220930	51018	387914	139886	644480	25825	4756	154807	84101	221336	8501	56704	55529	23363	10384	27074	10687	132720	84836	116379	80312	23129	403313	652995	2826	2162	65990	1671	10512	649094	23576	79695	116369	24141	11320	60675	3101	79762	3174	5074	1731	1380	5273	151473	23314	79587	112399	2232	57418	53342	56154	55244	90624	374354	2322	160335	493812	8807	644295	2542	27143	3815	10380	5425	84842	214	392490	79656	8658	150864	283663	8835	135293	5995	51449	5157	8809	90625	29098	56994	375704	389362	202781	26999	95	6096	2201	11184	79070	25938	55502	55609	5979	7407	126549	6402	9615	26120	51236	638	84706	283070	327	122953	81034	120892	64757	79154	80854	9863	285957	113655	5357	51092	383	55076	23254	54947	5723	134430	79161	290	91851	54549	256435	306	55366	1378	3239	84707	3887	1829	109	203547	157983	29953	6546	9831	6770	64064	79946	2178	10216	63932	84144	6988	22858	79680	440	51011	80209	245973	688	9744	4734	284098	2215	978	643224	642775	133308	222166	9468	441024	27350	55916	202	3899	389840	1236	27319	54832	113115	51006	254887	25960	144348	84152	596	9122	55	8503	51337	4548	153364	5092	92170	400027	8309	55084	11240	54682	54463	323	122060	9645	284759	285987	5732	9980	54739	548596	3005	23086	3695	10942	152189	10100	7841	10300	121551	3543	114876	2358	56898	246721	90843	1798	79109	55260	116028	348751	54836	10327	8525	643011	3206	23601	158	2592	2332	404550	84451	5096	148418	255512	84133	10493	9050	222553	5424	91056	100133941	55111	2643	414328	23516	6319	22824	114112	5790	6768	9781	25893	202451	57118	574029	440145	30061	54841	129804	54842	55612	257	200765	1432	7164	3932	192670
STK33_NOMO_UP	M2855		19490892	Scholl C,Froehling S,Dunn IF,Schinzel AC,Barbie DA,Kim SY,Silver SJ,Tamayo P,Wadlow RC,Ramaswamy S,Doehner K,Bullinger L,Sandy P,Boehm JS,Root DE,Jacks T,Hahn WC,Gilliland DG	GSE15151	control vs KD STK33 in nomo cells; top 300 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in NOMO-1 cells (AML) after knockdown of STK33 [Gene ID=65975] by RNAi.	NOMO-1 acute myeloid leukemia (AML) cells were stably transduced with different pLKO.1puro lentiviral shRNA vectors targeting STK33 or a nontargeting control shRNA. VSV-G-pseudotyped lentiviral particles were produced by cotransfection of 293T cells with pLKO.1 constructs and the compatible packaging plasmids pMD.G and pCMVR8.91. Virus was harvested 48 and 72 hours after transfection, cells were incubated with lentiviral supernatants for 30 hours, and infected cells were selected with 2ug/ml puromycin. RNA was isolated after 2 days of puromycin selection and isolation of viable cells by density gradient centrifugation, and gene expression was profiled using GeneChip Human Genome U133 Plus 2.0 microarrays (Affymetrix).					390	2697	2167	4312	6999	3162	444	9976	7857	5800	1959	5756	9966	54453	677	9732	8829	55022	6781	9518	84419	2920	19	2921	84981	2791	388	1843	7474	9788	3553	7107	6351	55026	221079	285513	27299	4254	55664	1293	366	3575	149111	6385	1960	5806	5997	168455	84868	3552	94234	5473	1073	7832	7525	9990	24145	8139	7056	3383	84159	602	22862	4973	8878	3984	55105	728	55145	1847	54210	143384	157807	2635	5328	222235	11057	3176	25897	23673	4013	4319	23643	80315	9321	90	1612	6016	549	6296	54813	8320	3428	90007	10461	51313	26959	10863	151011	7850	10123	6372	643424	604	84541	2012	220213	5534	28512	7673	126364	9891	166379	10771	150737	2673	54742	163486	8564	161742	132789	10457	25943	2353	3554	373	1398	389023	10254	2919	80219	26040	11015	283677	25780	115548	390940	8491	9915	81501	8693	201475	79717	9934	6446	7310	3587	284996	3759	941	284120	22863	23362	153222	84458	10144	66036	2651	9839	23174	27180	57568	22845	22822	57146	23645	51778	140947	55284	7177	7378	54	144811	28962	283131	9832	10228	7050	3586	30817	58155	161582	51133	1389	1571	51762	84849	8843	3290	729967	8867	406991	286148	200014	10950	57162	7096	23253	146795	57614	54532	55198	57561	3572	63905	3725	9706	25977	143279	714	10333	653754	3914	64651	3772	79660	57728	8879	7280	55684	55917	10507	85451	22797	9690	6482	8347	57552	2005	57419	2	8942	8870	65981	81617	3726	4893	1948	2034	1316	11282	60673	23764	127943	26128	91833	57520	79137	64400	401494	51128	55727	1326	123720	139231	3801	9262	7130	9975	64581	5738	23705	10472	219899	4213	5774	8339	2768	817	9520	79605	10135	135114	10668	6364	7538	23558	719	11010	115265	92689	3667	7546	114907	6041	4891	53346	219285	57613	55293	10871	1601	9778	6654
STK33_SKM_DN	M2856		19490892	Scholl C,Froehling S,Dunn IF,Schinzel AC,Barbie DA,Kim SY,Silver SJ,Tamayo P,Wadlow RC,Ramaswamy S,Doehner K,Bullinger L,Sandy P,Boehm JS,Root DE,Jacks T,Hahn WC,Gilliland DG	GSE15151	control vs KD STK33 in skm cells; bottom 300 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in SKM-1 cells (AML) after knockdown of STK33 [Gene ID=65975] by RNAi.	SKM-1 acute myeloid leukemia (AML) cells were stably transduced with different pLKO.1puro lentiviral shRNA vectors targeting STK33 or a nontargeting control shRNA. VSV-G-pseudotyped lentiviral particles were produced by cotransfection of 293T cells with pLKO.1 constructs and the compatible packaging plasmids pMD.G and pCMVR8.91. Virus was harvested 48 and 72 hours after transfection, cells were incubated with lentiviral supernatants for 30 hours, and infected cells were selected with 2ug/ml puromycin. RNA was isolated after 2 days of puromycin selection and isolation of viable cells by density gradient centrifugation, and gene expression was profiled using GeneChip Human Genome U133 Plus 2.0 microarrays (Affymetrix).					59350	387914	54996	23007	56704	8743	5273	55753	151888	353189	5055	645919	4051	197358	3399	7164	114928	55799	283663	55076	6004	25825	596	64757	79587	2620	79656	814	4778	652995	6770	10602	116843	139886	644480	55117	5507	2558	5271	7923	3781	222166	3983	55529	84144	152503	137196	9744	85003	79762	79946	440	56154	671	6352	932	154807	8614	56994	9750	202	23566	3899	387097	79071	767	109	8577	115265	831	8309	7414	5291	54855	26084	389125	323	290	53831	5004	1432	79154	150864	346689	240	2322	4883	915	10170	1669	90665	6457	374899	11240	10544	978	222553	55765	79070	134430	84983	1122	8501	100129603	54751	64064	1397	132720	2557	340107	84836	2888	5074	84306	401262	58191	55784	60675	23363	5100	5420	157638	27285	9771	116154	642775	54802	22873	83699	220930	56981	170371	57418	2882	2824	202243	126549	6123	23329	4796	5577	10252	29122	55703	8987	7004	352909	55686	388969	7693	11027	201305	653605	253827	6689	254887	84070	3815	6590	5723	27075	2053	9420	6653	353219	26999	3040	5092	51205	6694	5207	160428	340061	84989	4430	55612	7060	652226	54956	4082	283659	9204	435	636	5357	124976	91373	84327	8218	343171	285957	9900	57214	4548	1802	730101	84707	2861	55034	55024	7026	28	3914	8091	26287	6419	120892	95	55190	800	57460	55260	285382	7277	10609	5644	23682	389362	346171	5425	11096	55316	6319	55314	1005	3595	389023	84366	3782	151827	118738	57545	51236	5096	93986	401097	29098	26115	55286	2887	5213	25984	92170	84231	392490	84795	26050	6641	51232	85461	54682	5874	2637	5822	29904	660	150223	388942	339541	114112	55086	55589	5157	729230	81556	4811	1024	79161	3385	8871	29985	90624	84978	79695	65975	90634	10380	57198	54729	51119	79974	25816	644021	399693	7163	81034	23254	7703
STK33_SKM_UP	M2857		19490892	Scholl C,Froehling S,Dunn IF,Schinzel AC,Barbie DA,Kim SY,Silver SJ,Tamayo P,Wadlow RC,Ramaswamy S,Doehner K,Bullinger L,Sandy P,Boehm JS,Root DE,Jacks T,Hahn WC,Gilliland DG	GSE15151	control vs KD STK33 in skm cells; top 300 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in SKM-1 cells (AML) after knockdown of STK33 [Gene ID=65975] by RNAi.	SKM-1 acute myeloid leukemia (AML) cells were stably transduced with different pLKO.1puro lentiviral shRNA vectors targeting STK33 or a nontargeting control shRNA. VSV-G-pseudotyped lentiviral particles were produced by cotransfection of 293T cells with pLKO.1 constructs and the compatible packaging plasmids pMD.G and pCMVR8.91. Virus was harvested 48 and 72 hours after transfection, cells were incubated with lentiviral supernatants for 30 hours, and infected cells were selected with 2ug/ml puromycin. RNA was isolated after 2 days of puromycin selection and isolation of viable cells by density gradient centrifugation, and gene expression was profiled using GeneChip Human Genome U133 Plus 2.0 microarrays (Affymetrix).					219972	2167	390	9934	5800	9935	7035	9076	6351	7980	1026	5570	10842	7832	3696	2791	55022	22797	8339	6446	9586	94241	7056	8349	137835	284021	2353	7305	5756	8347	1958	7096	5996	1073	3553	1839	51676	23643	400410	948	201895	8334	29103	65065	161582	4856	406991	54874	8969	56952	1850	283554	283635	9398	597	8336	8350	142891	9990	8358	57568	80315	3587	1847	644250	10769	2635	301	8477	92255	11010	8332	85373	84542	8356	4608	256643	444	55959	59	8564	1316	22822	284757	113540	3162	7538	54813	728	23673	284801	23285	132864	58484	23366	83953	338382	765	3017	10379	8365	116829	10333	84314	3955	389	150737	51351	55145	79901	5616	373	6252	2857	4133	140	26040	28984	9848	8878	10221	10773	55198	9534	56975	100505968	3552	1880	729967	10863	64582	4973	23002	388439	85451	135114	4688	153222	64115	1843	23174	1028	80035	57728	440309	388	81793	26780	90427	23305	3759	145389	55727	10161	3012	474170	4815	64089	50804	116448	1398	744	51063	10875	1102	257068	2268	55333	84947	8357	1513	196394	6016	11326	390035	10135	11138	2713	27125	3956	9949	339500	55664	160418	8970	115548	25897	7378	2634	131408	58476	255403	10254	7084	7813	89848	64718	93953	256236	55196	284390	84780	221079	25780	127544	114625	5997	29767	118490	84981	928	133	644656	7107	8968	84458	3600	50862	91120	1536	8354	4238	90007	84159	5328	121512	284161	29933	286148	10388	57561	9404	79739	5797	2115	9668	23657	51626	55284	65124	3428	25977	965	643072	55628	143872	55329	546	56977	7124	3659	123920	963	285147	23022	9321	152518	79717	64802	84984	56670	3726	7041	57520	11080	200132	114885	84804	602	27242	4084	284756	3018	7127	57669	2014	6498	4982	171392	23654	54206	727815	942	10228	10019	64332	4254	27128	4792	166379
STK33_UP	M2858		19490892	Scholl C,Froehling S,Dunn IF,Schinzel AC,Barbie DA,Kim SY,Silver SJ,Tamayo P,Wadlow RC,Ramaswamy S,Doehner K,Bullinger L,Sandy P,Boehm JS,Root DE,Jacks T,Hahn WC,Gilliland DG	GSE15151	control vs KD STK33 in nomo & skm cells; top 300 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in NOMO-1 and SKM-1 cells (AML) after knockdown of STK33 [Gene ID=65975] by RNAi.	NOMO-1 and SKM-1 acute myeloid leukemia (AML) cells were stably transduced with different pLKO.1puro lentiviral shRNA vectors targeting STK33 or a nontargeting control shRNA. VSV-G-pseudotyped lentiviral particles were produced by cotransfection of 293T cells with pLKO.1 constructs and the compatible packaging plasmids pMD.G and pCMVR8.91. Virus was harvested 48 and 72 hours after transfection, cells were incubated with lentiviral supernatants for 30 hours, and infected cells were selected with 2ug/ml puromycin. RNA was isolated after 2 days of puromycin selection and isolation of viable cells by density gradient centrifugation, and gene expression was profiled using GeneChip Human Genome U133 Plus 2.0 microarrays (Affymetrix).					2167	390	5800	6351	55022	5756	219972	2791	9934	444	3162	7832	3553	7056	9935	7035	1073	6446	2353	2697	1026	22797	10842	23643	5570	9976	8339	9990	9076	7096	8347	4312	7980	1847	6999	1843	388	2635	80315	137835	94241	9732	728	284021	1958	84981	3552	161582	406991	5996	7107	221079	55664	55145	23673	8878	54813	4973	1959	57568	2921	948	3587	8564	5997	51676	4254	2920	150737	22822	84159	10863	373	84868	366	283635	8829	602	11010	65065	25897	9398	5328	6016	8349	1316	283554	54874	54210	3696	24145	22862	10333	7538	1398	7305	90007	9321	153222	3383	3428	23174	1850	55198	3759	729967	149111	677	201895	10254	9788	143384	115548	9966	8477	85451	11057	25780	55105	1839	57728	9586	8334	19	83953	166379	9518	7378	10379	8139	84458	135114	1612	79717	55727	26959	23285	2857	90	161742	55284	84542	142891	644250	116829	8350	286148	51351	132864	3984	10221	57561	10161	10135	58484	25977	201475	4688	10228	25943	28512	84541	604	56975	11326	92255	23366	8491	7050	7857	168455	7673	64089	145389	6296	90427	94234	3726	8867	200014	27299	284801	57162	57520	2673	84419	64651	55959	23253	56952	113540	3955	132789	9839	66036	54532	2012	140	283677	389	57552	928	597	3725	400410	257068	23002	22863	1960	133	5534	79739	91833	23657	10950	549	6781	23645	63905	4856	301	643424	8356	26780	123920	152518	79901	2919	51778	5473	28962	127544	23764	196394	8942	388439	80219	8693	338758	10472	28755	118490	8336	284757	10773	54453	85373	9891	7124	27125	55026	26040	4013	64400	23558	285513	10875	26035	55298	11120	64115	3572	440309	64582	51626	7310	6252	81793	4213	126364	157807	1293	6310	284996	29922	3176	9306	6654	7474	151011	51313	9266	220213	84849	57614	10771	91369	4238	50862	1027	29103	64718	219285
KRAS.AMP.LUNG_UP.V1_DN	M2859		GSE17643	Boehm J		AALE-KRAS WT vs AALE-Vector: bottom 150 genes (diff. means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in epithelial lung cancer cell lines over-expressing KRAS [Gene ID=3845] gene.	Profiling of immortalized human lung epithelial cells following oncogenic KRAS expression and TBK1 suppression. The purpose of the dataset is to analyze expression of genes induced by KRAS and regulated by TBK1. The proto-oncogene KRAS is mutated in a wide array of human cancers, most of which are aggressive and respond poorly to standard therapies. Although the identification of specific oncogenes has led to the development of clinically effective, molecularly targeted therapies in some cases, KRAS has remained refractory to this approach. An alternative strategy for targeting KRAS is to identify gene products that, when suppressed or inhibited, result in cell death only in the presence of an oncogenic allele. Here we have used systematic RNA interference (RNAi) to detect synthetic lethal partners of oncogenic KRAS and found that the non-canonical IkB kinase, TBK1, was selectively essential in cells that harbor mutant KRAS. Suppression of TBK1 induced apoptosis specifically in human cancer cell lines that depend on oncogenic KRAS expression. In these cells, TBK1 activated NF-kappaB anti-apoptotic signals involving cREL and BCL-XL that were essential for survival, providing mechanistic insights into this synthetic lethal interaction. These observations identify TBK1 as a potential therapeutic target in KRAS mutant tumors and establish a general approach for the rational identification of co-dependent pathways in cancer. Knock out of TBK1 in the contect of KRAS activation (mutant) and control (WT).					80174	867	653423	147657	5896	1609	3579	79696	7693	2811	8842	3227	79640	3039	83463	1562	2901	3010	95681	10752	55150	6524	1489	23493	79883	3635	79412	2213	5030	2515	79933	10716	786	54715	3384	6916	8541	55339	5794	8578	2840	54532	10391	10	1833	400410	9625	152	2781	1816	29953	2662	50940	51291	644951	5331	1408	100507605	8538	9245	23547	5167	2658	4322	9739	3593	55890	3224	51564	4297	9651	4956	400961	643641	80092	6336	149628	84034	6620	9754	5133	8350	10875	50944	11314	2560	29935	25833	8970	3444	8659	28968	8536	387751	1838	8839	27037	80704	51286	2015	10814	947	2488	215	10411	5971	10993	3882	57805	80705	57825	3352	346562	778	79919	55766	1630	2035	5625	727	79780	9886	7018	54858	51214	10297	55211	1759	3446	10686	57460	1636	54212	8854	3780	100132341	10086	759	7099	9143	4158	11194	5016	10669	11096	5023
KRAS.AMP.LUNG_UP.V1_UP	M2860		GSE17643	Boehm J		AALE-KRAS WT vs AALE-Vector: top 150 genes (diff. means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in epithelial lung cancer cell lines over-expressing KRAS [Gene ID=3845] gene.	Profiling of immortalized human lung epithelial cells following oncogenic KRAS expression and TBK1 suppression. The purpose of the dataset is to analyze expression of genes induced by KRAS and regulated by TBK1. The proto-oncogene KRAS is mutated in a wide array of human cancers, most of which are aggressive and respond poorly to standard therapies. Although the identification of specific oncogenes has led to the development of clinically effective, molecularly targeted therapies in some cases, KRAS has remained refractory to this approach. An alternative strategy for targeting KRAS is to identify gene products that, when suppressed or inhibited, result in cell death only in the presence of an oncogenic allele. Here we have used systematic RNA interference (RNAi) to detect synthetic lethal partners of oncogenic KRAS and found that the non-canonical IkB kinase, TBK1, was selectively essential in cells that harbor mutant KRAS. Suppression of TBK1 induced apoptosis specifically in human cancer cell lines that depend on oncogenic KRAS expression. In these cells, TBK1 activated NF-kappaB anti-apoptotic signals involving cREL and BCL-XL that were essential for survival, providing mechanistic insights into this synthetic lethal interaction. These observations identify TBK1 as a potential therapeutic target in KRAS mutant tumors and establish a general approach for the rational identification of co-dependent pathways in cancer. Knock out of TBK1 in the contect of KRAS activation (mutant) and control (WT).					2848	6690	919	4753	56165	401466	29944	4868	64800	90485	8468	1749	644128	1447	2832	2205	4105	3305	2569	284001	7448	9271	9884	10316	4023	27158	728448	9746	4867	54575	150160	2559	7139	27314	4986	29064	10021	1551	8341	55891	4111	50856	2623	434	2793	732	79368	58529	1944	11251	6708	2922	83447	64084	1795	10806	2252	27287	4065	55472	3284	368	146712	11136	2570	55821	3250	56914	92552	51807	6666	3718	26140	1411	23601	3746	168667	1943	79972	79949	10231	1053	23072	64067	55073	5078	3310	59353	27112	81494	6751	4857	2207	2162	611	916	23762	83734	4324	10402	651803	5593	3297	57134	6533	57172	6517	6504	51233	5978	6696	8128	719	51032	3018	174	5172	64240	2646	1670	208	7512	3083	55801	1852	54766	113835	6356	23263	4803	1950	9506	2830	57051	26105	1780	4112	56673	9723	43847	2695	8111	763	400451
KRAS.DF.V1_DN	M2861		GSE17643	Barbie DA,Tamayo P,Boehm JS,Kim SY,Moody SE,Dunn IF,Schinzel AC,Sandy P,Meylan E,Scholl C,Froehling S,Chan EM,Sos ML,Michel K,Mermel C,Silver SJ,Weir BA,Reiling JH,Sheng Q,Gupta PB,Wadlow RC,Le H,Hoersch S,Wittner BS,Ramaswamy S,Livingston DM,Sabatini DM,Meyerson M,Thomas RK,Lander ES,Mesirov JP,Root DE,Gilliland DG,Jacks T,Hahn WC	GSE17643	AALE-KRAS vs AALE-Vector top 200 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in epithelial lung cancer cell lines over-expressing an oncogenic form of KRAS [Gene ID=3845] gene.	Profiling of immortalized human lung epithelial cells following oncogenic KRAS expression and TBK1 suppression. The purpose of the dataset is to analyze expression of genes induced by KRAS and regulated by TBK1. The proto-oncogene KRAS is mutated in a wide array of human cancers, most of which are aggressive and respond poorly to standard therapies. Although the identification of specific oncogenes has led to the development of clinically effective, molecularly targeted therapies in some cases, KRAS has remained refractory to this approach. An alternative strategy for targeting KRAS is to identify gene products that, when suppressed or inhibited, result in cell death only in the presence of an oncogenic allele. Here we have used systematic RNA interference (RNAi) to detect synthetic lethal partners of oncogenic KRAS and found that the non-canonical IkB kinase, TBK1, was selectively essential in cells that harbor mutant KRAS. Suppression of TBK1 induced apoptosis specifically in human cancer cell lines that depend on oncogenic KRAS expression. In these cells, TBK1 activated NF-kappaB anti-apoptotic signals involving cREL and BCL-XL that were essential for survival, providing mechanistic insights into this synthetic lethal interaction. These observations identify TBK1 as a potential therapeutic target in KRAS mutant tumors and establish a general approach for the rational identification of co-dependent pathways in cancer. Knock out of TBK1 in the contect of KRAS activation (mutant) and control (WT).					5743	3936	9076	23242	3485	1525	8462	6876	27074	64221	54566	2201	5723	51012	4059	6668	26053	11009	3604	29896	5154	55076	80352	154	5784	26628	23016	6855	8936	3371	10165	64418	64386	8535	79868	1844	9314	55258	4974	6874	1271	23092	1559	23615	1269	8608	399664	9734	149986	23046	57115	3817	51226	79627	196	5866	8731	4761	4956	11010	9875	11202	3224	4992	55105	54546	463	623	7475	8864	3451	5063	9324	57506	23345	6667	54955	8187	2178	55930	7781	7148	25818	79845	55623	83481	1133	57556	55915	3207	3364	946	11097	4356	4091	10620	914	11005	10466	7345	4301	27134	127534	9437	4013	6568	10512	6699	29113	26285	140885	60676	92595	54894	7109	79269	86	1673	9972	126393	7286	490	56475	3931	8345	8337	3263	643854	10892	55738	57292	51533	7259	79012	51660	3802	26532	54587	57473	240	55793	7403	4092	6809	5652	23544	54039	65999	2081	1543	5129	60682	285596	2596	79571	2114	5979	9455	8115	27445	9883	6326	343068	8828	10732	6753	28999	1857	57415	9053	7043	5079	3359	1287	5731	3274	51560	343071	221749	4142	652	27128	6722	3954	23552	8175	79794	80168	245	1302	57128	4803	3486	3996
KRAS.DF.V1_UP	M2863		GSE17643	Barbie DA,Tamayo P,Boehm JS,Kim SY,Moody SE,Dunn IF,Schinzel AC,Sandy P,Meylan E,Scholl C,Froehling S,Chan EM,Sos ML,Michel K,Mermel C,Silver SJ,Weir BA,Reiling JH,Sheng Q,Gupta PB,Wadlow RC,Le H,Hoersch S,Wittner BS,Ramaswamy S,Livingston DM,Sabatini DM,Meyerson M,Thomas RK,Lander ES,Mesirov JP,Root DE,Gilliland DG,Jacks T,Hahn WC	GSE17643	AALE-KRAS vs AALE-Vector: top 200 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in epithelial lung cancer cell lines over-expressing an oncogenic form of KRAS [Gene ID=3845] gene.	Profiling of immortalized human lung epithelial cells following oncogenic KRAS expression and TBK1 suppression. The purpose of the dataset is to analyze expression of genes induced by KRAS and regulated by TBK1. The proto-oncogene KRAS is mutated in a wide array of human cancers, most of which are aggressive and respond poorly to standard therapies. Although the identification of specific oncogenes has led to the development of clinically effective, molecularly targeted therapies in some cases, KRAS has remained refractory to this approach. An alternative strategy for targeting KRAS is to identify gene products that, when suppressed or inhibited, result in cell death only in the presence of an oncogenic allele. Here we have used systematic RNA interference (RNAi) to detect synthetic lethal partners of oncogenic KRAS and found that the non-canonical IkB kinase, TBK1, was selectively essential in cells that harbor mutant KRAS. Suppression of TBK1 induced apoptosis specifically in human cancer cell lines that depend on oncogenic KRAS expression. In these cells, TBK1 activated NF-kappaB anti-apoptotic signals involving cREL and BCL-XL that were essential for survival, providing mechanistic insights into this synthetic lethal interaction. These observations identify TBK1 as a potential therapeutic target in KRAS mutant tumors and establish a general approach for the rational identification of co-dependent pathways in cancer. Knock out of TBK1 in the contect of KRAS activation (mutant) and control (WT).					9173	4312	3598	6364	8406	650	1836	3624	3059	10098	444	27241	7097	23574	5646	2004	9945	1293	2791	7424	23613	8829	1462	2921	25907	1440	2953	11226	7980	54922	10544	6286	81570	8821	901	11127	79980	5793	10561	2745	55022	2919	65084	23767	2713	6676	64754	3669	1975	7122	10964	10000	8644	4017	55279	1992	978	22944	501	65981	3434	5997	2281	57730	8819	8519	54504	2014	9862	10656	654	8612	64236	3430	1808	230	6236	26872	79733	10020	4054	10253	6447	653127	51076	9064	4071	26873	10379	55500	81031	6583	1774	7837	9871	6810	2109	79783	9540	5880	3959	659	23316	5054	26207	22839	2627	157567	1030	55711	22943	1643	1138	2539	10247	3294	84869	2643	10630	9415	7079	28227	101	7804	23201	37	9497	3622	50650	1806	9961	27175	5327	23624	220	3429	11138	905	976	3576	26575	9955	5328	26585	290	81691	11007	54958	10079	9212	6374	9651	4507	847	6604	254102	79866	602	10226	7220	3717	65990	27165	57162	51282	6594	9252	84939	1429	56259	6525	4351	598	56271	23475	6789	11151	22876	11146	79991	3306	55347	9787	9590	8623	51063	51191	8493	2530	604	9	54884	55284
TBK1.DF_DN	M2864		GSE17643	Barbie DA,Tamayo P,Boehm JS,Kim SY,Moody SE,Dunn IF,Schinzel AC,Sandy P,Meylan E,Scholl C,Froehling S,Chan EM,Sos ML,Michel K,Mermel C,Silver SJ,Weir BA,Reiling JH,Sheng Q,Gupta PB,Wadlow RC,Le H,Hoersch S,Wittner BS,Ramaswamy S,Livingston DM,Sabatini DM,Meyerson M,Thomas RK,Lander ES,Mesirov JP,Root DE,Gilliland DG,Jacks T,Hahn WC	GSE17643	AALE-KRAS + shTBK1 vs controls; top 300 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in epithelial lung cancer cell lines upon over-expression of an oncogenic form of KRAS [Gene ID=3845] gene and knockdown of TBK1 [Gene ID=29110] gene by RNAi.	Profiling of immortalized human lung epithelial cells following oncogenic KRAS expression and TBK1 suppression. The purpose of the dataset is to analyze expression of genes induced by KRAS and regulated by TBK1. The proto-oncogene KRAS is mutated in a wide array of human cancers, most of which are aggressive and respond poorly to standard therapies. Although the identification of specific oncogenes has led to the development of clinically effective, molecularly targeted therapies in some cases, KRAS has remained refractory to this approach. An alternative strategy for targeting KRAS is to identify gene products that, when suppressed or inhibited, result in cell death only in the presence of an oncogenic allele. Here we have used systematic RNA interference (RNAi) to detect synthetic lethal partners of oncogenic KRAS and found that the non-canonical IkB kinase, TBK1, was selectively essential in cells that harbor mutant KRAS. Suppression of TBK1 induced apoptosis specifically in human cancer cell lines that depend on oncogenic KRAS expression. In these cells, TBK1 activated NF-kappaB anti-apoptotic signals involving cREL and BCL-XL that were essential for survival, providing mechanistic insights into this synthetic lethal interaction. These observations identify TBK1 as a potential therapeutic target in KRAS mutant tumors and establish a general approach for the rational identification of co-dependent pathways in cancer. Knock out of TBK1 in the contect of KRAS activation (mutant) and control (WT).					22936	642	2803	29110	5270	3267	29766	102	55284	1836	9134	659	55893	6198	7525	3660	6734	22928	9818	949	2040	65124	3007	55038	51809	1282	1021	2697	9675	7003	3694	8050	8266	4155	64116	2186	2619	51752	29123	1287	6535	4646	894	83737	79980	54876	79717	223	167227	9928	10438	11160	7057	6048	10643	2801	4548	163486	51134	8065	663	79618	1525	28996	54874	1398	51319	10201	23405	1633	688	51361	80347	5929	23466	55322	10098	622	23527	25978	56937	3673	54908	55149	51388	55320	9475	23137	7014	29083	11127	79183	10020	55500	51621	23376	9575	23190	645619	51138	528	1308	6584	1825	3434	23341	26009	64750	4001	22943	54700	51441	10198	51449	839	10165	59339	23767	5898	23086	3006	8502	54014	55601	64897	3198	8148	23049	23468	60560	1104	64854	6645	57698	51650	140609	10114	50628	54680	1039	26298	5154	6256	730092	10640	79657	8543	8202	23274	51765	23683	4436	54904	4750	598	10247	571	51479	7443	9173	51747	8575	51773	55279	57187	9949	7094	7586	9747	80143	2773	55703	55183	10949	79646	490	26000	218	23389	996	8439	373	11231	8364	5050	3157	64864	84726	2542	23326	55435	51701	54819	3416	3008	23607	7019	80155	79982	4507	595	10512	55032	54842	10159	55159	3895	10007	9748	23112	55214	8609	3954	146057	56886	55450	9860	55005	865	51575	9360	59338	3170	51026	55213	10142	23633	4763	3987	8436	6018	11019	3557	6595	79230	4128	9536	5092	114876	9682	901	1203	51101	84864	10253	5366	79768	55102	11130	8777	5696	55156	26065	4957	55364	9169	4090	2957	29907	10927	5936	51129	26064	4801	112	27125	9112	1290	2591	5698	63917	57613	26060	7993	670	9766	11212	8204	26031	5611	51133	6949	25957	2353	51079	51141	10564
TBK1.DF_UP	M2867		GSE17643	Barbie DA,Tamayo P,Boehm JS,Kim SY,Moody SE,Dunn IF,Schinzel AC,Sandy P,Meylan E,Scholl C,Froehling S,Chan EM,Sos ML,Michel K,Mermel C,Silver SJ,Weir BA,Reiling JH,Sheng Q,Gupta PB,Wadlow RC,Le H,Hoersch S,Wittner BS,Ramaswamy S,Livingston DM,Sabatini DM,Meyerson M,Thomas RK,Lander ES,Mesirov JP,Root DE,Gilliland DG,Jacks T,Hahn WC	GSE17643	AALE-KRAS + shTBK1 vs controls; bottom 300 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in epithelial lung cancer cell lines upon over-expression of an oncogenic form of KRAS [Gene ID=3845] gene and knockdown of TBK1 [Gene ID=29110] gene by RNAi.	Profiling of immortalized human lung epithelial cells following oncogenic KRAS expression and TBK1 suppression. The purpose of the dataset is to analyze expression of genes induced by KRAS and regulated by TBK1. The proto-oncogene KRAS is mutated in a wide array of human cancers, most of which are aggressive and respond poorly to standard therapies. Although the identification of specific oncogenes has led to the development of clinically effective, molecularly targeted therapies in some cases, KRAS has remained refractory to this approach. An alternative strategy for targeting KRAS is to identify gene products that, when suppressed or inhibited, result in cell death only in the presence of an oncogenic allele. Here we have used systematic RNA interference (RNAi) to detect synthetic lethal partners of oncogenic KRAS and found that the non-canonical IkB kinase, TBK1, was selectively essential in cells that harbor mutant KRAS. Suppression of TBK1 induced apoptosis specifically in human cancer cell lines that depend on oncogenic KRAS expression. In these cells, TBK1 activated NF-kappaB anti-apoptotic signals involving cREL and BCL-XL that were essential for survival, providing mechanistic insights into this synthetic lethal interaction. These observations identify TBK1 as a potential therapeutic target in KRAS mutant tumors and establish a general approach for the rational identification of co-dependent pathways in cancer. Knock out of TBK1 in the contect of KRAS activation (mutant) and control (WT).					8323	50999	6399	54566	2643	90	3480	1789	27445	5925	6279	6695	7846	10635	3321	4860	10519	10314	1024	2196	7844	3552	55216	57720	3396	55022	8612	26278	369	79901	10602	28962	3705	79850	54453	388650	64759	29967	9635	8030	23089	115	3554	54830	150759	55287	26872	285203	23200	23673	2009	28966	8460	54020	1462	4318	7837	11157	23002	1847	9638	9765	7159	80146	57162	28232	8601	7286	66008	25800	9885	80149	8027	1114	5328	25937	50486	9648	9792	57019	10950	11151	4046	2791	8440	4804	1152	54662	2907	3162	23255	8462	637	23075	399664	4952	5754	840	80772	23596	2135	79837	55192	145389	8773	55076	9741	9100	124152	53916	7039	4603	192669	27342	5329	9907	5998	290	81831	7779	2960	9988	6288	55013	29071	643224	9710	118433	1741	3576	55568	26504	1975	1364	4790	861	25816	54868	1942	5744	5753	9404	101	80205	27349	29887	6019	23052	79669	7355	97	256227	4800	2281	9997	55274	55852	9837	1390	22876	23011	6622	79666	152006	1839	57415	1397	7127	57205	2014	9308	79616	57496	23080	57212	51071	4794	1601	84909	582	10243	25801	9540	818	5275	5316	54436	140885	5523	9562	10425	91647	6237	375449	8560	6016	7128	9886	8732	10668	58488	2021	5533	57157	10746	4832	6699	3670	23031	440026	4771	2965	9197	29965	22978	23548	467	29916	309	6809	8644	5627	79695	29	8406	81552	9519	152559	3685	23015	7280	8899	694	54629	55208	9039	3306	23585	29970	5877	976	7030	6515	23178	1845	10049	64429	55630	29982	1382	55081	80323	5293	11163	55521	8795	55204	100507436	29115	10979	55454	9388	2877	2026	3290	5026	7079	23564	11343	9289	9341	56271	8934	26511	2920	9697	221749	81031	4783	5646	11072	51601	56935	55686	25829	57037	7126	65987	23333	64411
TBK1.DN.48HRS_DN	M2868		GSE17643	Barbie DA,Tamayo P,Boehm JS,Kim SY,Moody SE,Dunn IF,Schinzel AC,Sandy P,Meylan E,Scholl C,Froehling S,Chan EM,Sos ML,Michel K,Mermel C,Silver SJ,Weir BA,Reiling JH,Sheng Q,Gupta PB,Wadlow RC,Le H,Hoersch S,Wittner BS,Ramaswamy S,Livingston DM,Sabatini DM,Meyerson M,Thomas RK,Lander ES,Mesirov JP,Root DE,Gilliland DG,Jacks T,Hahn WC	GSE17643	AALE-KRAS + shTBK1 vs controls; top 1000 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in epithelial lung cancer cell lines upon over-expression of an oncogenic form of KRAS [Gene ID=3845] gene and knockdown of TBK1 [Gene ID=29110] gene by RNAi.	Profiling of immortalized human lung epithelial cells following oncogenic KRAS expression and TBK1 suppression. The purpose of the dataset is to analyze expression of genes induced by KRAS and regulated by TBK1. The proto-oncogene KRAS is mutated in a wide array of human cancers, most of which are aggressive and respond poorly to standard therapies. Although the identification of specific oncogenes has led to the development of clinically effective, molecularly targeted therapies in some cases, KRAS has remained refractory to this approach. An alternative strategy for targeting KRAS is to identify gene products that, when suppressed or inhibited, result in cell death only in the presence of an oncogenic allele. Here we have used systematic RNA interference (RNAi) to detect synthetic lethal partners of oncogenic KRAS and found that the non-canonical IkB kinase, TBK1, was selectively essential in cells that harbor mutant KRAS. Suppression of TBK1 induced apoptosis specifically in human cancer cell lines that depend on oncogenic KRAS expression. In these cells, TBK1 activated NF-kappaB anti-apoptotic signals involving cREL and BCL-XL that were essential for survival, providing mechanistic insights into this synthetic lethal interaction. These observations identify TBK1 as a potential therapeutic target in KRAS mutant tumors and establish a general approach for the rational identification of co-dependent pathways in cancer. Knock out of TBK1 in the contect of KRAS activation (mutant) and control (WT).					8870	8050	1950	1429	5154	9703	5997	55111	94239	2582	56940	332	1861	2769	5050	1738	9270	5899	51569	64422	8727	1633	51382	55608	4482	8821	596	670	5498	1846	3597	329	1282	6804	10270	8869	5696	54386	5588	80347	8895	5898	5889	983	57761	23	7494	2958	3303	5601
TBK1.DN.48HRS_UP	M2869		GSE17643	Barbie DA,Tamayo P,Boehm JS,Kim SY,Moody SE,Dunn IF,Schinzel AC,Sandy P,Meylan E,Scholl C,Froehling S,Chan EM,Sos ML,Michel K,Mermel C,Silver SJ,Weir BA,Reiling JH,Sheng Q,Gupta PB,Wadlow RC,Le H,Hoersch S,Wittner BS,Ramaswamy S,Livingston DM,Sabatini DM,Meyerson M,Thomas RK,Lander ES,Mesirov JP,Root DE,Gilliland DG,Jacks T,Hahn WC	GSE17643	AALE-KRAS + shTBK1 vs controls; bottom 1000 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in epithelial lung cancer cell lines upon over-expression of an oncogenic form of KRAS [Gene ID=3845] gene and knockdown of TBK1 [Gene ID=29110] gene by RNAi.	Profiling of immortalized human lung epithelial cells following oncogenic KRAS expression and TBK1 suppression. The purpose of the dataset is to analyze expression of genes induced by KRAS and regulated by TBK1. The proto-oncogene KRAS is mutated in a wide array of human cancers, most of which are aggressive and respond poorly to standard therapies. Although the identification of specific oncogenes has led to the development of clinically effective, molecularly targeted therapies in some cases, KRAS has remained refractory to this approach. An alternative strategy for targeting KRAS is to identify gene products that, when suppressed or inhibited, result in cell death only in the presence of an oncogenic allele. Here we have used systematic RNA interference (RNAi) to detect synthetic lethal partners of oncogenic KRAS and found that the non-canonical IkB kinase, TBK1, was selectively essential in cells that harbor mutant KRAS. Suppression of TBK1 induced apoptosis specifically in human cancer cell lines that depend on oncogenic KRAS expression. In these cells, TBK1 activated NF-kappaB anti-apoptotic signals involving cREL and BCL-XL that were essential for survival, providing mechanistic insights into this synthetic lethal interaction. These observations identify TBK1 as a potential therapeutic target in KRAS mutant tumors and establish a general approach for the rational identification of co-dependent pathways in cancer. Knock out of TBK1 in the contect of KRAS activation (mutant) and control (WT).					4891	11319	348	55033	4216	3486	11200	10123	4043	54881	23149	84722	10513	9943	79187	26292	3930	57178	9375	1906	1019	1845	9276	5287	4638	29890	9761	1050	7358	29928	7158	51465	9650	29978	1029	808	55748	54499	6657	54681	2920	6342	780	8731	4850	25805	5747	22889	79643	6390
CORDENONSI_YAP_CONSERVED_SIGNATURE	M2871		22078877	Cordenonsi M,Zanconato F,Azzolin L,Forcato M,Rosato A,Frasson C,Inui M,Montagner M,Parenti AR,Poletti A,Daidone MG,Dupont S,Basso G,Bicciato S,Piccolo S	Cordenonsi_et_al_2011_table_S3	Table 3S			HG-U133A	Pablo Tamayo	Broad Institute	YAP conserved signature.	Cancer stem cells (CSCs) are proposed to drive tumor initiation and progression. Yet, our understanding of the cellular and molecular mechanisms that underlie CSC properties is limited. Here we show that the activity of TAZ, a transducer of the Hippo pathway, is required to sustain self-renewal and tumor-initiation capacities in breast CSCs. TAZ protein levels and activity are elevated in prospective CSCs and in poorly differentiated human tumors and have prognostic value. Gain of TAZ endows self-renewal capacity to non-CSCs. In epithelial cells, TAZ forms a complex with the cell-polarity determinant Scribble, and loss of Scribble--or induction of the epithelial-mesenchymal transition (EMT)--disrupts the inhibitory association of TAZ with the core Hippo kinases MST and LATS. This study links the CSC concept to the Hippo pathway in breast cancer and reveals a mechanistic basis of the control of Hippo kinases by cell polarity					51421	27063	558	80114	332	991	1031	1063	1285	51232	1490	3491	1601	23576	50807	10395	1843	1854	1894	2013	2119	2247	2316	6624	11167	4616	2621	8836	2744	3074	3161	3268	3689	3693	10186	4082	29969	10397	64236	26227	5376	29970	8436	5054	6446	63898	79801	9353	3925	7042	7052	7057	7083	7139	7145	7153	10099
JAK2_DN.V1_DN	M2872			Ebert B		JAK2_sh vs controls; bottom 200 genes			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in HEL cells (erythroleukemia) after knockdown of JAK2 [Gene ID=3717] gene by RNAi.						246126	80035	91694	283131	51336	643314	474170	285189	80215	80079	4297	5991	51380	81698	55525	80100	286053	27071	57235	55680	730394	440270	64577	79159	202181	54799	389177	1937	23015	201163	92106	84786	85021	85459	55591	80174	55104	4603	80012	116829	55917	25879	29044	80154	9884	389634	440345	8526	57466	2550	22995	54516	57730	54808	29065	643328	414777	80167	63971	155060	25956	647357	79800	57238	167153	84820	349152	7091	6447	60412	95681	54441	79854	90233	2069	80005	84629	8420	54816	29060	1621	2897	80055	2825	641807	440423	27308	57018	51616	152100	2913	3204	5021	92249	10003	22909	10773	8504	2564	55052	136227	8034	29068	11000	65981	9623	90338	1826	55243	170960	30062	54507	80022	55521	10903	84851	26263	57835	5820	284266	221078	5205	1001	285231	79917	51303	29931	8777	29021	23731	284040	4249	57711	9852	7350	374977	10011	275	85373	79939	56123	30837	55275	81615	283755	388677	79598	8910	6565	472	51152	56260	728411	51710	1842	9988	64850	22807	7638	91646	57061	9358	10683	4761	57239	54792	6638	11112	162972	23181	6689	56605	25957
JAK2_DN.V1_UP	M2873			Ebert B		JAK2_sh vs controls; top 200 genes			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in HEL cells (erythroleukemia) after knockdown of JAK2 [Gene ID=3717] gene by RNAi.						7776	100288903	25984	2999	3238	51621	2301	56124	5244	2838	10660	5800	6701	1446	2915	6620	3195	2266	881	64122	57047	7051	305	8403	8712	50939	9293	4640	148229	3007	7471	785	1890	64284	8785	6318	735	4222	5670	5949	2323	9215	8735	2688	55565	731	84444	4254	1961	54457	54596	10744	5764	51268	186	3579	4753	79776	9597	2297	1188	79006	1149	9283	3250	2895	54847	7473	54544	5950	85453	90199	1475	80333	3018	10990	1545	2914	10846	650	51190	303	29951	57332	249	79024	6546	653423	81552	8794	9678	23639	2168	6698	8433	1412	11009	100132285	54993	80823	440895	81285	595	10994	10639	64321	6846	1366	9154	10164	3061	9752	3846	22866	8383	6366	10876	89797	6469	22844	1609	53905	1293	117	3891	59347	8999	2707	2584	51310	259217	284217	8468	1003	83481	79974	3231	6693	9229	26018	1009	1756	51052	79723	138046	1758	3605	4107	342538	575	5905	1464	7142	7827	58494	432	2042	79774	926	1288	4161	389715	26281	6935	59	51490	729230	1556	6317	51807	433	9037	2104	26272	11255	29881	9118	26033	9472	56107	9945	221749	59335	79858	11317	3899	3814	9348
KRAS.300_UP.V1_DN	M2874		19847166	Boehm J	GSE17671	AALE-KRAS vs AALE-Vector: top 150 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in four lineages of epithelial cell lines over-expressing an oncogenic form of KRAS [Gene ID=3845] gene.						3860	6278	3851	3868	7051	1014	57007	4842	2053	10964	8687	51214	8581	6699	11254	3834	5275	6707	57825	4600	27202	7068	6236	6664	5790	149628	8541	4908	3351	440895	7226	6531	525	79861	10993	5243	29930	79887	2051	1421	50832	169611	23553	1237	10669	7356	170679	10912	259197	2912	23498	25861	8431	57016	8743	10686	1838	10398	676	7367	57118	25809	54209	3955	79990	79917	8911	3352	29881	867	27254	26083	23242	5158	2633	3451	154661	3848	1521	51754	4261	10913	3963	684	8437	2261	1807	54847	56287	1382	5608	1805	7782	1830	10242	85374	83463	1129	11238	11346	113878	5624	7137	4825	3753	6519	338	10085	92154	50853	55534	54587	258	6876	7104	390998	79883	51087	10584	72	5626	79755	79958	10307	6262	56154	5023	1048	84679	6712	2299	4938	64108	4599	50940	9468	23495	959	388714	3218	3786	26353	4586
KRAS.300_UP.V1_UP	M2875		19847166	Boehm J	GSE17671	AALE-KRAS vs AALE-Vector: top 150 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in four lineages of epithelial cell lines over-expressing an oncogenic form of KRAS [Gene ID=3845] gene.						3598	2	6447	9173	3673	25758	2254	50486	793	3290	4897	9732	9892	6781	27112	1780	10402	1038	6616	51129	2115	50863	4320	2745	5950	3689	2119	5178	5649	3080	55885	23462	7015	79168	10170	909	101	284266	2731	3800	5473	29106	3249	5100	3363	1114	6374	2170	1081	202018	83447	54207	6035	6857	5138	8715	84436	401034	4888	79846	23676	2921	51270	2123	10089	55515	55466	55859	10083	83478	2828	477	3798	1848	5959	131566	8728	2118	1496	57733	2903	653127	89795	5602	1113	8382	347	288	6252	6324	1440	10253	10371	1056	4168	55107	3757	1084	5121	4674	290	4312	54752	10231	26052	55117	6653	147343	1673	9358	202181	11184	2554	1656	23143	8851	60489	167	26059	58528	64800	27098	56729	2556	57829	6326	28951	81796	2842	136227	460	27324	1621	92552	8348	7476	3037	7681	55521	6696	7035	26212	5806	634	339524	10394
KRAS.50_UP.V1_DN	M2876		19847166	Boehm J	GSE17671	AALE-KRAS vs AALE-Vector: top 25 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in four lineages of epithelial cell lines over-expressing an oncogenic form of KRAS [Gene ID=3845] gene.						3860	6278	3851	3868	7051	1014	57007	4842	2053	10964	8687	51214	8581	6699	11254	3834	5275	6707	57825	4600	27202	7068	6236	6664	5790	149628	8541	4908	3351	440895	7226	6531	525	79861	10993	5243	29930	79887	2051	1421	50832	169611	23553	1237	10669	7356	170679	10912	259197
KRAS.50_UP.V1_UP	M2878		19847166	Boehm J	GSE17671	AALE-KRAS vs AALE-Vector: top 25 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in four lineages of epithelial cell lines over-expressing an oncogenic form of KRAS [Gene ID=3845] gene.						3598	2	6447	9173	3673	25758	2254	50486	793	3290	4897	9732	9892	6781	27112	1780	10402	1038	6616	51129	2115	50863	4320	2745	5950	3689	2119	5178	5649	3080	55885	23462	7015	79168	10170	909	101	284266	2731	3800	5473	29106	3249	5100	3363	1114	6374	2170
KRAS.600_UP.V1_DN	M2880		19847166	Boehm J	GSE17671	AALE-KRAS vs AALE-Vector: top 300 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in four lineages of epithelial cell lines over-expressing an oncogenic form of KRAS [Gene ID=3845] gene.						3860	6278	3851	3868	7051	1014	57007	4842	2053	10964	8687	51214	8581	6699	11254	3834	5275	6707	57825	4600	27202	7068	6236	6664	5790	149628	8541	4908	3351	440895	7226	6531	525	79861	10993	5243	29930	79887	2051	1421	50832	169611	23553	1237	10669	7356	170679	10912	259197	2912	23498	25861	8431	57016	8743	10686	1838	10398	676	7367	57118	25809	54209	3955	79990	79917	8911	3352	29881	867	27254	26083	23242	5158	2633	3451	154661	3848	1521	51754	4261	10913	3963	684	8437	2261	1807	54847	56287	1382	5608	1805	7782	1830	10242	85374	83463	1129	11238	11346	113878	5624	7137	4825	3753	6519	338	10085	92154	50853	55534	54587	258	6876	7104	390998	79883	51087	10584	72	5626	79755	79958	10307	6262	56154	5023	1048	84679	6712	2299	4938	64108	4599	50940	9468	23495	959	388714	3218	3786	26353	4586	5657	64137	1562	3881	3442	8350	3449	5650	1158	55277	363	7200	6698	3111	79799	1271	3872	8857	100288903	9547	9073	79822	10590	1557	25770	1750	29949	1828	54739	29760	199731	64919	54328	1907	27240	9022	401466	56100	2797	80125	22924	80163	6504	7042	317781	10825	948	2249	9172	3965	151	1464	27113	9369	710	3224	81030	731	5794	79782	3779	11279	79056	80020	28815	644872	57399	1280	23396	55025	1906	57110	11255	55258	51806	7704	2049	11314	3567	43849	80144	6332	7056	9808	6336	55432	51384	5625	27076	4814	2813	5287	1258	10882	23591	30848	54558	55867	2315	10407	1146	51274	56999	8993	389136	79097	10451	7710	810	10004	54967	27293	50508	2847	79839	5409	54848	9970	8647	57523	417	9635	27063	797	6524	3613	5167	10268	50489	79820	57124	9293	26998	1269	4147	23031	80833	55315	80174	1472	489	4543	10076	65989	2350	3713
KRAS.600_UP.V1_UP	M2882		19847166	Boehm J	GSE17671	AALE-KRAS vs AALE-Vector: top 300 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in four lineages of epithelial cell lines over-expressing an oncogenic form of KRAS [Gene ID=3845] gene.						3598	2	6447	9173	3673	25758	2254	50486	793	3290	4897	9732	9892	6781	27112	1780	10402	1038	6616	51129	2115	50863	4320	2745	5950	3689	2119	5178	5649	3080	55885	23462	7015	79168	10170	909	101	284266	2731	3800	5473	29106	3249	5100	3363	1114	6374	2170	1081	202018	83447	54207	6035	6857	5138	8715	84436	401034	4888	79846	23676	2921	51270	2123	10089	55515	55466	55859	10083	83478	2828	477	3798	1848	5959	131566	8728	2118	1496	57733	2903	653127	89795	5602	1113	8382	347	288	6252	6324	1440	10253	10371	1056	4168	55107	3757	1084	5121	4674	290	4312	54752	10231	26052	55117	6653	147343	1673	9358	202181	11184	2554	1656	23143	8851	60489	167	26059	58528	64800	27098	56729	2556	57829	6326	28951	81796	2842	136227	460	27324	1621	92552	8348	7476	3037	7681	55521	6696	7035	26212	5806	634	339524	10394	6804	7852	2861	650293	9038	6935	25960	4318	1358	27179	2116	390616	55853	9705	3764	5617	8309	4319	6795	7424	7052	9966	1447	29114	10687	2672	55079	63978	5743	7850	9196	57711	9228	1839	23268	4916	54825	941	9271	401525	2012	9953	3777	6926	7166	11082	495	7805	1136	3445	3481	3746	9047	79844	1670	2791	5382	51311	1501	4110	10123	11155	6690	51085	51286	28231	5327	3815	79686	1240	4618	4993	5207	25907	8811	23321	29048	1438	84754	655	5328	23531	3624	1594	2670	80183	8829	3741	2911	55613	6304	28986	3706	248	4326	54769	6585	259	56891	22998	4477	54886	3902	400451	4336	23574	3018	2324	57161	8013	11320	7099	80263	3769	5101	79949	2841	1846	8605	80008	651803	2020	7258	90133	6662	50487	23233	79616	114897	23057	1235	51308	114793	80188	64577	9404	117	8896	7368	64084	2290
KRAS.600.LUNG.BREAST_UP.V1_DN	M2885			Boehm J		AALE-KRAS vs AALE-Vector: top 300 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in epithelial lung and breast cancer cell lines over-expressing an oncogenic form of KRAS [Gene ID=3845] gene.						8581	3860	23031	1954	525	6278	7104	2053	51806	79953	5158	3713	6712	5023	79097	1010	57016	7137	10249	338	5275	3851	10398	79400	80761	6519	55610	10268	3868	1838	25840	440895	10912	169611	54587	57124	2261	7051	5608	29799	3351	6664	9547	242	7252	259197	25809	5287	7226	79148	5139	1672	258	80162	3635	810	54847	6332	10451	83463	79957	5896	4842	57007	8687	10716	9472	113878	10039	27165	9635	417	948	1280	1805	27063	29930	50832	80144	10964	25806	1290	5087	610	80070	5624	3568	642671	100288903	119	5816	8350	85374	653423	3963	64108	3779	4908	27202	51214	55084	9073	84991	114088	1589	2593	3834	2321	388714	3449	4524	2015	64097	3965	3485	55258	79887	221078	51156	8743	154661	923	283345	64167	23242	10086	6261	2668	7915	3354	57523	1382	623	10076	797	6536	10665	8739	8578	6559	8911	5919	79635	2557	1014	676	79958	4625	5540	23129	2246	8424	10242	10297	2812	79085	3848	5737	59335	55150	51704	4814	64066	1360	129080	10004	9413	3595	11191	51206	84223	9755	1410	8842	79661	55776	26290	4261	55534	5126	9844	1807	26261	7306	79175	10686	79799	3579	25861	85359	57604	7781	9742	1310	6336	54441	6283	54875	55028	22999	6317	9843	11279	8991	2633	5795	8541	55277	50489	4214	8809	7356	2811	26083	3592	5458	23500	5076	79703	957	9149	6531	80833	79839	5818	3567	79166	51316	710	11238	79755	346157	8499	140	4760	79725	3745	1381	79986	25770	11118	7059	8086	3050	10993	41	9172	6401	22829	50509	90993	55799	644974	50616	5920	51087	149628	3613	30819	54993	3213	1750	25794	1158	58510	25893	51754	54474	921	79961	170679	100507605	56603	2619	1133	63904	64975	2890	22914	79852	2634	56154	43849	6457	3950	26291	8303	8736	3352
KRAS.600.LUNG.BREAST_UP.V1_UP	M2886			Boehm J		AALE-KRAS vs AALE-Vector: top 300 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in epithelial lung and breast cancer cell lines over-expressing an oncogenic form of KRAS [Gene ID=3845] gene.						9173	3598	3290	5473	6447	6374	4319	4312	1440	89795	29114	3885	11082	5138	27178	23676	5950	3294	57829	6690	7850	10170	101	50486	3624	56729	266	2920	1839	654	909	2672	60598	3249	639	2113	54752	2921	2745	7015	27112	5649	6781	54544	3976	27158	3445	6616	9966	3673	54744	1041	3576	2828	4318	3747	4901	3798	51454	27434	64084	79368	29044	6035	4620	2919	1496	3669	793	6192	9971	10253	51561	6364	401034	7462	1770	3770	9732	8728	3706	26212	5646	51129	23762	11155	10402	5801	57733	28231	3237	1437	7128	919	3746	1135	28424	6926	3800	83447	4753	81796	7185	9038	2556	1235	25758	1208	9892	55001	29948	11174	2922	951	4879	208	3037	1084	2	57821	3486	9081	196475	51270	27288	80380	5617	2995	79168	400451	11343	7681	10103	7258	7869	330	856	50863	1240	5743	3398	6473	83734	51193	9047	92552	5959	250	3884	9590	4066	191585	54866	1780	284266	23643	9196	2118	64663	3553	4803	10394	28959	4151	54596	25879	84754	148066	26272	731568	25960	23645	7139	9271	81789	5396	1299	2203	10648	10089	27179	4914	3741	160518	5329	3231	131566	9313	643314	6528	55107	2123	7399	4324	7035	5602	7476	51032	55753	1649	383	25907	81849	54490	80008	9734	3902	50487	6689	79846	3080	10319	4023	100129271	201191	79446	2324	55507	10371	3972	4653	80128	2903	6804	6755	50856	6367	150160	10744	27324	83478	54954	9435	64321	650	6425	6855	646649	668	2527	2826	112939	3090	4105	1673	4868	4618	4796	9024	55613	79891	5740	8877	63978	5365	347240	9353	202018	51179	57101	495	5645	6663	4684	11009	2791	3757	3284	4477	80263	786	7471	11283	51816	4110	8190	7122	83483	10316	4897	910	2670	79981	79999	11126	6276	3617	56891
KRAS.BREAST_UP.V1_DN	M2887			Boehm J		AALE-KRAS vs AALE-Vector: top 150 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in epithelial breast cancer cell lines over-expressing an oncogenic form of  KRAS [Gene ID=3845] gene.						79957	5243	79625	525	5454	23031	4842	7104	1838	5023	957	2053	113878	644974	6332	79635	3215	9172	5139	9746	4908	5818	11191	283345	341651	10912	55693	154661	114088	284001	80162	100129482	7137	417	79953	1807	10993	79799	9113	29799	338	1961	4776	11096	10085	4881	80852	5027	2812	3738	23554	80070	25770	1392	80833	242	610	55262	54785	259197	253982	27165	10086	80144	6712	8809	8687	5737	51156	9073	10665	3834	10268	51352	10004	51162	41	55084	11279	56667	710	5626	3449	1010	79887	29930	1954	10398	3250	55277	4524	51050	51013	56154	1381	5129	84679	79961	79400	3760	9899	27063	773	2261	11238	8991	797	57348	8048	27293	8368	7781	84991	84694	1805	54847	64174	7252	8536	440925	4625	3786	26584	2268	5087	10333	1589	388714	3050	9942	6546	1421	51206	5197	442258	2559	27343	2701	5158	55534	3903	22843	1290	7032	9844
KRAS.BREAST_UP.V1_UP	M2888			Boehm J		AALE-KRAS vs AALE-Vector: top 150 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in epithelial breast cancer cell lines over-expressing an oncogenic form of KRAS [Gene ID=3845] gene.						9173	3486	10170	57829	5473	54544	4319	7850	9971	27178	6690	11082	6447	64084	29114	11141	1041	3294	55466	60598	3290	3798	3037	5138	9038	639	654	4778	479	3885	201191	266	1208	4861	5396	711	4318	3747	3884	1299	3744	250	7399	51454	23676	2	4613	6855	3976	5653	64321	29044	1437	83445	9283	643314	6360	347240	2116	3770	55540	3069	11343	8000	8329	3737	2672	440334	1946	56105	43849	56649	2327	55	1215	347088	1240	2921	2745	793	4993	2556	650594	7185	8938	1673	79168	3777	6701	79368	51554	3481	2703	652159	51311	5596	9196	401525	3561	57091	634	10253	1084	7035	3553	4948	51700	5140	23645	9590	4066	10417	3773	159162	5545	330	646649	1297	645784	29948	29064	6276	27112	6804	4901	80217	6616	81833	2920	56901	3598	196475	6781	202018	57101	7128	51384	8796	58503	7681	55365	6367	27299	4879	7015	1496
KRAS.KIDNEY_UP.V1_DN	M2889				Broad KRAS (J. Boehm)	AALE-KRAS vs AALE-Vector: top 150 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in epithelial kidney cancer cell lines over-expressing an oncogenic form of KRAS [Gene ID=3845] gene.						54209	4879	91543	6528	3955	10763	3872	10964	10110	3627	51561	13	7068	5626	4599	23046	5790	390892	2113	8329	6953	4938	9242	3451	10307	5553	929	2918	399904	1907	8808	867	2914	7056	79802	23612	181	50853	5133	3169	3991	51162	55801	4803	401466	79748	25988	6373	1636	9970	2350	80760	3816	6262	6364	650488	80111	3849	150244	3641	10407	8676	70	570	11006	28875	79782	10942	4600	57451	6943	57825	1830	253190	23553	2912	8712	55220	51274	1473	10753	3750	5732	83887	80303	283871	2069	1129	9681	10022	3754	6492	23439	55025	6550	84789	2859	7123	255057	1071	83450	3780	54558	10850	4109	2044	8647	79574	652	3569	4188	390998	10437	54829	54716	779	21	9719	676	6865	3294	23547	55584	3273	1264	7305	9427	1436	79644	10317	64170	2626	9037	1146	29881	25956	23149	317781	64106	6714	5923	856
KRAS.KIDNEY_UP.V1_UP	M2892				Broad KRAS (J. Boehm)	AALE-KRAS vs AALE-Vector: top 150 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in epithelial kidney cancer cell lines over-expressing an oncogenic form of KRAS [Gene ID=3845] gene.						2254	1038	6252	4897	5121	2628	2115	9892	6414	29106	26289	6653	25840	477	4747	5178	8851	288	57088	9358	57161	55885	9745	9899	5354	5375	56253	4692	2	2012	793	114088	8404	2823	7504	1780	23236	2554	107	1114	285189	1410	51440	81617	2560	26059	5101	140597	2861	284266	2915	1113	760	51617	10529	23321	7102	10402	287	3800	55117	23462	2891	9865	6857	6422	7111	6304	6616	894	6507	10231	55190	2642	9053	6324	202134	10687	6014	26952	23302	26052	10457	51299	1656	2570	57468	55084	27065	361	5334	10205	4208	10777	8382	4674	216	10580	22998	2104	1848	11069	7976	5649	9378	10382	28951	2898	3741	23057	2842	5175	1363	3815	1428	79846	10896	2558	147343	6559	6447	55328	2691	6326	64066	8715	9935	23136	55273	443	9228	28986	26958	6529	2731	2596	5274	51704	7434	401034	2571	11197	22849	1356	3764
KRAS.LUNG_UP.V1_DN	M2893				Broad KRAS (J. Boehm)	AALE-KRAS vs AALE-Vector: bot 150 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in epithelial lung cancer cell lines over-expressing an oncogenic form of KRAS [Gene ID=3845] gene.						8581	6278	3713	3851	43849	3868	1014	51806	6707	3963	3860	9547	23242	5275	6317	57016	5608	6283	7051	5650	55	10631	8424	1410	11254	9935	57124	3635	64108	1954	653326	5287	23616	3351	3848	27113	79755	170679	1672	5625	23498	6261	1280	2215	129080	169611	51384	57399	57523	22802	282808	51458	10076	79097	79696	8852	11202	10249	4804	200315	79644	2327	1028	27076	8608	8578	26290	11012	222	8399	5158	1382	56603	6318	3485	7441	729230	3866	10451	55776	8495	9472	440895	810	6519	3549	1310	54587	1562	2619	2560	6457	79703	8743	23493	29953	3352	1580	6444	6536	11063	25840	933	339457	80761	867	643641	55610	81628	79132	6336	54441	119	100507605	27136	3587	1133	5624	5676	43	9651	778	2049	2078	4004	8392	4214	8842	79725	10457	7018	11250	6981	140	4161	5896	11341	5064	29986	1010	2668	7356	5540	6712	79969
KRAS.LUNG_UP.V1_UP	M2897				Broad KRAS (J. Boehm)	AALE-KRAS vs AALE-Vector: top 150 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in epithelial lung cancer cell lines over-expressing an oncogenic form of KRAS [Gene ID=3845] gene.						3598	6374	4312	9173	3290	1440	4753	89795	4868	4105	3624	3800	919	51032	5950	50486	57733	55753	26018	26272	10103	3249	27434	54752	146712	10806	3445	79981	51129	6538	6570	28959	1670	2113	6447	56729	50863	7139	5593	9508	719	2170	10402	100289255	101	9746	78995	51816	6795	81796	50856	157627	2527	5801	11155	401034	388567	909	55001	2903	51162	1524	5649	6926	4504	6364	50834	3804	685	150160	79846	55107	284266	3673	9955	83734	1839	1573	25758	27158	941	9595	54575	25907	6407	5243	3576	9047	11283	3104	51193	51561	3547	3718	80852	56157	4803	117	3237	962	2123	6532	4620	23676	6035	3741	54866	1482	23098	131566	2827	80380	433	55821	7476	10320	208	9313	3363	23539	1409	597	55024	5078	26212	116828	10763	28231	3902	55565	1794	27253	8829	9732	79625	10859	7258	29068	79940	5999	10394
KRAS.LUNG.BREAST_UP.V1_DN	M2898				Broad KRAS (J. Boehm)	AALE-KRAS vs AALE-Vector: top 300 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in epithelial breast cancer cell lines over-expressing an oncogenic form of  KRAS [Gene ID=3845 gene].						8581	3860	23031	1954	525	6278	7104	2053	51806	79953	5158	3713	6712	5023	79097	1010	57016	7137	10249	338	5275	3851	10398	79400	80761	6519	55610	10268	3868	1838	25840	440895	10912	169611	54587	57124	2261	7051	5608	29799	3351	6664	9547	242	7252	259197	25809	5287	7226	79148	5139	1672	258	80162	3635	810	54847	6332	10451	83463	79957	5896	4842	57007	8687	10716	9472	113878	10039	27165	9635	417	948	1280	1805	27063	29930	50832	80144	10964	25806	1290	5087	610	80070	5624	3568	642671	100288903	119	5816	8350	85374	653423	3963	64108	3779	4908	27202	51214	55084	9073	84991	114088	1589	2593	3834	2321	388714	3449	4524	2015	64097	3965	3485	55258	79887	221078	51156	8743	154661	923	283345	64167	23242	10086	6261	2668	7915	3354	57523	1382	623	10076	797	6536	10665	8739	8578	6559	8911	5919	79635	2557	1014
KRAS.LUNG.BREAST_UP.V1_UP	M2900				Broad KRAS (J. Boehm)	AALE-KRAS vs AALE-Vector: top 300 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in epithelial lung and breast cancer cell lines over-expressing an oncogenic form of KRAS [Gene ID=3845] gene.						9173	3598	3290	5473	6447	6374	4319	4312	1440	89795	29114	3885	11082	5138	27178	23676	5950	3294	57829	6690	7850	10170	101	50486	3624	56729	266	2920	1839	654	909	2672	60598	3249	639	2113	54752	2921	2745	7015	27112	5649	6781	54544	3976	27158	3445	6616	9966	3673	54744	1041	3576	2828	4318	3747	4901	3798	51454	27434	64084	79368	29044	6035	4620	2919	1496	3669	793	6192	9971	10253	51561	6364	401034	7462	1770	3770	9732	8728	3706	26212	5646	51129	23762	11155	10402	5801	57733	28231	3237	1437	7128	919	3746	1135	28424	6926	3800	83447	4753	81796	7185	9038	2556	1235	25758	1208	9892	55001	29948	11174	2922	951	4879	208	3037	1084	2	57821	3486	9081	196475	51270	27288	80380	5617	2995	79168	400451	11343	7681	10103	7258	7869	330	856	50863	1240	5743	3398	6473	83734	51193	9047
KRAS.PROSTATE_UP.V1_DN	M2901				Broad KRAS (J. Boehm)	AALE-KRAS vs AALE-Vector: bot 150 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in epithelial prostate cancer cell lines over-expressing an oncogenic form of KRAS [Gene ID=3845] gene.						6236	6698	6278	6707	6699	3868	3851	3486	7051	5243	23242	4060	1014	1271	6279	383	3860	10825	79861	259197	10382	51725	9935	56521	7704	29949	3381	10661	9245	55184	1510	3934	1950	5266	2826	3737	1421	57007	4842	10125	3818	4978	962	4868	6649	8431	79917	26548	5020	79809	28815	23769	10044	23236	5740	57118	3695	5657	727	9737	7782	79879	26289	51087	1906	64137	8745	4908	80704	148229	199731	11254	9498	56287	285189	3785	10584	26285	2306	79611	79822	1408	348035	55607	10669	2051	7021	10225	4693	6876	65012	3040	100129271	3973	11238	3069	2832	9077	5745	6663	5197	3425	94009	79755	2793	25770	3426	10993	2053	51326	10777	4585	79656	4129	79831	9628	56123	10457	5167	6754	3770	85374	80157	7429	5794	94025	9808	3109	5454	6608	8710	2315	219595	9081	23417	9625	65055	8796	5055	7200	2912	434	10743	389136
KRAS.PROSTATE_UP.V1_UP	M2902				Broad KRAS (J. Boehm)	AALE-KRAS vs AALE-Vector: top 150 genes (diff. of means)			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in epithelial prostate cancer cell lines over-expressing an oncogenic form of KRAS [Gene ID=3845] gene.						60489	10763	51308	3026	57379	1056	2119	3689	27010	27112	4326	4320	4004	973	7099	1380	5166	27006	89944	90204	3673	79187	7180	10737	5284	79807	57711	55024	7805	25758	6801	350	10170	197	856	54714	2869	6376	7038	53942	90133	4888	4648	645340	167	26873	8689	8928	51129	54886	79168	7291	6003	3642	651803	6861	80201	93664	79575	4214	3575	8715	151050	136227	51807	3904	57799	79924	7079	26648	23143	7135	51716	64130	120227	11074	941	7046	26291	11184	3075	78995	147	80774	1759	5919	92552	3034	79875	29799	23617	8309	6935	8013	53919	816	65250	51702	6555	9638	1954	51090	390616	58494	8808	10219	1136	79747	56146	2295	131578	56158	22987	2022	23520	440334	79412	83478	3444	51085	3080	64091	6545	26476	55853	2170	2243	80759	26960	5778	9651	171024	55415	8535	1002	3587	4653	79686	4114	25924	7424	11248	5540
LEF1_UP.V1_DN	M2903			Medici D,Hay E,Olsen B	GSE3229	DLD1+LEF-1 vs DLD1; bottom 150 genes			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes down-regulated in DLD1 cells (colon carcinoma) over-expressing LEF1 [Gene ID=51176].	We treated DLD1 cells with an adenoviral LEF-1 expression construct, which induced EMT within 48 hours. RNA was then extracted from these cells along with untreated DLD1 cells, then subjected to microarray analysis.					10551	3399	3606	6414	8991	1015	5652	79153	64167	7103	64757	10595	57111	10758	725	4832	9060	202	6374	23423	2947	5352	79176	54502	4973	23708	1266	5121	1045	55655	55008	4938	25924	57402	54682	5308	5157	6447	4940	56155	7098	8226	6928	8549	1803	4089	8790	1512	22998	1080	54716	6456	3815	54930	481	1371	10919	54795	23312	1545	2581	3784	4300	56603	79873	5874	55540	7504	3169	1573	5627	64699	956	6364	9961	4208	1999	1612	4126	3823	2920	5002	79170	64172	9781	6653	55034	64762	80237	80736	2888	2627	9966	10053	79932	8507	7915	80221	51479	28978	487	4071	10396	26298	25956	5783	3397	1948	50853	11274	54985	214	5196	9982	55314	1809	79639	7168	10401	7031	8644	80303	57088	79695	54474	25837	56034	10158	847	55684	6505	83989	1690	6819	6775	57235	1490	54809	10384	8284	54463	221078	5880	7134	51703	5644	624	288	90865	23221	5950	29969	53832	51573	1666	27012	10103	79762	79694	51316	4240	6405	51257	5058	6451	7552	9187	84786	23586	64759	1018	11162	10924	51149	56898	1363	83463	23596	29121	51348	65084	10481	51626	11223	27185	54854	9338	10325	85458	51090
LEF1_UP.V1_UP	M2905			Medici D,Hay E,Olsen B	GSE3229	DLD1+LEF-1 vs DLD1; top 150 genes			HUMAN_GENE_SYMBOL	Pablo Tamayo	Broad Institute	Genes up-regulated in DLD1 cells (colon carcinoma) over-expressing LEF1 [Gene ID=51176].	We treated DLD1 cells with an adenoviral LEF-1 expression construct, which induced EMT within 48 hours. RNA was then extracted from these cells along with untreated DLD1 cells, then subjected to microarray analysis.					5947	4753	4478	25984	3490	3852	894	55107	60481	5360	1396	2295	80723	10202	5551	7052	10974	79097	9201	3897	347733	50486	8572	3040	3002	7431	112464	875	3887	50515	115290	1627	29015	28984	5080	4923	27121	7535	2290	23363	4005	2273	63910	2248	56937	3860	10810	64220	1299	10913	6701	5172	3212	3037	978	864	8614	3956	23612	4128	64170	6515	8190	2908	58528	7570	7490	6273	59348	4016	2791	27344	83729	5054	558	6585	60489	2020	2786	2012	56675	6526	393	1960	5154	6322	79686	7776	9590	23037	6274	26053	6261	9047	23237	8061	3932	1236	10742	23414	3768	9829	4023	8728	1029	3303	79958	4129	2318	9936	22943	79156	5799	3755	9032	3992	7852	56967	2335	83604	9435	3783	7693	51177	1382	5631	51393	4237	2014	79865	6275	5730	2254	8530	10620	10149	4131	100288413	51477	7474	7111	1291	1491	115207	90273	8204	1959	384	4053	79901	51678	10763	2774	30817	6331	23493	51350	5563	54913	23057	4920	7054	3489	2625	3589	11095	3579	25907	23048	1114	5630	4295	7133	655	9486	64838	7062	7288	80014	10398	6919	55821	2705	2258	6535	79649	55503	10266	64097	29780	10683	5125	57161	24147	2004
